{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Title\n",
    "[]()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import sys\n",
    "import os\n",
    "sys.path.append(r\"C:\\Users\\silvh\\OneDrive\\lighthouse\\custom_python\")\n",
    "sys.path.append(r\"C:\\Users\\silvh\\OneDrive\\lighthouse\\Ginkgo coding\\content-summarization\\src\")\n",
    "from file_functions import *\n",
    "import time\n",
    "import re\n",
    "from itertools import product\n",
    "import openai\n",
    "\n",
    "from response_processing import *\n",
    "from article_processing import create_text_dict_from_folder\n",
    "import traceback\n",
    "from file_functions import *\n",
    "from summary_chain import *"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# set the option to wrap text within cells\n",
    "pd.set_option('display.max_colwidth', 100)\n",
    "pd.set_option('display.max_rows', 20)\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.width', None)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Set up"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "chatbot_dict = dict()\n",
    "simple_summaries_dict = dict()\n",
    "relevance_dict = dict()\n",
    "chain_results_dict = dict()\n",
    "qna_dict = dict()\n",
    "texts = dict()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Keys for text_dict: dict_keys([])\n",
      "\n",
      "Time completed: 2023-06-15 17:22:06.032058\n",
      "Dictionary keys: [0, 1, 2, 3, 4, 5, 6, 7, 8, 9]\n"
     ]
    }
   ],
   "source": [
    "# Create text dictionary\n",
    "folder_path = '../web_articles/' # ** UPDATE REQUIRED**\n",
    "text_id = 0\n",
    "\n",
    "encoding='ISO-8859-1'\n",
    "subset=None\n",
    "\n",
    "texts[text_id] = create_text_dict_from_folder(folder_path, encoding=encoding, subset=subset)\n",
    "text_dict = texts[text_id]\n",
    "\n",
    "main_text = dict()\n",
    "main_text[text_id] = loadpickle('text_dict_from_web2023-06-15_1057.sav', folder_path)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## text_id = 1 : text_dict with first 2 of 9 articles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys([0, 1])"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_id = 1\n",
    "main_text[text_id] = dict()\n",
    "for article in main_text[0]:\n",
    "    if article < 2:\n",
    "        main_text[text_id][article] = main_text[0][article]\n",
    "main_text[text_id].keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Trend of risk and correlates of under-five child undernutrition in Bangladesh: an analysis based on Bangladesh Demographic and Health Survey data, 2007–2017/2018\\n\\n<div class=\"panel-panel panel-col\">\\n    <div><div class=\"panel-pane pane-highwire-markup author-affiliates col-narrow-12 author-affiliates-corresp article\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div xmlns:xhtml=\"http://www.w3.org/1999/xhtml\" class=\"contributors\"><ol class=\"contributor-list\" id=\"contrib-group-1\"><li class=\"contributor\" id=\"contrib-1\"><a href=\"http://orcid.org/0000-0002-6002-2100\" class=\"bmjj-markup-orcid-logo\" target=\"_blank\">http://orcid.org/0000-0002-6002-2100</a><span class=\"name\">Md Tahidur Rahman</span><a id=\"xref-aff-1-1\" class=\"xref-aff\" href=\"#aff-1\">1</a><span class=\"xref-sep\">,</span><a id=\"xref-aff-2-1\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"contributor\" id=\"contrib-2\"><span class=\"name\">Md Jahangir Alam</span><a id=\"xref-aff-2-2\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"contributor\" id=\"contrib-3\"><span class=\"name\">Noyon Ahmed</span><a id=\"xref-aff-2-3\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"contributor\" id=\"contrib-4\"><span class=\"name\">Dulal Chandra Roy</span><a id=\"xref-aff-2-4\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"last\" id=\"contrib-5\"><span class=\"name\">Papia Sultana</span><a id=\"xref-aff-2-5\" class=\"xref-aff\" href=\"#aff-2\">2</a></li></ol><ol class=\"affiliation-list\"><li class=\"aff\"><a id=\"aff-1\" name=\"aff-1\"></a><address><sup>1</sup><span class=\"institution\">Department of Statistics</span>, <span class=\"institution\">Islamic University</span>, <span class=\"addr-line\">Kushtia</span>, Bangladesh</address></li><li class=\"aff\"><a id=\"aff-2\" name=\"aff-2\"></a><address><sup>2</sup><span class=\"institution\">Department of Statistics</span>, <span class=\"institution\">University of Rajshahi</span>, <span class=\"addr-line\">Rajshahi</span>, Bangladesh</address></li></ol><ol class=\"corresp-list\"><li class=\"corresp\" id=\"corresp-1\"><span class=\"corresp-label\">Correspondence to</span> Md Tahidur Rahman; <span class=\"em-link\"><span class=\"em-addr\">tahidur.iu{at}gmail.com</span></span></li></ol></div></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup abstract-with-bc\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"content-block\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div class=\"article abstract-view \"><span class=\"highwire-journal-article-marker-start\"></span><div class=\"section abstract\" id=\"abstract-1\"><h2>Abstract</h2><div id=\"sec-1\" class=\"subsection\"><p id=\"p-2\"><strong>Objectives</strong> The objectives of this study are to identify the trend of undernutrition risk among under-five children (U5C) in Bangladesh and the trend of its correlates.</p></div><div id=\"sec-2\" class=\"subsection\"><p id=\"p-3\"><strong>Design</strong> Multiple cross-sectional data sets from different time points were used.</p></div><div id=\"sec-3\" class=\"subsection\"><p id=\"p-4\"><strong>Setting</strong> Nationally representative Bangladesh Demographic and Health Surveys (BDHSs) were conducted in 2007, 2011, 2014 and 2017/2018.</p></div><div id=\"sec-4\" class=\"subsection\"><p id=\"p-5\"><strong>Participants</strong> In the BDHSs, the sample sizes for ever-married women (age: 15–49 years) were 5300 in 2007, 7647 in 2011, 6965 in 2014 and 7902 in 2017/2018.</p></div><div id=\"sec-5\" class=\"subsection\"><p id=\"p-6\"><strong>Outcomes</strong> Extant indicators of undernutrition (stunted, wasted and underweight) have been considered as the outcome variables.</p></div><div id=\"sec-6\" class=\"subsection\"><p id=\"p-7\"><strong>Materials and methods</strong> Descriptive statistics, bivariate analysis and factor loadings from factor analysis have been used to determine the prevalence of undernutrition over the years and find the trend of risk and its correlates.</p></div><div id=\"sec-7\" class=\"subsection\"><p id=\"p-8\"><strong>Results</strong> Risks of stunting among the U5C were 41.70%, 40.67%, 36.57% and 31.14%; that of wasting were 16.94%, 15.48%, 14.43% and 8.44%; and that of underweight were 39.79%, 35.80%, 32.45% and 22.46% in 2007, 2011, 2014 and 2017/2018, respectively. From the factor analysis, it has been found that the top five potential correlates of undernutrition are the wealth index, the education of the father and mother, the frequency of antenatal visits during pregnancy, the father’s occupation and/or the type of place of residence in the last four consecutive surveys.</p></div><div id=\"sec-8\" class=\"subsection\"><p id=\"p-9\"><strong>Conclusion</strong> This study helps us gain a better understanding of the impact of the top correlates on child undernutrition. To accelerate the reduction of child undernutrition more by 2030, Government and non-government organisations should focus on improving education and household income-generating activities among poor households and raising awareness among women about the importance of receiving antenatal care during pregnancy.</p></div></div><ul class=\"kwd-group\"><li class=\"kwd\">public health</li><li class=\"kwd\">paediatrics</li><li class=\"kwd\">nutrition &amp; dietetics</li></ul><div class=\"section data-availability\" id=\"sec-22\"><h2 class=\"\">Data availability statement</h2><p id=\"p-65\">No data are available. Data are available in a public, open access repository. Data are available upon reasonable request.</p></div><div class=\"license\" id=\"license-1\"><span class=\"ali-license-ref\"><a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a></span><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:\\xa0<a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p></div><span class=\"highwire-journal-article-marker-end\"></span></div><span class=\"related-urls\"></span></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-dfp-pane oas-ads oas-ads-mid pull-right\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div id=\"dfp-ad-mpu-wrapper\" class=\"dfp-tag-wrapper\">\\n\\n<div id=\"dfp-ad-mpu\" class=\"dfp-tag-wrapper\">\\n  <script type=\"text/javascript\">\\n    googletag.cmd.push(function() {\\n      googletag.display(\"dfp-ad-mpu\");\\n    });\\n  </script>\\n</div>\\n</div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-custom pane-3\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-070480\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-070480</a></p>\\n  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-altmetrics\">\\n  \\n        <h2 class=\"pane-title\">Statistics from Altmetric.com</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div data-badge-details=\"right\" data-badge-type=\"medium-donut\" data-doi=\"10.1136/bmjopen-2022-070480\" data-hide-no-mentions=\"true\" class=\"altmetric-embed\"></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-bmjj-jumplinks\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-list-wrapper\"><div class=\"highwire-list\"><ul></ul></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-custom pane-4 permissions-box\">\\n  \\n        <h2 class=\"pane-title\">Request Permissions</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p>\\n  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-panels-ajax-pane-content permissions-box pane-highwire-permission-link\" id=\"request-permissions\">\\n  \\n        <h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"panels-ajax-pane panels-ajax-pane-new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div class=\"article fulltext-view \"><span class=\"highwire-journal-article-marker-start\"></span><ul class=\"kwd-group\"><li class=\"kwd\"><a href=\"/keyword/public-health\" class=\"hw-term hw-article-keyword hw-article-keyword-public-health\" rel=\"nofollow\">public health</a></li><li class=\"kwd\"><a href=\"/keyword/paediatrics\" class=\"hw-term hw-article-keyword hw-article-keyword-paediatrics\" rel=\"nofollow\">paediatrics</a></li><li class=\"kwd\"><a href=\"/keyword/nutrition-dietetics\" class=\"hw-term hw-article-keyword hw-article-keyword-nutrition--dietetics\" rel=\"nofollow\">nutrition &amp; dietetics</a></li></ul><div class=\"boxed-text\" id=\"boxed-text-1\"><h3>STRENGTHS AND LIMITATIONS OF THIS STUDY</h3><ul class=\"list-unord \" id=\"list-1\"><li id=\"list-item-1\"><p id=\"p-10\">The main strength of the study is that nationally representative data have been used with large sample and enough information on child malnutrition for four consecutive years.</p></li><li id=\"list-item-2\"><p id=\"p-11\">Despite the above strengths, the study might have a recollection bias.</p></li><li id=\"list-item-3\"><p id=\"p-12\">The data do not have information on some important factors related to a kid’s development like the amount of diet given to children, the mobility pattern of children, etc.</p></li><li id=\"list-item-4\"><p id=\"p-13\">There is a lot of missing data for some existing variables in the data set, such as antenatal visits during pregnancy and duration of breast feeding; this study did not investigate the impact of missing data.</p></li></ul></div><div class=\"section intro\" id=\"sec-9\"><h2 class=\"\">Introduction</h2><p id=\"p-14\">Malnutrition has always been one of the most widespread causes of concerns pertaining to a person’s health which has negatively affected the health and welfare of countless people across the globe.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1–3</a> Millions of women and children worldwide, particularly in low and middle-income countries, continue to suffer from malnutrition, which includes undernutrition, overweight, obesity and deficiencies in some micronutrients.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> Malnutrition has been defined by the WHO as any insufficiencies, over or unevenness in a person’s intake of energy and/or nutrients.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The undernutrition status of children is an imperious indicator of poverty in a country; and it is obvious that poverty, undernutrition and disease are intertwined.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6 7</a> However, WHO has referred to malnutrition (undernutrition and overnutrition) as the sole supreme risk to the world’s public health, especially for the developing countries.<a id=\"xref-ref-5-2\" class=\"xref-bibr\" href=\"#ref-5\">5</a> Malnutrition is a primary cause of about half of the children’s deaths globally.<a id=\"xref-ref-8-1\" class=\"xref-bibr\" href=\"#ref-8\">8</a> Also malnutrition has been identified as a major risk factor for childhood mortality in some studies conducted in Bangladesh.<a id=\"xref-ref-9-1\" class=\"xref-bibr\" href=\"#ref-9\">9–11</a> Besides, Bangladesh belongs to countries with highly prevalent child malnutrition (stunting more than 54% of preschool-age children, underweight in 56% and wasting in 17%)<a id=\"xref-ref-12-1\" class=\"xref-bibr\" href=\"#ref-12\">12</a> and malnutrition-related mortality rate is about 53 per 1000 live birth according to Bangladesh Demographic and Health Survey (BDHS) 2011.<a id=\"xref-ref-13-1\" class=\"xref-bibr\" href=\"#ref-13\">13</a> Previous studies have shown that the prevalence of stunting in children has been steadily decreasing.<a id=\"xref-ref-5-3\" class=\"xref-bibr\" href=\"#ref-5\">5 14</a> Though the stunting rate in Bangladesh has significantly been reduced over the past two decades (from 51% in 2004 to 31% in 2017/2018),<a id=\"xref-ref-15-1\" class=\"xref-bibr\" href=\"#ref-15\">15</a> the global recommended rate of 3.9% for stunting is still not being met by the average annual rate of reduction.<a id=\"xref-ref-16-1\" class=\"xref-bibr\" href=\"#ref-16\">16</a> Consequently, the country is still behind the progress in achieving the Sustainable Development Goal (SDG) target 2.2 of reducing the stunting and wasting level below 20% and 7% by 2025, respectively. In addition, by 2030, the target is to end all forms of malnutrition, including achieving, by 2025, the internationally agreed targets on stunting and wasting among under-five children (U5C) which are 15.5% and 5%, respectively.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17</a> However, if we look back to the global target in reduction of child malnutrition and policies to implement,<a id=\"xref-ref-16-2\" class=\"xref-bibr\" href=\"#ref-16\">16 18–20</a> Bangladesh failed to fulfil the target implementing all proposed policies. To enable a sharp decline of malnutrition rate in children it is essential to monitor evidence-based effectiveness of implemented policies.</p><p id=\"p-15\">A wide range of studies have been conducted on child malnutrition in Bangladesh and/or its associated risk factors.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21–24</a> Some literature has shown that factors such as low birth weight, family size, lack of parental education, breastfeeding status, previous birth interval, mother’s body mass index (BMI), low dietary intake, incidence of diarrhoea and household economic status are significantly related to infant mortality and child malnutrition.<a id=\"xref-ref-21-2\" class=\"xref-bibr\" href=\"#ref-21\">21–28</a> Gender and birth order were significant correlates of malnutrition in previous studies.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> Socioeconomic factors and diseases are also found to be significant correlates of child malnutrition.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a> Another study has revealed that malnutrition is higher in rural areas in comparison to urban areas.<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26</a> Gender inequality owing to socioeconomic structure was found to be another important determinant of malnutrition in children in another study.<a id=\"xref-ref-27-1\" class=\"xref-bibr\" href=\"#ref-27\">27</a> Still, another study suggested that antenatal care seeking behaviour of mother and related knowledge of healthcare are significant differential of child malnutrition, especially for infants.<a id=\"xref-ref-28-1\" class=\"xref-bibr\" href=\"#ref-28\">28</a> In most of the previous studies<a id=\"xref-ref-20-1\" class=\"xref-bibr\" href=\"#ref-20\">20–28</a> they have used binary, multiple and multilevel generalised linear regression analysis to identify the correlates associated with child malnutrition in Bangladesh. However, regression analysis encounters multiple limitations in determining trends when dealing with correlated covariates.<a id=\"xref-ref-29-1\" class=\"xref-bibr\" href=\"#ref-29\">29 30</a> If one independent covariate in a multiple regression equation exhibits a high correlation with one or more other independent covariates, it indicates the presence of multicollinearity.<a id=\"xref-ref-29-2\" class=\"xref-bibr\" href=\"#ref-29\">29</a> Multicollinearity is a problem because it undermines the statistical significance of independent covariates.<a id=\"xref-ref-29-3\" class=\"xref-bibr\" href=\"#ref-29\">29 31</a> The aforementioned regression analysis is unable to address the issue of multicollinearity.<a id=\"xref-ref-32-1\" class=\"xref-bibr\" href=\"#ref-32\">32–34</a> In such cases, factor analysis scores can be used along with correlation analysis to solve the issue of multicollinearity.<a id=\"xref-ref-35-1\" class=\"xref-bibr\" href=\"#ref-35\">35 36</a> Moreover, scores/loading derived from the covariance matrix of factor analysis can be employed to detect patterns by identifying the relationships between the observed variables and the underlying factors.<a id=\"xref-ref-37-1\" class=\"xref-bibr\" href=\"#ref-37\">37 38</a> Remarkably few research studies have used factor loading to examine the pattern of correlates in other disciplines, such as psychology,<a id=\"xref-ref-39-1\" class=\"xref-bibr\" href=\"#ref-39\">39</a> social science<a id=\"xref-ref-40-1\" class=\"xref-bibr\" href=\"#ref-40\">40</a> and dietary patterns in nutrition.<a id=\"xref-ref-41-1\" class=\"xref-bibr\" href=\"#ref-41\">41 42</a> To the best of our knowledge, there is no research study that has explored the trend of undernutrition (stunting, wasting and underweight) among U5C in Bangladesh, as well as the trend of its correlates using factor analysis.</p><p id=\"p-16\">Therefore, this study aimed to investigate the trend of risk in stunting, wasting and underweight among U5C in Bangladesh from 2007 to 2017/2018 and to identify the trend of some selected socio-demographic and economic correlates using factor loading from factor analysis. Outcome of this study will provide evidence to the health department and policymakers of Bangladesh about effectiveness of implemented policies in reducing child malnutrition towards strengthening their mode of action against it and modifying existing nutrition policy through more meaningful nutrition intervention programmes if needed.</p></div><div class=\"section materials\" id=\"sec-10\"><h2 class=\"\">Materials and methods</h2><div id=\"sec-11\" class=\"subsection\"><h3>Data source and study design</h3><p id=\"p-17\">The data have been used from the BDHS 2007, 2011, 2014 and 2017/2018 conducted under the authority of the National Institute for Population Research and Training of the Ministry of Health and Family Welfare.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> Two-stage stratified sampling design was used to collect data in BDHS 2007, 2011, 2014 and 2017/2018. Data screening for Bangladeshi children under the age of five has been shown in <a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>.</p><div id=\"F1\" class=\"fig pos-float  odd\"><div class=\"highwire-figure\"><div class=\"fig-inline-img-wrapper\"><div class=\"fig-inline-img\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F1.large.jpg?width=800&amp;height=600&amp;carousel=1\" title=\"Data screening for under-five children in Bangladesh (BDHS-2007, 2011, 2014 and 2017). BDHS, Bangladesh Demographic and Health Survey.\" class=\"highwire-fragment fragment-images colorbox-load\" rel=\"gallery-fragment-images-1800294400\" data-figure-caption=\\'&lt;div class=\"highwire-markup\"&gt;Data screening for under-five children in Bangladesh (BDHS-2007, 2011, 2014 and 2017). BDHS, Bangladesh Demographic and Health Survey.&lt;/div&gt;\\' data-icon-position=\"\" data-hide-link-title=\"0\"><span class=\"hw-responsive-img\"><img class=\"highwire-fragment fragment-image lazyload\" alt=\"Figure 1\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F1.medium.gif\" width=\"440\" height=\"368\"><noscript><img class=\"highwire-fragment fragment-image\" alt=\"Figure 1\" src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F1.medium.gif\" width=\"440\" height=\"368\"></noscript></span></a></div></div><ul class=\"highwire-figure-links inline\"><li class=\"download-fig first\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F1.large.jpg?download=true\" class=\"highwire-figure-link highwire-figure-link-download\" title=\"Download Figure 1\" data-icon-position=\"\" data-hide-link-title=\"0\">Download figure</a></li>\\n<li class=\"new-tab\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F1.large.jpg\" class=\"highwire-figure-link highwire-figure-link-newtab\" target=\"_blank\" data-icon-position=\"\" data-hide-link-title=\"0\">Open in new tab</a></li>\\n<li class=\"download-ppt last\"><a href=\"/highwire/powerpoint/289328\" class=\"highwire-figure-link highwire-figure-link-ppt\" data-icon-position=\"\" data-hide-link-title=\"0\">Download powerpoint</a></li>\\n</ul></div><div class=\"fig-caption\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><span class=\"fig-label\">Figure 1</span> <p id=\"p-18\" class=\"first-child\">Data screening for under-five children in Bangladesh (BDHS-2007, 2011, 2014 and 2017). BDHS, Bangladesh Demographic and Health Survey.</p><div class=\"sb-div caption-clear\"></div></div></div></div><div id=\"sec-12\" class=\"subsection\"><h3>Outcome variables</h3><p id=\"p-19\">According to the 2006 WHO standard for children, the Z scores for height-for-age (HAZ), weight-for-height (WHZ) and weight-for-age (WAZ) were calculated as indicators of a child’s nutritional status. This indicator was calculated as follows: Z-score = (observed value − median value of the reference population)/SD value of the reference population.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44 45</a> Stunting was defined as an HAZ &lt; −2, wasting as a WHZ &lt; −2 and underweight as a WAZ &lt; −2. These three indicators have been used as outcome variables in this study for analysis.</p></div><div id=\"sec-13\" class=\"subsection\"><h3>Explanatory variables</h3><p id=\"p-20\">First, we collected possible explanatory variables of malnutrition from several literature reviews.<a id=\"xref-ref-21-3\" class=\"xref-bibr\" href=\"#ref-21\">21–28 30–63</a> Among them, a few explanatory variables were absent from the last four consecutive survey data sets. In addition, some of them were accessible but have numerous missing values (see <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix table S1</a>). Finally, we selected 14 common explanatory variables which were available in all four BDHS data sets. Description and coding plan of the selected study variables are given in <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">table 1</a>.</p><div id=\"DC1\" class=\"supplementary-material\"><h3 class=\"\">Supplemental material</h3><div><span class=\"inline-linked-media-wrapper\"><span id=\"DC1\" class=\"inline-linked-media\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/DC1/embed/inline-supplementary-material-1.pdf?download=true\" class=\"\" data-icon-position=\"\" data-hide-link-title=\"0\"><span class=\"icon-download-alt\"></span>[bmjopen-2022-070480supp001.pdf]</a></span></span></div></div><div id=\"T1\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289367/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289367/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 1</span> <p id=\"p-22\" class=\"first-child\">Description and coding plan for the selected study variables</p><div class=\"sb-div caption-clear\"></div></div></div></div><div id=\"sec-14\" class=\"subsection\"><h3>Statistical analysis</h3><p id=\"p-24\">We summarised the outcome variables of undernutrition (stunting, wasting and underweight) and explanatory variables by frequency distribution (n and %). The bivariate analysis χ<sup>2</sup> test was used to examine the association of each of the outcome variables with the explanatory variables. Associations were considered significant at the 5% level. To extract the trend of correlates of the undernutritional status of U5C in Bangladesh, factor analysis has been used. A factor can be considered a theoretical measure representing a group of actual measures that correlate highly with one another and lowly with the others in a set. The loadings are the polychoric correlations between the actual measures and the theoretical measures or factors. For ordinal variables, polychoric correlation assesses similarity between various raters.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> A factor is identified through an examination of the variables that load highly (ie, correlate highly) on it. Principal Component Analysis has been used for extraction of factors and orthogonal rotation (varimax option) to derive non-correlated factors.<a id=\"xref-ref-37-2\" class=\"xref-bibr\" href=\"#ref-37\">37 47 48</a> One factor was created with the data from undernourished children to rank the absolute loadings properly. In the factor analysis, any child with missing covariate data was completely dropped from the analysis. A total of 886 (17%), 1083 (14%), 2947 (42%) and 3296 (42%) observations were entirely dropped due to missing covariates in BDHS 2007, 2011, 2014 and 2017/2018, respectively. The high number of missing observations in 2014 and 2017/2018 was due to 41% missing data specifically related to the covariates of antenatal visits during pregnancy and the duration of breast feeding. The factor analysis included the remaining complete cases: 4414 (83%), 6564 (86%), 4018 (58%) and 4606 (58%). Statistical analysis was performed using the Stata/SE V.15.0 (Stata, USA) and R V.4.2.2.</p></div><div id=\"sec-15\" class=\"subsection\"><h3>Factor analysis</h3><p id=\"p-25\">Factor analysis, a multivariate analysis technique, is frequently used to reduce the dimensions of data by locating the underlying latent factors that account for the covariance among the observed variables. It can be used for pattern detection by identifying the relationships between the observed variables and the underlying factors. By reducing the number of variables to a smaller set of underlying factors, factor analysis can simplify complex data structures, and help interpreting the relationships among the variables. Factor analysis is widely used in fields such as psychology, marketing research, social sciences and many others to uncover the underlying structure of data and to gain insights into complex relationships among variables.<a id=\"xref-ref-37-3\" class=\"xref-bibr\" href=\"#ref-37\">37</a></p></div><div id=\"sec-16\" class=\"subsection\"><h3>Factor loading</h3><p id=\"p-26\">The observable random vector X, with p components, has mean µ and covariance matrix ∑. The factor model postulates X is linearly dependent on a few unobservable random variables F<sub>1,</sub> F<sub>2</sub>,…,F<sub>m</sub>, called common factors, and p additional sources of variation ℇ<sub>1</sub>,ℇ<sub>2,…</sub> ℇ<sub>p</sub> called errors. In particular, the factor analysis model is</p><p id=\"p-27\">X<sub>1</sub>-µ<sub>1</sub>=<em>l<sub>11</sub></em>F<sub>1</sub>+ <em>l<sub>12</sub></em>\\u2009<sub>F2</sub>+…+ <em>l<sub>1m</sub></em>F<sub>m</sub>+ ℇ<sub>1</sub></p><p id=\"p-28\">X<sub>2</sub>-µ<sub>2</sub>=<em>l<sub>21</sub></em>F<sub>1</sub>+ <em>l<sub>22</sub></em>\\u2009<sub>F2</sub>+…+ <em>l<sub>2m</sub></em>F<sub>m</sub>+ ℇ<sub>2.</sub></p><p id=\"p-29\">… … …</p><p id=\"p-30\">X<sub>p</sub>-µ<sub>p</sub>=<em>l<sub>p1</sub></em>F<sub>1</sub>+ <em>lp<sub>p2</sub></em>\\u2009<sub>F2</sub>+…+ <em>l<sub>pm</sub></em>F<sub>m</sub>+ ℇ<sub>p</sub></p><p id=\"p-31\">Or, in matrix notation, X-µ=L F+ ℇ</p><p id=\"p-32\">(p×1) (p×m) (m×1) (p×1)</p><p id=\"p-33\">The coefficient <em>l<sub>ij</sub></em> is called the loading of the ith variable on the jth factor, so the matrix L is the matrix of factor loading.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p></div><div id=\"sec-17\" class=\"subsection\"><h3>Patient and public involvement</h3><p id=\"p-34\">None.</p></div></div><div class=\"section results\" id=\"sec-18\"><h2 class=\"\">Results</h2><p id=\"p-35\">As shown in <a id=\"xref-table-wrap-2-1\" class=\"xref-table\" href=\"#T2\">table 2</a>, in this study, we included 5300, 7647, 6965 and 7902\\u2009U5C records from BDHS 2007, 2011, 2014 and 2017/2018, respectively, after excluding all unusable records (<a id=\"xref-fig-1-2\" class=\"xref-fig\" href=\"#F1\">figure 1</a>). From <a id=\"xref-fig-2-1\" class=\"xref-fig\" href=\"#F2\">figure 2</a>, it has been shown that the prevalence of child nutrition has improved steadily over the past decades. The prevalence of stunting among U5C has been declined from 41.7% (95% CI: 40.4% to 43.0%) in 2007 to 40.7% (95% CI: 39.5% to 41.7%) in 2011 to 36.6% (95% CI: 35.4% to 37.7%) in 2014 and then to 31.1% (95% CI: 30.10% to 32.2%) in 2017/2018. The prevalence of wasting has been declined from 16.9% (95% CI: 15.9% to 17.9%) in 2007 to 15.5% (95% CI: 14.6% to 16.2%) in 2011 to 14.4% (95% CI: 13.6% to 15.2%) in 2014 and then to 8.4% (95% CI: 7.8% to 9.1%) in 2017/2018 and underweight from 39.8% (95% CI: 38.5% to 41.1%) in 2007 to 35.8% (95% CI: 34.7% to 36.8%) in 2011 to 32.4% (95% CI: 31.3% to 35.5%) in 2014 and then to 22.5% (95%\\u2009CI: 21.5% to 23.4%) in 2017/2018.</p><div id=\"F2\" class=\"fig pos-float  odd\"><div class=\"highwire-figure\"><div class=\"fig-inline-img-wrapper\"><div class=\"fig-inline-img\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F2.large.jpg?width=800&amp;height=600&amp;carousel=1\" title=\"Trend of risk of stunting, wasting and underweight among under-five children in Bangladesh (2007–2017).\" class=\"highwire-fragment fragment-images colorbox-load\" rel=\"gallery-fragment-images-1800294400\" data-figure-caption=\\'&lt;div class=\"highwire-markup\"&gt;Trend of risk of stunting, wasting and underweight among under-five children in Bangladesh (2007–2017).&lt;/div&gt;\\' data-icon-position=\"\" data-hide-link-title=\"0\"><span class=\"hw-responsive-img\"><img class=\"highwire-fragment fragment-image lazyload\" alt=\"Figure 2\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F2.medium.gif\" width=\"440\" height=\"288\"><noscript><img class=\"highwire-fragment fragment-image\" alt=\"Figure 2\" src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F2.medium.gif\" width=\"440\" height=\"288\"></noscript></span></a></div></div><ul class=\"highwire-figure-links inline\"><li class=\"download-fig first\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F2.large.jpg?download=true\" class=\"highwire-figure-link highwire-figure-link-download\" title=\"Download Figure 2\" data-icon-position=\"\" data-hide-link-title=\"0\">Download figure</a></li>\\n<li class=\"new-tab\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e070480/F2.large.jpg\" class=\"highwire-figure-link highwire-figure-link-newtab\" target=\"_blank\" data-icon-position=\"\" data-hide-link-title=\"0\">Open in new tab</a></li>\\n<li class=\"download-ppt last\"><a href=\"/highwire/powerpoint/289388\" class=\"highwire-figure-link highwire-figure-link-ppt\" data-icon-position=\"\" data-hide-link-title=\"0\">Download powerpoint</a></li>\\n</ul></div><div class=\"fig-caption\"><span class=\"fig-label\">Figure 2</span> <p id=\"p-36\" class=\"first-child\">Trend of risk of stunting, wasting and underweight among under-five children in Bangladesh (2007–2017).</p><div class=\"sb-div caption-clear\"></div></div></div><div id=\"T2\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289384/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289384/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 2</span> <p id=\"p-37\" class=\"first-child\">Characteristics of the study subjects, BDHS: 2007, 2011, 2014, 2017/2018</p><div class=\"sb-div caption-clear\"></div></div></div><p id=\"p-40\">Among the U5C, 50.4%, 51.1%, 51.3% and 52.2% were men and 49.6%, 48.9%, 48.7% and 47.8% were women in 2007, 2011, 2014 and 2017/2018, respectively. About 37.4%, 33.1%, 21.0% and 8.1% mothers had no antenatal visits during pregnancy and 26.9%, 18.9%, 15.5% and 7.2% mothers had no formal education in 2007, 2011, 2014 and 2017/2018, respectively. Of the respondents, 65.1% in 2007, 69.4% in 2011, 68.6% in 2014 and 65.9% in 2017/2018 came from rural areas, and 19.8% in 2007, 22.0% in 2011, 21.7% in 2014 and 22.4% in 2017/2018 had the lowest wealth index.</p><p id=\"p-41\">From <a id=\"xref-supplementary-material-1-2\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix table S2</a>, we found that age in months of the children, preceding birth interval (months), age of mother at first birth (years), mother’s BMI, frequency of antenatal visits during pregnancy, duration of breast feeding, mother’s educational level, mother’s employment status, father’s educational level, father’s occupation, administrative division, type of place of residence and wealth index are found to be significantly associated with undernutrition among U5C in Bangladesh. It has also been observed that among the stunted children in 2007, 9.6% were of age &lt;12 months, 19.2% were of age 12–23 months, 25.2% were of 24–35 months, 24.9% were of age 36–47 months and 21.1% were of age 48–59 months. Among the stunted children in 2011 those figures were 9.9%, 22.6%, 21.6%, 25.0% and 20.9%, respectively. Furthermore, among the stunted children in 2014 those percentages were 9.0%, 22.2%, 23.4%, 24.7% and 20.8%, respectively, and in 2017/2018 those figures were 14.1%, 23.5%, 23.9%, 20.5% and 18.0%, respectively. Similar pattern has been found among wasted and underweight children. It has also been found that preceding birth interval, age of mothers at first birth, mothers BMI, frequency of antenatal visits during pregnancy, mothers educational status, father’s educational status, administrative division, type of place of residence and wealth indices were found to be significantly associated with all kinds of undernutrition in the consecutive surveys.</p><p id=\"p-42\">Factor loadings derived from single-factor factor analysis have been reported in <a id=\"xref-table-wrap-3-1\" class=\"xref-table\" href=\"#T3\">tables 3–5</a>. It has been found that top-most-five correlates of stunting in 2007 were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and place of residence; in 2011 the correlates were household wealth index, mother’s educational level, father’s educational level, frequency of antenatal visits during pregnancy and place of residence; in 2014, they were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and place of residence; and in 2017/2018, they were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and father’s occupation (<a id=\"xref-table-wrap-3-2\" class=\"xref-table\" href=\"#T3\">table 3</a>).</p><div id=\"T3\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289383/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289383/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 3</span> <p id=\"p-43\" class=\"first-child\">Factor loadings (pattern matrix) and rank of absolute loading of each variable among under-five stunted children in Bangladesh (BDHS: 2017/2018, 2014, 2011 and 2007)</p><div class=\"sb-div caption-clear\"></div></div></div><div id=\"T4\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289382/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289382/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 4</span> <p id=\"p-45\" class=\"first-child\">Factor loadings (pattern matrix) and rank of absolute loading of each variable among under-five wasted children in Bangladesh (BDHS: 2017/2018, 2014, 2011 and 2007)</p><div class=\"sb-div caption-clear\"></div></div></div><div id=\"T5\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289387/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289387/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 5</span> <p id=\"p-47\" class=\"first-child\">Factor loadings (pattern matrix) and rank of absolute loading of each variable among under-five underweight children in Bangladesh (BDHS:2017/2018, 2014, 2011 and 2007)</p><div class=\"sb-div caption-clear\"></div></div></div><p id=\"p-49\">The top-most-five correlates of wasting in 2007 were father’s educational level, household wealth index, mother’s educational level, frequency of antenatal visits during pregnancy and father’s occupation; in 2011 the correlates were household wealth index, mother’s educational level, father’s educational level, frequency of antenatal visits during pregnancy and father’s occupation; in 2014 they were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and place of residence; and in 2017/2018, they were wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and father’s occupation (<a id=\"xref-table-wrap-4-1\" class=\"xref-table\" href=\"#T4\">table 4</a>).</p><p id=\"p-50\">The top-most-five correlates of underweight in 2007 were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and father’s occupation; in 2011 the correlates were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and type of place of residence; in 2014 they were father’s educational level, household wealth index, mother’s educational level, frequency of antenatal visits during pregnancy and type of place of residence; in 2017/2018, they were household wealth index, father’s educational level, mother’s educational level, frequency of antenatal visits during pregnancy and father’s occupation (<a id=\"xref-table-wrap-5-1\" class=\"xref-table\" href=\"#T5\">table 5</a>).</p></div><div class=\"section discussion\" id=\"sec-19\"><h2 class=\"\">Discussion</h2><p id=\"p-51\">In the last few decades, a lot of policies and interventional programmes have been implemented by the government of Bangladesh and non-governmental organisations to improve the nutritional status of U5C. But, it is essential to work more with child malnutrition to fulfil the target of SDG which directs reduction of malnutrition among young children by integrating child malnutrition and related strategies. However, from this study it has been found that the risk of stunting among U5C has declined from 41.7% in 2007 to 31.1% in 2017/2018. It declined by 10.6\\u2009percentage points over the past 10 years. The level of underweight has declined from 39.8% in 2007 to 22.5% in 2017/2018. Particularly in the last 10 years, underweight has declined by 17.3\\u2009percentage points. It is still at a critically high level of about 15%, according to WHO.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> The prevalence of wasting came down from 16.9% in 2007 to 8.4% in 2017/2018, that is, it declined by 8.5\\u2009percentage points (decreased 50%) in the last 10 years.</p><p id=\"p-52\">The findings of the bivariate and factor analysis revealed that the wealth index, the educational levels of the father and mother, the frequency of antenatal visits during pregnancy and the father’s occupation and/or the type of place of residence have remained among the top five leading correlates that were highly associated with undernutrition over the years. The wealth index was found to be the most significant among the top five correlates of undernutrition. The poorest households have actively contributed to U5C malnutrition, which is a natural result of their failure to ensure adequate food security, maintain proper hygiene, provide treatment facilities, etc. A similar discussion was also reported in some previous studies conducted in Bangladesh<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49 50</a> and other countries.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51–55</a> In Bangladesh, 18.7% of the population remains below the national poverty line, with 10% experiencing extreme poverty.<a id=\"xref-ref-56-1\" class=\"xref-bibr\" href=\"#ref-56\">56</a> The government of Bangladesh has implemented various poverty reduction programmes over the years to reduce wealth index inequalities, such as the Social Safety Net Programmes (SSNPs),<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a> World Food Programme<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> Food and Agricultural Organisation,<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a> etc. Some of the prominent SSNPs implemented by the Government of Bangladesh include Vulnerable Group Feeding, Open Market Sales, Cash for Work, Food for Work, Vulnerable Group Development, Gratuitous Relief and the 100 days employment guarantee scheme. Though, SSNPs in Bangladesh have played a role in poverty reduction, their coverage is so limited compared with the extent of extreme poverty in the country, particularly in certain regions like the haor areas in the northeast, Noakhali’s chars, river erosion-prone areas and parts of the north-central region.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60 61</a> Although the programmes mainly target rural poverty, some indicators suggest that urban poverty is more severe.<a id=\"xref-ref-61-1\" class=\"xref-bibr\" href=\"#ref-61\">61</a> As a result, the government may fail to address wealth index inequalities related to child malnutrition, which remains a critical issue over the years. Poverty leads to increased illiteracy and malnutrition among children, as it hinders access to education and proper healthcare.<a id=\"xref-ref-62-1\" class=\"xref-bibr\" href=\"#ref-62\">62</a> Contrarily, the children from rich families have greater access to health facilities, better environmental conditions including drinkable water, sanitation and access to enough food may account for the decreased risks of child stunting associated with higher wealth index. Also, it is possible that parents from the wealthiest families have a higher level of education and are more accountable for their children’s health compared with parents who come from the poorest households.<a id=\"xref-ref-63-1\" class=\"xref-bibr\" href=\"#ref-63\">63</a> The key findings of the current study imply that raising household wealth status may significantly reduce the chance of undernutrition in children.</p><p id=\"p-53\">Parental education has another significant impact on the level of undernutrition among U5C and our results are consistent with those of earlier studies.<a id=\"xref-ref-64-1\" class=\"xref-bibr\" href=\"#ref-64\">64–66</a> Education is a valuable type of human capital that enhances the productivity, health and nutrition of individuals within a nation while also mitigating population growth.<a id=\"xref-ref-67-1\" class=\"xref-bibr\" href=\"#ref-67\">67</a> In Bangladesh, promoting inclusive education is challenging due to geographical factors like indigenous children, tea garden children, coastal area children, border area children and children in monga and flood-affected areas. Over the course of time, these children will become parents. These groups are facing numerous barriers to receiving quality education over the years.<a id=\"xref-ref-68-1\" class=\"xref-bibr\" href=\"#ref-68\">68</a> Sultana <em>et al</em><a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> have discussed that educated parents are more aware about health, nutrition, proper child care, health services, hygiene, proper food for children, etc. Educated parents generally refer to those who have received formal education or have a certain level of academic or intellectual knowledge. They also contribute positively to promoting household income, which can support providing the above-mentioned resources to their children. Other authors have discussed that educated mothers are better able to cope with inadequate family income and provide healthcare facilities efficiently. They are also more likely to limit family size, promote health-stimulating activities and afford quality healthcare for their children.<a id=\"xref-ref-49-2\" class=\"xref-bibr\" href=\"#ref-49\">49 50 69 70</a> However, current study shows that a significant percentage of children of higher educated parents were found to be malnourished over the years. On the other hand, prevalence of malnourished U5C among employed mothers was remarkably higher in 2017/2018 than previous years, which was consistent with the findings of previous studies conducted in Bangladesh<a id=\"xref-ref-71-1\" class=\"xref-bibr\" href=\"#ref-71\">71</a> and in other countries.<a id=\"xref-ref-72-1\" class=\"xref-bibr\" href=\"#ref-72\">72</a> Theoretically, a working mother has two major effects on the home that we can classify into the income effect and the substitution effect. The income effect can make it possible for kids to buy healthy food and essential medications. On the other hand, maternal care time for children is reduced due to the substitution effect. If the income effect is greater than the substitution effect, the children’s nutritional status would be better; it would be worse for the child’s nutritional status if the substitution effect is higher than the income effect. In addition, nowadays, most of the families are nuclear and the employed parents are obligatory bound to leave their children at home under illiterate maid. This is important considering the fact that as much as 77% of companies in Bangladesh do not offer childcare facilities to their female employees at workplaces.<a id=\"xref-ref-73-1\" class=\"xref-bibr\" href=\"#ref-73\">73</a> Therefore, the government and policymakers may rethink about the social infrastructure of Bangladesh to intervene and establish a day-care system for employed mothers.</p><p id=\"p-54\">Bangladesh has made great strides in improving the health of its population, but maternal health and healthcare facilities still face vulnerabilities.<a id=\"xref-ref-74-1\" class=\"xref-bibr\" href=\"#ref-74\">74</a> Children whose mothers had received antenatal care more times during their pregnancies had lower rates of undernutrition. According to earlier studies, antenatal care was associated with a reduction in child stunting.<a id=\"xref-ref-75-1\" class=\"xref-bibr\" href=\"#ref-75\">75 76</a> Both mother and child can avoid numerous health issues like infections, anaemia, iron deficiency and more by receiving antenatal care during pregnancy.<a id=\"xref-ref-65-1\" class=\"xref-bibr\" href=\"#ref-65\">65</a> Type of place of residence showed a similar pattern for all the three kinds of child undernutrition over the years. The place of residence for stunting was in the fifth position in 2007 which went back to sixth position in 2017/2018. In the past decade a lot of infrastructure developmental activities, like the National Strategy for Accelerated Poverty Reduction II,<a id=\"xref-ref-77-1\" class=\"xref-bibr\" href=\"#ref-77\">77</a> the Asian Development Bank (ADB) country strategy and programme, 2006–2010 for Bangladesh,<a id=\"xref-ref-78-1\" class=\"xref-bibr\" href=\"#ref-78\">78</a> the ADB country strategy and programme, 2011–2015 for Bangladesh,<a id=\"xref-ref-79-1\" class=\"xref-bibr\" href=\"#ref-79\">79</a> etc, were implemented in rural areas regional divisions in Bangladesh which opened scope for better access to services and institutions, including education, healthcare, livestock, microfinance and cooperatives. Besides, microfinance agencies, including non-governmental organisations (NGOs) expanded their services to the poor in the root level areas of regional divisions significantly in the past decades. All these helped to minimise the regional inequalities in stunting among U5C in Bangladesh.</p><p id=\"p-55\">Maternal BMI is an important correlate of both maternal and child nutrition but it did not have a place in the top five correlates. According to our findings, the trend of prevalence of low BMI (&lt;18.5) among women of childbearing age has declined over the years but it is still found to be highly associated with the three forms of child’s undernutrition. This outcome is consistent with earlier research done in Bangladesh<a id=\"xref-ref-24-2\" class=\"xref-bibr\" href=\"#ref-24\">24 80–82</a> and also in low-income and middle-income countries.<a id=\"xref-ref-83-1\" class=\"xref-bibr\" href=\"#ref-83\">83 84</a> For a mother to be able to breast feed and recover from the physical and possibly mental stress of being pregnant and giving birth as well as deal with raising and caring for children, she needs to be in good nutritional condition.</p><div id=\"sec-20\" class=\"subsection\"><h3>Conclusion</h3><p id=\"p-56\">This study explored how socioeconomic status and demographic correlates were significantly related to child undernutrition as well as examined the trend of the top five leading correlates that changed from 2007 to 2017/2018. The potential top five correlates are associated with undernutrition among U5C in Bangladesh, namely the wealth index, the educational level of the father and mother, the frequency of antenatal visits during pregnancy, the father’s occupation and/or the type of place of residence. For investment and policy guidance, it is essential to understand the levels and trends of the major correlates of undernutrition among U5C. It is also important to monitor the trends of leading correlates of undernutrition over time to see where interventions are working and where more attention is needed. Therefore, the findings of this study strongly highlight the necessity of improving other factors which are directly or indirectly related to these top leading five-factors including social infrastructure to achieve better nutritional status among U5C in Bangladesh.</p></div><div id=\"sec-21\" class=\"subsection\"><h3>Recommendations</h3><p id=\"p-57\">It is very important to integrate child malnutrition and related strategies in order to meet the SDG aim of reducing malnutrition among young children. To accelerate the reduction of undernutrition, the authors think that any comprehensive interventional programme taken by the government and public–private owner organisations at the community level should be focused on improving education and household income-generating activities among poor households and raising women’s awareness about receiving antenatal care facilities during pregnancy. In addition to the existing policy for improving the nutritional status of U5C, the government, the NGOs or policymakers should take necessary steps for controlling these related factors by new intervention strategies.</p></div></div><div class=\"section data-availability\" id=\"sec-22\"><h2 class=\"\">Data availability statement</h2><p id=\"p-65\">No data are available. Data are available in a public, open access repository. Data are available upon reasonable request.</p></div><div class=\"section ethics-statement\" id=\"sec-23\"><h2 class=\"\">Ethics statements</h2><div class=\"section\" id=\"sec-24\"><h3>Patient consent for publication</h3><p id=\"p-66\" class=\"ethics-consent-to-publish\">Not applicable.</p></div><div class=\"section\" id=\"sec-25\"><h3>Ethics approval</h3><p id=\"p-67\" class=\"ethics-approval\">The National Institute of Population Research and Training (NIPORT) of the Ministry of Health and Family Welfare (MOHFW) were in charge of conducting the Bangladesh Demographic and Health Survey (BDHS). Responsible authority followed a standard ethics to conduct the survey and make it open for researchers.</p></div></div><div class=\"section ack\" id=\"ack-1\"><h2>Acknowledgments</h2><p id=\"p-58\">The authors would like to acknowledge the translation and editing cell of the Department of English, University of Rajshahi, Rajshahi, Bangladesh, and Sinan Mustanjid Haque for their constructive feedback to improve the English of the paper.</p></div><div class=\"section ref-list\" id=\"ref-list-1\"><h2 class=\"\">References</h2><ol class=\"cit-list ref-use-labels\"><li><span class=\"ref-label\">1.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-1-1\" title=\"View reference 1 in text\" id=\"ref-1\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.1\" data-doi=\"10.1542/peds.2010-0461\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Wojcicki</span>  <span class=\"cit-name-given-names\">JM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Heyman</span>  <span class=\"cit-name-given-names\">MB</span></span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition and the role of the soft drink industry in improving child health in sub-Saharan Africa</span>. <abbr class=\"cit-jnl-abbrev\">Pediatrics</abbr> <span class=\"cit-pub-date\">2010</span>;<span class=\"cit-vol\">126</span>:<span class=\"cit-fpage\">e1617</span>–<span class=\"cit-lpage\">21</span>. <a href=\"http://dx.doi.org/10.1542/peds.2010-0461\">doi:10.1542/peds.2010-0461</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DPediatrics%26rft_id%253Dinfo%253Adoi%252F10.1542%252Fpeds.2010-0461%26rft_id%253Dinfo%253Apmid%252F21059717%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1542/peds.2010-0461&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=21059717&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">2.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-1-1\" title=\"View reference 2 in text\" id=\"ref-2\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.2\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Belli</span>  <span class=\"cit-name-given-names\">P</span></span></li></ol><cite>. <span class=\"cit-article-title\">The economic implications of malnutrition: the dismal science Revisited</span>. <abbr class=\"cit-jnl-abbrev\">Economic Development and Cultural Change</abbr> <span class=\"cit-pub-date\">1971</span>;<span class=\"cit-vol\">20</span>:<span class=\"cit-fpage\">1</span>–<span class=\"cit-lpage\">23</span>. <a href=\"http://dx.doi.org/10.1086/450527\">doi:10.1086/450527</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DEconomic%2BDevelopment%2Band%2BCultural%2BChange%26rft.volume%253D20%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">3.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-1-1\" title=\"View reference 3 in text\" id=\"ref-3\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.3\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Brundtland</span>  <span class=\"cit-name-given-names\">GH</span></span></li></ol><cite>. <span class=\"cit-article-title\">Nutrition for health and Development (NHD) world health Organization- turning the tide of malnutrition: responding to the challenge of the 21st century</span>. <span class=\"cit-pub-date\">2000</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">4.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-4-1\" title=\"View reference 4 in text\" id=\"ref-4\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.4\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Keats</span>  <span class=\"cit-name-given-names\">EC</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das</span>  <span class=\"cit-name-given-names\">JK</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Salam</span>  <span class=\"cit-name-given-names\">RA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Effective interventions to address maternal and child malnutrition: an update of the evidence</span>. <abbr class=\"cit-jnl-abbrev\">Lancet Child Adolesc Health</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">5</span>:<span class=\"cit-fpage\">367</span>–<span class=\"cit-lpage\">84</span>. <a href=\"http://dx.doi.org/10.1016/S2352-4642(20)30274-1\">doi:10.1016/S2352-4642(20)30274-1</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DLancet%2BChild%2BAdolesc%2BHealth%26rft.volume%253D5%26rft.spage%253D367%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">5.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-5-1\" title=\"View reference 5 in text\" id=\"ref-5\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.5\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">WHO</span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition</span>. <span class=\"cit-pub-date\">2023</span>. <span class=\"cit-comment\">Available</span>: <a href=\"http://www.who.int/topics/malnutrition/en/\">www.who.int/topics/malnutrition/en/</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">6.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-6-1\" title=\"View reference 6 in text\" id=\"ref-6\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.6\" data-doi=\"10.1146/annurev.nutr.22.120701.141104\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Peña</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bacallao</span>  <span class=\"cit-name-given-names\">J</span></span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition and poverty</span>. <abbr class=\"cit-jnl-abbrev\">Annu Rev Nutr</abbr> <span class=\"cit-pub-date\">2002</span>;<span class=\"cit-vol\">22</span>:<span class=\"cit-fpage\">241</span>–<span class=\"cit-lpage\">53</span>. <a href=\"http://dx.doi.org/10.1146/annurev.nutr.22.120701.141104\">doi:10.1146/annurev.nutr.22.120701.141104</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAnnu%2BRev%2BNutr%26rft_id%253Dinfo%253Adoi%252F10.1146%252Fannurev.nutr.22.120701.141104%26rft_id%253Dinfo%253Apmid%252F12055345%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1146/annurev.nutr.22.120701.141104&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=12055345&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000179917900012&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><span class=\"ref-label\">7.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-6-1\" title=\"View reference 7 in text\" id=\"ref-7\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.7\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Farhadi</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ovchinnikov</span>  <span class=\"cit-name-given-names\">R</span></span></li></ol><cite>. <span class=\"cit-article-title\">The relationship between nutrition and infectious diseases: A review</span>. <abbr class=\"cit-jnl-abbrev\">Biomed Biotechnol Res J</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">2</span>:<span class=\"cit-fpage\">168</span>. <a href=\"http://dx.doi.org/10.4103/bbrj.bbrj_69_18\">doi:10.4103/bbrj.bbrj_69_18</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBiomed%2BBiotechnol%2BRes%2BJ%26rft.volume%253D2%26rft.spage%253D168%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">8.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-8-1\" title=\"View reference 8 in text\" id=\"ref-8\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.8\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">WHO</span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition</span>. <span class=\"cit-pub-date\">2023</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.who.int/news-room/fact-sheets/detail/malnutrition\">https://www.who.int/news-room/fact-sheets/detail/malnutrition</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">9.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-9-1\" title=\"View reference 9 in text\" id=\"ref-9\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.9\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Madzingira</span>  <span class=\"cit-name-given-names\">N</span></span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition in children under five in Zimbabwe: effect of socioeconomic factors and disease</span>. <abbr class=\"cit-jnl-abbrev\">Soc Biol</abbr> <span class=\"cit-pub-date\">1995</span>;<span class=\"cit-vol\">42</span>:<span class=\"cit-fpage\">239</span>–<span class=\"cit-lpage\">46</span>. <a href=\"http://dx.doi.org/10.1080/19485565.1995.9988904\">doi:10.1080/19485565.1995.9988904</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DSocial%2Bbiology%26rft.stitle%253DSoc%2BBiol%26rft.aulast%253DMadzingira%26rft.auinit1%253DN.%26rft.volume%253D42%26rft.issue%253D3-4%26rft.spage%253D239%26rft.epage%253D246%26rft.atitle%253DMalnutrition%2Bin%2Bchildren%2Bunder%2Bfive%2Bin%2BZimbabwe%253A%2Beffect%2Bof%2Bsocioeconomic%2Bfactors%2Band%2Bdisease.%26rft_id%253Dinfo%253Apmid%252F8738549%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=8738549&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">10.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-9-1\" title=\"View reference 10 in text\" id=\"ref-10\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.10\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chen</span>  <span class=\"cit-name-given-names\">LC</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chowdhury</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Huffman</span>  <span class=\"cit-name-given-names\">SL</span></span></li></ol><cite>. <span class=\"cit-article-title\">Anthropometric assessment of energy-protein malnutrition and subsequent risk of mortality among preschool aged children</span>. <abbr class=\"cit-jnl-abbrev\">Am J Clin Nutr</abbr> <span class=\"cit-pub-date\">1980</span>;<span class=\"cit-vol\">33</span>:<span class=\"cit-fpage\">1836</span>–<span class=\"cit-lpage\">45</span>. <a href=\"http://dx.doi.org/10.1093/ajcn/33.8.1836\">doi:10.1093/ajcn/33.8.1836</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DThe%2BAmerican%2BJournal%2Bof%2BClinical%2BNutrition%26rft.stitle%253DAm%2BJ%2BClin%2BNutr%26rft.aulast%253DChen%26rft.auinit1%253DL.%2BC.%26rft.volume%253D33%26rft.issue%253D8%26rft.spage%253D1836%26rft.epage%253D1845%26rft.atitle%253DAnthropometric%2Bassessment%2Bof%2Benergy-protein%2Bmalnutrition%2Band%2Bsubsequent%2Brisk%2Bof%2Bmortality%2Bamong%2Bpreschool%2Baged%2Bchildren%26rft_id%253Dinfo%253Apmid%252F6773410%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpjbiI7czo1OiJyZXNpZCI7czo5OiIzMy84LzE4MzYiO3M6NDoiYXRvbSI7czoyNjoiL2Jtam9wZW4vMTMvNi9lMDcwNDgwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><span class=\"ref-label\">11.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-9-1\" title=\"View reference 11 in text\" id=\"ref-11\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.11\" data-doi=\"10.1136/bmj.287.6399.1097\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Roy</span>  <span class=\"cit-name-given-names\">SK</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chowdhury</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahaman</span>  <span class=\"cit-name-given-names\">MM</span></span></li></ol><cite>. <span class=\"cit-article-title\">Excess mortality among children discharged from hospital after treatment for diarrhoea in rural Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">BMJ</abbr> <span class=\"cit-pub-date\">1983</span>;<span class=\"cit-vol\">287</span>:<span class=\"cit-fpage\">1097</span>–<span class=\"cit-lpage\">9</span>. <a href=\"http://dx.doi.org/10.1136/bmj.287.6399.1097\">doi:10.1136/bmj.287.6399.1097</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.aulast%253DRoy%26rft.auinit1%253DS%2BK%26rft.volume%253D287%26rft.issue%253D6399%26rft.spage%253D1097%26rft.epage%253D1099%26rft.atitle%253DExcess%2Bmortality%2Bamong%2Bchildren%2Bdischarged%2Bfrom%2Bhospital%2Bafter%2Btreatment%2Bfor%2Bdiarrhoea%2Bin%2Brural%2BBangladesh.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.287.6399.1097%26rft_id%253Dinfo%253Apmid%252F6414583%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjEzOiIyODcvNjM5OS8xMDk3IjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA3MDQ4MC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><span class=\"ref-label\">12.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-12-1\" title=\"View reference 12 in text\" id=\"ref-12\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.12\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zafreen</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahman</span>  <span class=\"cit-name-given-names\">MM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahman</span>  <span class=\"cit-name-given-names\">MH</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Nutritional status of under-five children of Chattogram Hill tracts</span>. <abbr class=\"cit-jnl-abbrev\">J Armed Forces Med Coll</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">14</span>:<span class=\"cit-fpage\">21</span>–<span class=\"cit-lpage\">3</span>. <a href=\"http://dx.doi.org/10.3329/jafmc.v14i1.42715\">doi:10.3329/jafmc.v14i1.42715</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BArmed%2BForces%2BMed%2BColl%26rft.volume%253D14%26rft.spage%253D21%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">13.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-13-1\" title=\"View reference 13 in text\" id=\"ref-13\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.13\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hossain</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Islam</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Munira</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Infant and child mortality status of Bangladesh: A study on demographic and health survey</span>. <abbr class=\"cit-jnl-abbrev\">AJSSS</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">3</span>:<span class=\"cit-fpage\">43</span>. <a href=\"http://dx.doi.org/10.20849/ajsss.v3i1.330\">doi:10.20849/ajsss.v3i1.330</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAJSSS%26rft.volume%253D3%26rft.spage%253D43%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">14.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-5-3\" title=\"View reference 14 in text\" id=\"ref-14\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.14\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">NIPORT</span></li></ol><cite>. <span class=\"cit-source\">National Institute of population research and training (NIPORT). Mitra and Associates, ICF International Bangladesh demographic and health survey</span>. <span class=\"cit-pub-date\">2014</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">15.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-15-1\" title=\"View reference 15 in text\" id=\"ref-15\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.15\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Baffour</span>  <span class=\"cit-name-given-names\">B</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Richardson</span>  <span class=\"cit-name-given-names\">A</span></span></li></ol><cite>. <span class=\"cit-article-title\">Prevalence of child Undernutrition measures and their Spatio-demographic inequalities in Bangladesh: an application of Multilevel Bayesian Modelling</span>. <abbr class=\"cit-jnl-abbrev\">BMC Public Health</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">22</span>:<span class=\"cit-elocation-id\">1008</span>. <a href=\"http://dx.doi.org/10.1186/s12889-022-13170-4\">doi:10.1186/s12889-022-13170-4</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">16.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-16-1\" title=\"View reference 16 in text\" id=\"ref-16\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.16\" data-doi=\"10.1111/mcn.12009\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">de Onis</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Dewey</span>  <span class=\"cit-name-given-names\">KG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Borghi</span>  <span class=\"cit-name-given-names\">E</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">The world health organization\\'s global target for reducing childhood Stunting by 2025: rationale and proposed actions</span>. <abbr class=\"cit-jnl-abbrev\">Matern Child Nutr</abbr> <span class=\"cit-pub-date\">2013</span>;<span class=\"cit-vol\">9</span>:<span class=\"cit-fpage\">6</span>–<span class=\"cit-lpage\">26</span>. <a href=\"http://dx.doi.org/10.1111/mcn.12075\">doi:10.1111/mcn.12075</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DMatern%2BChild%2BNutr%26rft.volume%253D9%26rft.spage%253D6%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fmcn.12009%26rft_id%253Dinfo%253Apmid%252F24074315%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1111/mcn.12009&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=24074315&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">17.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 17 in text\" id=\"ref-17\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.17\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">BBS</span></li></ol><cite>. <span class=\"cit-article-title\">SDG Tracker Bangladesh development mirror</span>. <span class=\"cit-pub-date\">2022</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.sdg.gov.bd/page/allgoals/4#2\">https://www.sdg.gov.bd/page/allgoals/4#2</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">18.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-16-2\" title=\"View reference 18 in text\" id=\"ref-18\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.18\" data-doi=\"10.1111/mcn.12231\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">de Onis</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Branca</span>  <span class=\"cit-name-given-names\">F</span></span></li></ol><cite>. <span class=\"cit-article-title\">Childhood Stunting: a global perspective</span>. <abbr class=\"cit-jnl-abbrev\">Matern Child Nutr</abbr> <span class=\"cit-pub-date\">2016</span>;<span class=\"cit-vol\">12</span>:<span class=\"cit-fpage\">12</span>–<span class=\"cit-lpage\">26</span>. <a href=\"http://dx.doi.org/10.1111/mcn.12231\">doi:10.1111/mcn.12231</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DMatern%2BChild%2BNutr%26rft.volume%253D12%26rft.spage%253D12%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fmcn.12231%26rft_id%253Dinfo%253Apmid%252F27187907%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1111/mcn.12231&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=27187907&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">19.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-16-2\" title=\"View reference 19 in text\" id=\"ref-19\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.19\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">WHO</span></li></ol><cite>. <span class=\"cit-article-title\">Global nutrition targets 2025: stunting policy brief</span>. <span class=\"cit-comment\">n.d.</span> <span class=\"cit-comment\">Available</span>: <a href=\"https://apps.who.int/iris/bitstream/handle/10665/149019/WHO_NMH_NHD_14.3_eng.pdf\">https://apps.who.int/iris/bitstream/handle/10665/149019/WHO_NMH_NHD_14.3_eng.pdf</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">20.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-16-2\" title=\"View reference 20 in text\" id=\"ref-20\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.20\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Shekar</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kakietek</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">D’Alimonte</span>  <span class=\"cit-name-given-names\">MR</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Reaching the global target to reduce Stunting: an investment framework</span>. <abbr class=\"cit-jnl-abbrev\">Health Policy Plan</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">32</span>:<span class=\"cit-fpage\">657</span>–<span class=\"cit-lpage\">68</span>. <a href=\"http://dx.doi.org/10.1093/heapol/czw184\">doi:10.1093/heapol/czw184</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DHealth%2BPolicy%2BPlan%26rft.volume%253D32%26rft.spage%253D657%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">21.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-1\" title=\"View reference 21 in text\" id=\"ref-21\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.21\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Alom</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Quddus</span>  <span class=\"cit-name-given-names\">MA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Islam</span>  <span class=\"cit-name-given-names\">MA</span></span></li></ol><cite>. <span class=\"cit-article-title\">Nutritional status of under-five children in Bangladesh: A Multilevel analysis</span>. <abbr class=\"cit-jnl-abbrev\">J Biosoc Sci</abbr> <span class=\"cit-pub-date\">2012</span>;<span class=\"cit-vol\">44</span>:<span class=\"cit-fpage\">525</span>–<span class=\"cit-lpage\">35</span>. <a href=\"http://dx.doi.org/10.1017/S0021932012000181\">doi:10.1017/S0021932012000181</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bbiosocial%2Bscience%26rft.stitle%253DJ%2BBiosoc%2BSci%26rft.aulast%253DAlom%26rft.auinit1%253DJ.%26rft.volume%253D44%26rft.issue%253D5%26rft.spage%253D525%26rft.epage%253D535%26rft.atitle%253DNutritional%2Bstatus%2Bof%2Bunder-five%2Bchildren%2Bin%2BBangladesh%253A%2Ba%2Bmultilevel%2Banalysis.%26rft_id%253Dinfo%253Apmid%252F22716955%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=22716955&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">22.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-1\" title=\"View reference 22 in text\" id=\"ref-22\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.22\" data-doi=\"10.1016/s0140-6736(07)60032-4\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Grantham-McGregor</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Cheung</span>  <span class=\"cit-name-given-names\">YB</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Cueto</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Developmental potential in the first 5 years for children in developing countries</span>. <abbr class=\"cit-jnl-abbrev\">The Lancet</abbr> <span class=\"cit-pub-date\">2007</span>;<span class=\"cit-vol\">369</span>:<span class=\"cit-fpage\">60</span>–<span class=\"cit-lpage\">70</span>. <a href=\"http://dx.doi.org/10.1016/S0140-6736(07)60032-4\">doi:10.1016/S0140-6736(07)60032-4</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DThe%2BLancet%26rft.volume%253D369%26rft.spage%253D60%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fs0140-6736%252807%252960032-4%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/s0140-6736(07)60032-4&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a></div></div></li><li><span class=\"ref-label\">23.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-1\" title=\"View reference 23 in text\" id=\"ref-23\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.23\" data-doi=\"10.2105/AJPH.87.8.1356\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bégin</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Habicht</span>  <span class=\"cit-name-given-names\">JP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Frongillo</span>  <span class=\"cit-name-given-names\">EA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">The deterioration in children’s nutritional status in rural Chad: the effect of mothers’ influence on feeding</span>. <abbr class=\"cit-jnl-abbrev\">Am J Public Health</abbr> <span class=\"cit-pub-date\">1997</span>;<span class=\"cit-vol\">87</span>:<span class=\"cit-fpage\">1356</span>–<span class=\"cit-lpage\">9</span>. <a href=\"http://dx.doi.org/10.2105/ajph.87.8.1356\">doi:10.2105/ajph.87.8.1356</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAmerican%2BJournal%2Bof%2BPublic%2BHealth%26rft.stitle%253DAJPH%26rft.aulast%253DBegin%26rft.auinit1%253DF%26rft.volume%253D87%26rft.issue%253D8%26rft.spage%253D1356%26rft.epage%253D1359%26rft.atitle%253DThe%2Bdeterioration%2Bin%2Bchildren%2527s%2Bnutritional%2Bstatus%2Bin%2Brural%2BChad%253A%2Bthe%2Beffect%2Bof%2Bmothers%2527%2Binfluence%2Bon%2Bfeeding.%26rft_id%253Dinfo%253Adoi%252F10.2105%252FAJPH.87.8.1356%26rft_id%253Dinfo%253Apmid%252F9279276%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.2105/AJPH.87.8.1356&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=9279276&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=A1997XR78600018&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><span class=\"ref-label\">24.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-1\" title=\"View reference 24 in text\" id=\"ref-24\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.24\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sultana</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahman</span>  <span class=\"cit-name-given-names\">MM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Akter</span>  <span class=\"cit-name-given-names\">J</span></span></li></ol><cite>. <span class=\"cit-article-title\">Correlates of Stunting among under-five children in Bangladesh: A Multilevel approach</span>. <abbr class=\"cit-jnl-abbrev\">BMC Nutr</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">5</span>:<span class=\"cit-elocation-id\">41</span>. <a href=\"http://dx.doi.org/10.1186/s40795-019-0304-9\">doi:10.1186/s40795-019-0304-9</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">25.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-2\" title=\"View reference 25 in text\" id=\"ref-25\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.25\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Faruque</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ahmed</span>  <span class=\"cit-name-given-names\">AS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ahmed</span>  <span class=\"cit-name-given-names\">T</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Nutrition: basis for healthy children and mothers in Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">J Health Popul Nutr</abbr> <span class=\"cit-pub-date\">2008</span>;<span class=\"cit-vol\">26</span>. <a href=\"http://dx.doi.org/10.3329/jhpn.v26i3.1899\">doi:10.3329/jhpn.v26i3.1899</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">26.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-2\" title=\"View reference 26 in text\" id=\"ref-26\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.26\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Muaz</span>  <span class=\"cit-name-given-names\">SSA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hasan</span>  <span class=\"cit-name-given-names\">MR</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Shamim</span>  <span class=\"cit-name-given-names\">SA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Nutritional status of 1-5 years children of the tea workers in Sylhet division</span>. <abbr class=\"cit-jnl-abbrev\">Bangladesh J Child Health</abbr> <span class=\"cit-pub-date\">1970</span>;<span class=\"cit-vol\">34</span>:<span class=\"cit-fpage\">11</span>–<span class=\"cit-lpage\">6</span>. <a href=\"http://dx.doi.org/10.3329/bjch.v34i1.5696\">doi:10.3329/bjch.v34i1.5696</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBangladesh%2BJ%2BChild%2BHealth%26rft.volume%253D34%26rft.spage%253D11%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">27.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-2\" title=\"View reference 27 in text\" id=\"ref-27\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.27\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rousham</span>  <span class=\"cit-name-given-names\">EK</span></span></li></ol><cite>. <span class=\"cit-article-title\">Socio-economic influences on gender inequalities in child health in rural Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">Eur J Clin Nutr</abbr> <span class=\"cit-pub-date\">1996</span>;<span class=\"cit-vol\">50</span>:<span class=\"cit-fpage\">560</span>–<span class=\"cit-lpage\">4</span>.</cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DEuropean%2BJournal%2Bof%2BClinical%2BNutrition%26rft.stitle%253DEuropean%2BJournal%2Bof%2BClinical%2BNutrition%26rft.aulast%253DRousham%26rft.auinit1%253DE.%2BK.%26rft.volume%253D50%26rft.issue%253D8%26rft.spage%253D560%26rft.epage%253D564%26rft.atitle%253DSocio-economic%2Binfluences%2Bon%2Bgender%2Binequalities%2Bin%2Bchild%2Bhealth%2Bin%2Brural%2BBangladesh.%26rft_id%253Dinfo%253Apmid%252F8863018%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=8863018&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">28.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-2\" title=\"View reference 28 in text\" id=\"ref-28\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.28\" data-doi=\"10.1016/0165-2281(82)90011-X\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Cochrane</span>  <span class=\"cit-name-given-names\">SH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Leslie</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">O’Hara</span>  <span class=\"cit-name-given-names\">DJ</span></span></li></ol><cite>. <span class=\"cit-article-title\">O’Hara DJ: parental education and child health: Intracountry evidence</span>. <abbr class=\"cit-jnl-abbrev\">Health Policy Educ</abbr> <span class=\"cit-pub-date\">1982</span>;<span class=\"cit-vol\">2</span>:<span class=\"cit-fpage\">213</span>–<span class=\"cit-lpage\">50</span>. <a href=\"http://dx.doi.org/10.1016/0165-2281(82)90011-x\">doi:10.1016/0165-2281(82)90011-x</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DHealth%2Bpolicy%2Band%2Beducation%26rft.stitle%253DHealth%2BPolicy%2BEduc%26rft.aulast%253DCochrane%26rft.auinit1%253DS.%2BH.%26rft.volume%253D2%26rft.issue%253D3-4%26rft.spage%253D213%26rft.epage%253D250%26rft.atitle%253DParental%2Beducation%2Band%2Bchild%2Bhealth%253A%2Bintracountry%2Bevidence.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0165-2281%252882%252990011-X%26rft_id%253Dinfo%253Apmid%252F10298649%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/0165-2281(82)90011-X&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=10298649&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=A1982NN75200002&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><span class=\"ref-label\">29.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-29-1\" title=\"View reference 29 in text\" id=\"ref-29\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.29\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Gujarati</span>  <span class=\"cit-name-given-names\">DN</span></span></li></ol><cite>. <span class=\"cit-source\">Basic econometrics, 4th edn</span>. <span class=\"cit-publ-name\">The McGraw−Hill Companies</span>, <span class=\"cit-pub-date\">2004</span>. <a href=\"http://dx.doi.org/10.1126/science.1186874\">doi:10.1126/science.1186874</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">30.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-29-1\" title=\"View reference 30 in text\" id=\"ref-30\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.30\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Daw</span>  <span class=\"cit-name-given-names\">JR</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hatfield</span>  <span class=\"cit-name-given-names\">LA</span></span></li></ol><cite>. <span class=\"cit-article-title\">Matching and regression to the mean in difference-in-differences analysis</span>. <abbr class=\"cit-jnl-abbrev\">Health Serv Res</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">53</span>:<span class=\"cit-fpage\">4138</span>–<span class=\"cit-lpage\">56</span>. <a href=\"http://dx.doi.org/10.1111/1475-6773.12993\">doi:10.1111/1475-6773.12993</a> <span class=\"cit-comment\">Available</span>: <a href=\"https://onlinelibrary.wiley.com/toc/14756773/53/6\">https://onlinelibrary.wiley.com/toc/14756773/53/6</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DHealth%2BServ%2BRes%26rft.volume%253D53%26rft.spage%253D4138%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">31.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-29-3\" title=\"View reference 31 in text\" id=\"ref-31\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.31\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Allen</span>  <span class=\"cit-name-given-names\">MP</span></span></li></ol><cite>. <span class=\"cit-source\">Understanding regression analysis</span>. <span class=\"cit-publ-loc\">Boston, MA: New York</span>: <span class=\"cit-publ-name\">Springer</span>, <span class=\"cit-pub-date\">1997</span>. <a href=\"http://dx.doi.org/10.1007/b102242\">doi:10.1007/b102242</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">32.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-32-1\" title=\"View reference 32 in text\" id=\"ref-32\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.32\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Senaviratna</span>  <span class=\"cit-name-given-names\">NAMR</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">A. Cooray</span>  <span class=\"cit-name-given-names\">TMJ</span></span></li></ol><cite>. <span class=\"cit-article-title\">Diagnosing Multicollinearity of logistic regression model</span>. <abbr class=\"cit-jnl-abbrev\">AJPAS</abbr> <span class=\"cit-pub-date\">2019</span>:<span class=\"cit-fpage\">1</span>–<span class=\"cit-lpage\">9</span>. <a href=\"http://dx.doi.org/10.9734/ajpas/2019/v5i230132\">doi:10.9734/ajpas/2019/v5i230132</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">33.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-32-1\" title=\"View reference 33 in text\" id=\"ref-33\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.33\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Aguilera</span>  <span class=\"cit-name-given-names\">AM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Escabias</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Valderrama</span>  <span class=\"cit-name-given-names\">MJ</span></span></li></ol><cite>. <span class=\"cit-article-title\">Using principal components for estimating logistic regression with high-dimensional Multicollinear data</span>. <abbr class=\"cit-jnl-abbrev\">Comput Stat Data Anal</abbr> <span class=\"cit-pub-date\">2006</span>;<span class=\"cit-vol\">50</span>:<span class=\"cit-fpage\">1905</span>–<span class=\"cit-lpage\">24</span>. <a href=\"http://dx.doi.org/10.1016/j.csda.2005.03.011\">doi:10.1016/j.csda.2005.03.011</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DComput%2BStat%2BData%2BAnal%26rft.volume%253D50%26rft.spage%253D1905%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">34.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-32-1\" title=\"View reference 34 in text\" id=\"ref-34\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.34\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Yu</span>  <span class=\"cit-name-given-names\">H</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jiang</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Land</span>  <span class=\"cit-name-given-names\">KC</span></span></li></ol><cite>. <span class=\"cit-article-title\">Multicollinearity in Hierarchical linear models</span>. <abbr class=\"cit-jnl-abbrev\">Soc Sci Res</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">53</span>:<span class=\"cit-fpage\">118</span>–<span class=\"cit-lpage\">36</span>. <a href=\"http://dx.doi.org/10.1016/j.ssresearch.2015.04.008\">doi:10.1016/j.ssresearch.2015.04.008</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DSoc%2BSci%2BRes%26rft.volume%253D53%26rft.spage%253D118%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">35.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-35-1\" title=\"View reference 35 in text\" id=\"ref-35\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.35\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tabachnick</span>  <span class=\"cit-name-given-names\">BG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Fidell</span>  <span class=\"cit-name-given-names\">LS</span></span></li></ol><cite>. <span class=\"cit-source\">Using multivariate statistics title: using multivariate statistics</span>. <span class=\"cit-pub-date\">2019</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">36.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-35-1\" title=\"View reference 36 in text\" id=\"ref-36\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.36\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Keskin</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Daskiran</span>  <span class=\"cit-name-given-names\">I</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kor</span>  <span class=\"cit-name-given-names\">A</span></span></li></ol><cite>. <span class=\"cit-article-title\">Factor analysis scores in a multiple linear regression model for the prediction of carcass weight in Akkeci kids</span>. <abbr class=\"cit-jnl-abbrev\">J Appl Animal Res</abbr> <span class=\"cit-pub-date\">2007</span>;<span class=\"cit-vol\">31</span>:<span class=\"cit-fpage\">201</span>–<span class=\"cit-lpage\">4</span>. <a href=\"http://dx.doi.org/10.1080/09712119.2007.9706664\">doi:10.1080/09712119.2007.9706664</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BAppl%2BAnimal%2BRes%26rft.volume%253D31%26rft.spage%253D201%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">37.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-37-1\" title=\"View reference 37 in text\" id=\"ref-37\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.37\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hair</span>  <span class=\"cit-name-given-names\">JF</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Anderson</span>  <span class=\"cit-name-given-names\">RE</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tatham</span>  <span class=\"cit-name-given-names\">RL</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-source\">Multivariate data analysis with readings, 5nd edn</span>. <span class=\"cit-pub-date\">1998</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">38.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-37-1\" title=\"View reference 38 in text\" id=\"ref-38\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.38\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Barbara</span>  <span class=\"cit-name-given-names\">G</span></span></li></ol><cite>. <span class=\"cit-source\">Tabachnick LSF: using multivariate statistics, 6th edn</span>. <span class=\"cit-publ-name\">Pearson</span>, <span class=\"cit-pub-date\">2013</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">39.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-39-1\" title=\"View reference 39 in text\" id=\"ref-39\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.39\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tulachan</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lama</span>  <span class=\"cit-name-given-names\">PY</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Upadhyaya</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Translation, adaptation and validation of Nepali version of Rosenberg self esteem scale in adult Nepali population</span>. <abbr class=\"cit-jnl-abbrev\">SSM - Mental Health</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">2</span>:<span class=\"cit-fpage\">100150</span>. <a href=\"http://dx.doi.org/10.1016/j.ssmmh.2022.100150\">doi:10.1016/j.ssmmh.2022.100150</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DSSM%2B-%2BMental%2BHealth%26rft.volume%253D2%26rft.spage%253D100150%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">40.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-40-1\" title=\"View reference 40 in text\" id=\"ref-40\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.40\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Aletras</span>  <span class=\"cit-name-given-names\">VH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kostarelis</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsitouridou</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Development and preliminary validation of a questionnaire to measure satisfaction with home care in Greece: an exploratory factor analysis of Polychoric correlations</span>. <abbr class=\"cit-jnl-abbrev\">BMC Health Serv Res</abbr> <span class=\"cit-pub-date\">2010</span>;<span class=\"cit-vol\">10</span>:<span class=\"cit-elocation-id\">189</span>. <a href=\"http://dx.doi.org/10.1186/1472-6963-10-189\">doi:10.1186/1472-6963-10-189</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">41.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-41-1\" title=\"View reference 41 in text\" id=\"ref-41\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.41\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">de Gavelle</span>  <span class=\"cit-name-given-names\">E</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Huneau</span>  <span class=\"cit-name-given-names\">J-F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mariotti</span>  <span class=\"cit-name-given-names\">F</span></span></li></ol><cite>. <span class=\"cit-article-title\">Patterns of protein food intake are associated with nutrient adequacy in the general French adult population</span>. <abbr class=\"cit-jnl-abbrev\">Nutrients</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">10</span>:<span class=\"cit-fpage\">226</span>. <a href=\"http://dx.doi.org/10.3390/nu10020226\">doi:10.3390/nu10020226</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNutrients%26rft.volume%253D10%26rft.spage%253D226%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">42.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-41-1\" title=\"View reference 42 in text\" id=\"ref-42\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.42\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zárate-Ortiz</span>  <span class=\"cit-name-given-names\">AG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Melse-Boonstra</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rodríguez-Ramírez</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Dietary patterns and the double burden of malnutrition in Mexican adolescents: results from ENSANUT-2006</span>. <abbr class=\"cit-jnl-abbrev\">Nutrients</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">11</span>:<span class=\"cit-fpage\">2753</span>. <a href=\"http://dx.doi.org/10.3390/nu11112753\">doi:10.3390/nu11112753</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNutrients%26rft.volume%253D11%26rft.spage%253D2753%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">43.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-43-1\" title=\"View reference 43 in text\" id=\"ref-43\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.43\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">NIPORT</span></li></ol><cite>. <span class=\"cit-chapter-title\">Bangladesh demographic and health survey 2007</span>. <span class=\"cit-comment\">In</span>: <span class=\"cit-source\">National Institute of Population Research and training (NIPORT), Mitra and Associates and ORC Macro</span>. <span class=\"cit-publ-loc\">Calverton, MD</span>, <span class=\"cit-pub-date\">2009</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">44.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-44-1\" title=\"View reference 44 in text\" id=\"ref-44\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.44\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">De Onis</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Blössner</span>  <span class=\"cit-name-given-names\">M</span></span></li></ol><cite>. <span class=\"cit-article-title\">WHO global database on child growth and malnutrition</span>. <abbr class=\"cit-jnl-abbrev\">Program Nutr</abbr> <span class=\"cit-pub-date\">1997</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">45.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-44-1\" title=\"View reference 45 in text\" id=\"ref-45\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.45\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">Report of a WHO Expert Committee</span></li></ol><cite>. <span class=\"cit-article-title\">Physical status: the use and interpretation of Anthropometry</span>. <abbr class=\"cit-jnl-abbrev\">World Health Organ Tech Rep Ser</abbr> <span class=\"cit-pub-date\">1995</span>;<span class=\"cit-vol\">854</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">46.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 46 in text\" id=\"ref-46\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.46\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Karl</span>  <span class=\"cit-name-given-names\">PFR</span></span></li></ol><cite>. <span class=\"cit-article-title\">I. mathematical contributions to the theory of evolution. —VII. on the correlation of characters not quantitatively measurable</span>. <abbr class=\"cit-jnl-abbrev\">Phil Trans R Soc Lond A</abbr> <span class=\"cit-pub-date\">1901</span>;<span class=\"cit-vol\">195</span>:<span class=\"cit-fpage\">1</span>–<span class=\"cit-lpage\">47</span>. <a href=\"http://dx.doi.org/10.1098/rsta.1900.0022\">doi:10.1098/rsta.1900.0022</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DPhil%2BTrans%2BR%2BSoc%2BLond%2BA%26rft.volume%253D195%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">47.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 47 in text\" id=\"ref-47\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.47\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mardia</span>  <span class=\"cit-name-given-names\">KV</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kent</span>  <span class=\"cit-name-given-names\">JT</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bibby</span>  <span class=\"cit-name-given-names\">JM</span></span></li></ol><cite>. <span class=\"cit-chapter-title\">Multivariate analysis</span>. <span class=\"cit-comment\">In</span>: <span class=\"cit-source\">Probability and mathematical statistics. London-New York-Toronto-Sydney-San Francisco, Academic Press 1979</span>. <span class=\"cit-publ-loc\">London</span>,</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">48.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 48 in text\" id=\"ref-48\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.48\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ruggeri</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kenett</span>  <span class=\"cit-name-given-names\">RS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Faltin</span>  <span class=\"cit-name-given-names\">FW</span></span></li></ol><cite>. <span class=\"cit-chapter-title\">Encyclopedia of Statistics in quality and reliability</span>. <span class=\"cit-comment\">In</span>: <span class=\"cit-source\">Applied multivariate statistical analysis, 6th edn</span>. <span class=\"cit-day\">14</span> <span class=\"cit-month\">December</span> <span class=\"cit-pub-date\">2007</span>. <a href=\"http://dx.doi.org/10.1002/9780470061572\">doi:10.1002/9780470061572</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">49.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 49 in text\" id=\"ref-49\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.49\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mostafa Kamal</span>  <span class=\"cit-name-given-names\">SM</span></span></li></ol><cite>. <span class=\"cit-article-title\">Socio-economic determinants of severe and moderate Stunting among under-five children of rural Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">Malays J Nutr</abbr> <span class=\"cit-pub-date\">2011</span>;<span class=\"cit-vol\">17</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">50.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 50 in text\" id=\"ref-50\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.50\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Islam</span>  <span class=\"cit-name-given-names\">MM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Alam</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tariquzaman</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Predictors of the number of under-five malnourished children in Bangladesh: application of the generalized Poisson regression model</span>. <abbr class=\"cit-jnl-abbrev\">BMC Public Health</abbr> <span class=\"cit-pub-date\">2013</span>;<span class=\"cit-vol\">13</span>:<span class=\"cit-elocation-id\">11</span>. <a href=\"http://dx.doi.org/10.1186/1471-2458-13-11\">doi:10.1186/1471-2458-13-11</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">51.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 51 in text\" id=\"ref-51\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.51\" data-doi=\"10.3961/jpmph.2008.41.4.232\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hien</span>  <span class=\"cit-name-given-names\">NN</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kam</span>  <span class=\"cit-name-given-names\">S</span></span></li></ol><cite>. <span class=\"cit-article-title\">Nutritional status and the characteristics related to malnutrition in children under five years of age in Nghean</span>. <abbr class=\"cit-jnl-abbrev\">J Prev Med Public Health</abbr> <span class=\"cit-pub-date\">2008</span>;<span class=\"cit-vol\">41</span>:<span class=\"cit-fpage\">232</span>–<span class=\"cit-lpage\">40</span>. <a href=\"http://dx.doi.org/10.3961/jpmph.2008.41.4.232\">doi:10.3961/jpmph.2008.41.4.232</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.stitle%253DJ%2BPrev%2BMed%2BPublic%2BHealth%26rft.aulast%253DHien%26rft.auinit1%253DN.%2BN.%26rft.volume%253D41%26rft.issue%253D4%26rft.spage%253D232%26rft.epage%253D240%26rft.atitle%253DNutritional%2Bstatus%2Band%2Bthe%2Bcharacteristics%2Brelated%2Bto%2Bmalnutrition%2Bin%2Bchildren%2Bunder%2Bfive%2Byears%2Bof%2Bage%2Bin%2BNghean%252C%2BVietnam.%26rft_id%253Dinfo%253Adoi%252F10.3961%252Fjpmph.2008.41.4.232%26rft_id%253Dinfo%253Apmid%252F18664729%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.3961/jpmph.2008.41.4.232&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=18664729&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">52.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 52 in text\" id=\"ref-52\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.52\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Meshram</span>  <span class=\"cit-name-given-names\">II</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Arlappa</span>  <span class=\"cit-name-given-names\">N</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Balakrishna</span>  <span class=\"cit-name-given-names\">N</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Trends in the prevalence of Undernutrition, nutrient &amp; food intake and predictors of Undernutrition among under five year tribal children in India</span>. <abbr class=\"cit-jnl-abbrev\">Asia Pac J Clin Nutr</abbr> <span class=\"cit-pub-date\">2012</span>;<span class=\"cit-vol\">21</span>:<span class=\"cit-fpage\">568</span>–<span class=\"cit-lpage\">76</span>.</cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAsia%2BPacific%2Bjournal%2Bof%2Bclinical%2Bnutrition%26rft.stitle%253DAsia%2BPac%2BJ%2BClin%2BNutr%26rft.aulast%253DMeshram%26rft.auinit1%253DI.%2BI.%26rft.volume%253D21%26rft.issue%253D4%26rft.spage%253D568%26rft.epage%253D576%26rft.atitle%253DTrends%2Bin%2Bthe%2Bprevalence%2Bof%2Bundernutrition%252C%2Bnutrient%2Band%2Bfood%2Bintake%2Band%2Bpredictors%2Bof%2Bundernutrition%2Bamong%2Bunder%2Bfive%2Byear%2Btribal%2Bchildren%2Bin%2BIndia.%26rft_id%253Dinfo%253Apmid%252F23017315%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=23017315&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">53.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 53 in text\" id=\"ref-53\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.53\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sah</span>  <span class=\"cit-name-given-names\">N</span></span></li></ol><cite>. <span class=\"cit-article-title\">Determinants of child malnutrition in Nepal: a case analysis from Dhanusha, central Terai of Nepal</span>. <abbr class=\"cit-jnl-abbrev\">J Nepal Health Res Counc</abbr> <span class=\"cit-pub-date\">2004</span>;<span class=\"cit-vol\">2</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">54.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 54 in text\" id=\"ref-54\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.54\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ruwali</span>  <span class=\"cit-name-given-names\">D</span></span></li></ol><cite>. <span class=\"cit-article-title\">Nutritional status of children under five years of age and factors associated in Padampur VDC, Chitwan</span>. <abbr class=\"cit-jnl-abbrev\">Health Prospect</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">10</span>:<span class=\"cit-fpage\">14</span>–<span class=\"cit-lpage\">8</span>. <a href=\"http://dx.doi.org/10.3126/hprospect.v10i0.5639\">doi:10.3126/hprospect.v10i0.5639</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DHealth%2BProspect%26rft.volume%253D10%26rft.spage%253D14%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">5.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 5 in text\" id=\"ref-55\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.55\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Babatunde</span>  <span class=\"cit-name-given-names\">RO</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Olagunju</span>  <span class=\"cit-name-given-names\">FI</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Fakayode</span>  <span class=\"cit-name-given-names\">SB</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-comment\">n.d.</span> <span class=\"cit-article-title\">Prevalence and determinants of malnutrition among under-five children of farming households in Kwara state, Nigeria</span>. <abbr class=\"cit-jnl-abbrev\">JAS</abbr>;<span class=\"cit-vol\">3</span>. <a href=\"http://dx.doi.org/10.5539/jas.v3n3p173\">doi:10.5539/jas.v3n3p173</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">56.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 56 in text\" id=\"ref-56\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.56\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Star</span>  <span class=\"cit-name-given-names\">TD</span></span></li></ol><cite>. <span class=\"cit-article-title\">Poverty reduced significantly</span>. <span class=\"cit-pub-date\">2023</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.thedailystar.net/business/news/commerce-minister-seeks-uzbek-investment-sezs-3323536\">https://www.thedailystar.net/business/news/commerce-minister-seeks-uzbek-investment-sezs-3323536</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">57.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 57 in text\" id=\"ref-57\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.57\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">The World Bank</span></li></ol><cite>. <span class=\"cit-article-title\">Social safety nets in Bangladesh help reduce poverty and improve human capital</span>. <span class=\"cit-pub-date\">2019</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.worldbank.org/en/news/feature/2019/04/29/social-safety-nets-in-bangladesh-help-reduce-poverty-and-improve-human-capital\">https://www.worldbank.org/en/news/feature/2019/04/29/social-safety-nets-in-bangladesh-help-reduce-poverty-and-improve-human-capital</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">58.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 58 in text\" id=\"ref-58\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.58\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">UNICEF</span></li></ol><cite>. <span class=\"cit-article-title\">World food programme: saving lives changing lives</span>. <span class=\"cit-pub-date\">2021</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.wfp.org\">https://www.wfp.org</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">59.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 59 in text\" id=\"ref-59\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.59\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">UN</span></li></ol><cite>. <span class=\"cit-article-title\">FAO in Bangladesh</span>. <span class=\"cit-pub-date\">2023</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://www.fao.org/bangladesh/en\">https://www.fao.org/bangladesh/en</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">60.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 60 in text\" id=\"ref-60\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.60\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ahmed</span>  <span class=\"cit-name-given-names\">N</span></span></li></ol><cite>. <span class=\"cit-source\">How do we overcome spatial inequality in Bangladesh</span>. <span class=\"cit-pub-date\">2022</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">61.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 61 in text\" id=\"ref-61\">↵</a><div class=\"cit ref-cit ref-web\" id=\"cit-13.6.e070480.61\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">Information C for R</span></li></ol><cite>. <span class=\"cit-article-title\">Poverty reduction in Bangladesh: recent progress</span>. <span class=\"cit-pub-date\">2014</span>. <span class=\"cit-comment\">Available</span>: <a href=\"https://cri.org.bd/2014/07/02/poverty-reduction-in-bangladesh-recent-progress\">https://cri.org.bd/2014/07/02/poverty-reduction-in-bangladesh-recent-progress</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">62.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 62 in text\" id=\"ref-62\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.62\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das</span>  <span class=\"cit-name-given-names\">TK</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Haldar</span>  <span class=\"cit-name-given-names\">SK</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das Gupta</span>  <span class=\"cit-name-given-names\">I</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">River Bank erosion induced human displacement and its consequences</span>. <abbr class=\"cit-jnl-abbrev\">Living Rev Landscape Res</abbr> <span class=\"cit-pub-date\">2014</span>;<span class=\"cit-vol\">8</span>. <a href=\"http://dx.doi.org/10.12942/lrlr-2014-3\">doi:10.12942/lrlr-2014-3</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">63.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-21-3\" title=\"View reference 63 in text\" id=\"ref-63\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.63\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chowdhury</span>  <span class=\"cit-name-given-names\">TR</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chakrabarty</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rakib</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Risk factors for child Stunting in Bangladesh: an analysis using MICS 2019 data</span>. <abbr class=\"cit-jnl-abbrev\">Arch Public Health</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">80</span>:<span class=\"cit-elocation-id\">126</span>. <a href=\"http://dx.doi.org/10.1186/s13690-022-00870-x\">doi:10.1186/s13690-022-00870-x</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">64.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-64-1\" title=\"View reference 64 in text\" id=\"ref-64\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.64\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hossain</span>  <span class=\"cit-name-given-names\">MM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Abdulla</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahman</span>  <span class=\"cit-name-given-names\">A</span></span></li></ol><cite>. <span class=\"cit-article-title\">Prevalence and determinants of wasting of Under-5 children in Bangladesh: Quantile regression approach</span>. <abbr class=\"cit-jnl-abbrev\">PLoS One</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">17</span>:<span class=\"cit-elocation-id\">e0278097</span>. <a href=\"http://dx.doi.org/10.1371/journal.pone.0278097\">doi:10.1371/journal.pone.0278097</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">65.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-64-1\" title=\"View reference 65 in text\" id=\"ref-65\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.65\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sharaf</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rashad</span>  <span class=\"cit-name-given-names\">A</span></span></li></ol><cite>. <span class=\"cit-article-title\">Economic and socio-demographic determinants of child nutritional status in Egypt: a comprehensive analysis using Quantile regression approach</span>. <abbr class=\"cit-jnl-abbrev\">Work Pap - Dep Econ Univ Alberta</abbr> <span class=\"cit-pub-date\">2016</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">66.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-64-1\" title=\"View reference 66 in text\" id=\"ref-66\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.66\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Aheto</span>  <span class=\"cit-name-given-names\">JMK</span></span></li></ol><cite>. <span class=\"cit-article-title\">Simultaneous Quantile regression and determinants of under-five severe chronic malnutrition in Ghana</span>. <abbr class=\"cit-jnl-abbrev\">BMC Public Health</abbr> <span class=\"cit-pub-date\">2020</span>;<span class=\"cit-vol\">20</span>. <a href=\"http://dx.doi.org/10.1186/s12889-020-08782-7\">doi:10.1186/s12889-020-08782-7</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">67.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-67-1\" title=\"View reference 67 in text\" id=\"ref-67\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.67\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Haddad</span>  <span class=\"cit-name-given-names\">WD</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Carnoy</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rinaldi</span>  <span class=\"cit-name-given-names\">R</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Education and development: evidence for new priorities</span>. <abbr class=\"cit-jnl-abbrev\">World Bank Discuss Pap</abbr> <span class=\"cit-pub-date\">1990</span>;<span class=\"cit-vol\">95</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">68.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-68-1\" title=\"View reference 68 in text\" id=\"ref-68\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.68\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Begum</span>  <span class=\"cit-name-given-names\">HA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Perveen</span>  <span class=\"cit-name-given-names\">R</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chakma</span>  <span class=\"cit-name-given-names\">E</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">The challenges of geographical inclusive education in rural Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">International Journal of Inclusive Education</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">23</span>:<span class=\"cit-fpage\">7</span>–<span class=\"cit-lpage\">22</span>. <a href=\"http://dx.doi.org/10.1080/13603116.2018.1514729\">doi:10.1080/13603116.2018.1514729</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DInternational%2BJournal%2Bof%2BInclusive%2BEducation%26rft.volume%253D23%26rft.spage%253D7%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">69.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-49-2\" title=\"View reference 69 in text\" id=\"ref-69\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.69\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Gulshan</span>  <span class=\"cit-name-given-names\">J</span></span></li></ol><cite>. <span class=\"cit-article-title\">Different forms of malnutrition among under five children in Bangladesh: A cross sectional study on prevalence and determinants</span>. <abbr class=\"cit-jnl-abbrev\">BMC Nutr</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">3</span>. <a href=\"http://dx.doi.org/10.1186/s40795-016-0122-2\">doi:10.1186/s40795-016-0122-2</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">70.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-49-2\" title=\"View reference 70 in text\" id=\"ref-70\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.70\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Islam</span>  <span class=\"cit-name-given-names\">MS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sultana Jothi</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Huq</span>  <span class=\"cit-name-given-names\">AKO</span></span></li></ol><cite>. <span class=\"cit-source\">Nutritional status of rural and urban under-five children in Tangail District, Bangladesh</span>. <span class=\"cit-pub-date\">2014</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">71.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-71-1\" title=\"View reference 71 in text\" id=\"ref-71\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.71\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hosen</span>  <span class=\"cit-name-given-names\">MZ</span></span></li></ol><cite>. <span class=\"cit-article-title\">Impact of maternal employment on children malnutrition status in bangladesh: an empirical analysis</span>. <abbr class=\"cit-jnl-abbrev\">J Soc Econ Dev</abbr> <span class=\"cit-pub-date\">2023</span>. <a href=\"http://dx.doi.org/10.1007/s40847-023-00232-5\">doi:10.1007/s40847-023-00232-5</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">72.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-72-1\" title=\"View reference 72 in text\" id=\"ref-72\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.72\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rashad</span>  <span class=\"cit-name-given-names\">AS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sharaf</span>  <span class=\"cit-name-given-names\">MF</span></span></li></ol><cite>. <span class=\"cit-article-title\">Does maternal employment affect child nutrition status? New evidence from Egypt</span>. <abbr class=\"cit-jnl-abbrev\">Oxford Development Studies</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">47</span>:<span class=\"cit-fpage\">48</span>–<span class=\"cit-lpage\">62</span>. <a href=\"http://dx.doi.org/10.1080/13600818.2018.1497589\">doi:10.1080/13600818.2018.1497589</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DOxford%2BDevelopment%2BStudies%26rft.volume%253D47%26rft.spage%253D48%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">73.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-73-1\" title=\"View reference 73 in text\" id=\"ref-73\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.73\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jakaria</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bakshi</span>  <span class=\"cit-name-given-names\">RK</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hasan</span>  <span class=\"cit-name-given-names\">MM</span></span></li></ol><cite>. <span class=\"cit-article-title\">Is maternal employment detrimental to children’s nutritional status</span>. <abbr class=\"cit-jnl-abbrev\">Review Development Economics</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">26</span>:<span class=\"cit-fpage\">85</span>–<span class=\"cit-lpage\">111</span>. <a href=\"http://dx.doi.org/10.1111/rode.12819\">doi:10.1111/rode.12819</a> <span class=\"cit-comment\">Available</span>: <a href=\"https://onlinelibrary.wiley.com/toc/14679361/26/1\">https://onlinelibrary.wiley.com/toc/14679361/26/1</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DReview%2BDevelopment%2BEconomics%26rft.volume%253D26%26rft.spage%253D85%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">74.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-74-1\" title=\"View reference 74 in text\" id=\"ref-74\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.74\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Al-Zubayer</span>  <span class=\"cit-name-given-names\">MA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Shanto</span>  <span class=\"cit-name-given-names\">HH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kumkum</span>  <span class=\"cit-name-given-names\">R</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Ahammed B: prevalence and socioeconomic determinants of awareness and Visitation of community clinic among ever married women: evidence from Bangladesh demographic and health survey, 2017-2018</span>. <abbr class=\"cit-jnl-abbrev\">BMJ Open</abbr> <span class=\"cit-pub-date\">2023</span>;<span class=\"cit-vol\">13</span>:<span class=\"cit-elocation-id\">e067823</span>. <a href=\"http://dx.doi.org/10.1136/bmjopen-2022-067823\">doi:10.1136/bmjopen-2022-067823</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">75.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-75-1\" title=\"View reference 75 in text\" id=\"ref-75\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.75\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kuhnt</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Vollmer</span>  <span class=\"cit-name-given-names\">S</span></span></li></ol><cite>. <span class=\"cit-article-title\">Antenatal care services and its implications for vital and health outcomes of children: evidence from 193 surveys in 69 low-income and middle-income countries</span>. <abbr class=\"cit-jnl-abbrev\">BMJ Open</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">7</span>:<span class=\"cit-elocation-id\">e017122</span>. <a href=\"http://dx.doi.org/10.1136/bmjopen-2017-017122\">doi:10.1136/bmjopen-2017-017122</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">76.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-75-1\" title=\"View reference 76 in text\" id=\"ref-76\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.76\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Abdulla</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rahman</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hossain</span>  <span class=\"cit-name-given-names\">MM</span></span></li></ol><cite>. <span class=\"cit-article-title\">Prevalence and risk predictors of childhood Stunting in Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">PLoS One</abbr> <span class=\"cit-pub-date\">2023</span>;<span class=\"cit-vol\">18</span>:<span class=\"cit-elocation-id\">e0279901</span>. <a href=\"http://dx.doi.org/10.1371/journal.pone.0279901\">doi:10.1371/journal.pone.0279901</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">77.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-77-1\" title=\"View reference 77 in text\" id=\"ref-77\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e070480.77\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">GoB</span></li></ol><cite>. <span class=\"cit-source\">Sector development plan FY 2011-2025: water supply and sanitation sector in Bangladesh</span>. <span class=\"cit-pub-date\">2011</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">78.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-78-1\" title=\"View reference 78 in text\" id=\"ref-78\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.78\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">BANK AD</span></li></ol><cite>. <span class=\"cit-article-title\">Bangladesh: country strategy and program (2006-2010). institutional document</span>. <span class=\"cit-pub-date\">2005</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">79.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-79-1\" title=\"View reference 79 in text\" id=\"ref-79\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.79\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">BANK AD</span></li></ol><cite>. <span class=\"cit-article-title\">Bangladesh: country partnership strategy (2011-2015)</span>. <span class=\"cit-pub-date\">2011</span>.</cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">80.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-24-2\" title=\"View reference 80 in text\" id=\"ref-80\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.80\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hong</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Id</span>  <span class=\"cit-name-given-names\">N</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tauseef</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">And hypertension in Bangladesh2004To 2022</span>. <span class=\"cit-pub-date\">2022</span>:<span class=\"cit-fpage\">1</span>–<span class=\"cit-lpage\">20</span>. <a href=\"http://dx.doi.org/10.1371/journal.pone.0275151\">doi:10.1371/journal.pone.0275151</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">81.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-24-2\" title=\"View reference 81 in text\" id=\"ref-81\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.81\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Siddiqi</span>  <span class=\"cit-name-given-names\">MNA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Haque</span>  <span class=\"cit-name-given-names\">MN</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Goni</span>  <span class=\"cit-name-given-names\">MA</span></span></li></ol><cite>. <span class=\"cit-article-title\">Malnutrition of under-five children: evidence from Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">Asian J Med Sci</abbr> <span class=\"cit-pub-date\">2011</span>;<span class=\"cit-vol\">2</span>:<span class=\"cit-fpage\">113</span>–<span class=\"cit-lpage\">9</span>. <a href=\"http://dx.doi.org/10.3126/ajms.v2i2.3662\">doi:10.3126/ajms.v2i2.3662</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAsian%2BJ%2BMed%2BSci%26rft.volume%253D2%26rft.spage%253D113%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><span class=\"ref-label\">82.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-24-2\" title=\"View reference 82 in text\" id=\"ref-82\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.82\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Das</span>  <span class=\"cit-name-given-names\">R</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kabir</span>  <span class=\"cit-name-given-names\">MF</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ashorn</span>  <span class=\"cit-name-given-names\">P</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Maternal Underweight and its association with composite index of Anthropometric failure among children under two years of age with diarrhea in Bangladesh</span>. <abbr class=\"cit-jnl-abbrev\">Nutrients</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">14</span>:<span class=\"cit-elocation-id\">1935</span>. <a href=\"http://dx.doi.org/10.3390/nu14091935\">doi:10.3390/nu14091935</a></cite></div><div class=\"cit-extra\"></div></div></li><li><span class=\"ref-label\">83.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-83-1\" title=\"View reference 83 in text\" id=\"ref-83\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.83\" data-doi=\"10.1016/s0140-6736(21)00394-9\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Victora</span>  <span class=\"cit-name-given-names\">CG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Christian</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Vidaletti</span>  <span class=\"cit-name-given-names\">LP</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Revisiting maternal and child Undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda</span>. <abbr class=\"cit-jnl-abbrev\">Lancet</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">397</span>:<span class=\"cit-fpage\">1388</span>–<span class=\"cit-lpage\">99</span>. <a href=\"http://dx.doi.org/10.1016/S0140-6736(21)00394-9\">doi:10.1016/S0140-6736(21)00394-9</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.volume%253D397%26rft.spage%253D1388%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fs0140-6736%252821%252900394-9%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/s0140-6736(21)00394-9&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><span class=\"ref-label\">84.</span><a class=\"rev-xref-ref\" href=\"#xref-ref-83-1\" title=\"View reference 84 in text\" id=\"ref-84\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e070480.84\" data-doi=\"10.1016/S0140-6736(07)61690-0\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Black</span>  <span class=\"cit-name-given-names\">RE</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Allen</span>  <span class=\"cit-name-given-names\">LH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bhutta</span>  <span class=\"cit-name-given-names\">ZA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Maternal and child Undernutrition: global and regional exposures and health consequences</span>. <abbr class=\"cit-jnl-abbrev\">Lancet</abbr> <span class=\"cit-pub-date\">2008</span>;<span class=\"cit-vol\">371</span>:<span class=\"cit-fpage\">243</span>–<span class=\"cit-lpage\">60</span>. <a href=\"http://dx.doi.org/10.1016/S0140-6736(07)61690-0\">doi:10.1016/S0140-6736(07)61690-0</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DBlack%26rft.auinit1%253DR.%2BE.%26rft.volume%253D371%26rft.issue%253D9608%26rft.spage%253D243%26rft.epage%253D260%26rft.atitle%253DMaternal%2Band%2Bchild%2Bundernutrition%253A%2Bglobal%2Band%2Bregional%2Bexposures%2Band%2Bhealth%2Bconsequences.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252807%252961690-0%26rft_id%253Dinfo%253Apmid%252F18207566%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/S0140-6736(07)61690-0&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=18207566&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe070480.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000252471900028&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li></ol></div><span class=\"highwire-journal-article-marker-end\"></span></div><span class=\"related-urls\"></span></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-article-data-supp\" id=\"supplementary-materials\">\\n  \\n        <h2 class=\"pane-title\">Supplementary materials</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"item-list\"><ul><li class=\"first last\"><div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"content-block\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div><span class=\"highwire-journal-article-marker-start\"></span><div class=\"auto-clean\"><span style=\"font-family: Verdana,Arial,Helvetica,sans-serif;  font-size: 83.33%\">\\n         \\n            <h2>Supplementary Data</h2>\\n            <p>This web only file has been produced by the BMJ Publishing Group from an electronic\\n               file supplied by the author(s) and has not been edited for content.\\n            </p>\\n            <ul><li><a href=\"/highwire/filestream/289395/field_highwire_adjunct_files/0/bmjopen-2022-070480supp001_data_supplement.pdf\" class=\"rewritten\" data-icon-position=\"\" data-hide-link-title=\"0\">Data supplement 1</a> \\n                  \\n               </li></ul>\\n         </span>\\n      \\n   </div><span class=\"highwire-journal-article-marker-end\"></span></div><span id=\"related-urls\"></span></div></div></li>\\n</ul></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup footnotes\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div xmlns:xhtml=\"http://www.w3.org/1999/xhtml\" class=\"section fn-group\" id=\"fn-group-1\"><h2>Footnotes</h2><ul><li class=\"fn-other\" id=\"fn-7\"><p id=\"p-59\"><span class=\"fn-label\">Contributors</span> Study design and data curation: MTR and PS. Statistical analysis and interpretation: MTR and PS. Drafting the manuscript: MTR, PS, MJA and NA. Review and editing: PS, MJA, DCR and NA. Contributed to discussion and finishing: MTR, PS, MJA and DCR. Supervision: PS and DCR. All authors have read and approved the final manuscript. MTR is the guarantor of the study.</p></li><li class=\"fn-other\" id=\"fn-8\"><p id=\"p-60\"><span class=\"fn-label\">Funding</span> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p></li><li class=\"fn-conflict\" id=\"fn-9\"><p id=\"p-61\"><span class=\"fn-label\">Competing interests</span> None declared.</p></li><li class=\"fn-other\" id=\"fn-10\"><p id=\"p-62\"><span class=\"fn-label\">Patient and public involvement</span> Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.</p></li><li class=\"fn-other\" id=\"fn-11\"><p id=\"p-63\"><span class=\"fn-label\">Provenance and peer review</span> Not commissioned; externally peer reviewed.</p></li><li class=\"fn-other\" id=\"fn-12\"><p id=\"p-64\"><span class=\"fn-label\">Supplemental material</span> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></li></ul></div></div></div>  </div>\\n\\n  \\n  </div>\\n</div>\\n  </div>'"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "main_text[text_id][1]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Iteration 1"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## prompts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "prep_step = [\n",
    "    \"Think about why this might be relevant for the audience in the grand scheme of things.\\\n",
    "    \\nIdentify 1 or 2 key concepts from this article that would make interesting or helpful health content. \\\n",
    "    Exclude details that do not add value to the audience.\\\n",
    "    \\nBased on the key concepts from the previous steps, extract the key points and result statistics to\",\n",
    "]\n",
    "\n",
    "summarize_task = [\n",
    "    \"summarize for a LinkedIn post.\",\n",
    "    # \"Describe the interesting points to your coworker at the water cooler\",\n",
    "    # \"Create an Instagram post without hashtags.\",\n",
    "]\n",
    "edit_task = [\n",
    "    \"\\nIf applicable, include a brief description of the research participants, \\\n",
    "    such as age and sex, within the body of the summary. \\\n",
    "    Otherwise, you can skip this step.\\\n",
    "    \\nEvaluate whether or not your writing may be confusing or redundant. \\\n",
    "    \\nIf so, re-write it so it is clear and concise. Otherwise, keep it the same. \\\n",
    "    \\nCreate an intriguing headline to hook the audience.\\\n",
    "    \\nReturn your response in this format:\\\n",
    "    \\n<headline>\\n\\n<summary>\\\n",
    "    \\nwhere the summary is a publication-ready format.\\\n",
    "    \\nDo not label the headline and summary.\",\n",
    "]\n",
    "\n",
    "system_role = \"You are a journalist writing content based on science research articles.\"\n",
    "prompts_df = pd.DataFrame(product(prep_step, summarize_task, edit_task), \n",
    "    columns=['prep_step', 'summarize_task', 'edit_task'])\n",
    "\n",
    "user_simplify_task = [\n",
    "    \"\"\"If needed, rewrite the headline and text using terms appropriate for the audience. If not keep it the same.\\\n",
    "    Follow these steps to accomplish this: \\\n",
    "    \\n1. Check if the content and language are appropriate for the audience. \\\n",
    "    \\n2. If it is suitable for the audience, keep it the same. If not, rewrite using terms appropriate for the audience. \\ \n",
    "    \\n3. Return the final version of the headline and text to be shown to the audience. \\\n",
    "    \\nIt should be in this format:\\\n",
    "    \\n<headline>\\n\\n<summary>\\\n",
    "    \\n\\nwhere the summary is in paragraph form.\\\n",
    "    \\n4. Remove the backticks. Do not label the headline and summary. \",\n",
    "    \\n\\nYour audience is\"\"\",\n",
    "]\n",
    "\n",
    "simplify_audience = [\n",
    "    # \"a lay audience\",\n",
    "    \"people who are not science experts\",\n",
    "]\n",
    "\n",
    "user_relevance_task = [\n",
    "    \"\"\"Rewrite the headline and text to include a statement of how it is relevant for the audience. \\\n",
    "    Follow these steps to accomplish this: \\\n",
    "    \\n1. Think about why this might be relevant for the audience in the grand scheme of things.\\\n",
    "    \\n2. If it is not evident why the text is relevant for the audience in the grand scheme of things, \\\n",
    "    add a sentence to inform the audience. Otherwise, keep it the same. \\\n",
    "    Avoid making claims that are not supported by science.\\\n",
    "    \\n3. Modify the content if needed to reduce redundancy. \\\n",
    "    \\n4. Check if the content and language are appropriate for the audience. \\\n",
    "    If it is suitable for the audience, keep it the same. If not, rewrite using terms appropriate for the audience. \\ \n",
    "    \\n5. Return the final version of the headline and text to be shown to the audience. \\\n",
    "    \\nIt should be in this format:\\\n",
    "    \\n<headline>\\n\\n<summary>\\\n",
    "    \\n\\nwhere the summary is in paragraph form.\\\n",
    "    \\n6. Remove the backticks. Do not label the headline and summary. \",\n",
    "    \\n\\nYour audience consists of\"\"\",\n",
    "]\n",
    "\n",
    "relevance_audience = [\n",
    "    \"seniors\",\n",
    "    # \"people who enjoy sports\",\n",
    "    # \"people new to resistance training\",\n",
    "    \"people starting an exercise program\"\n",
    "]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**Text #0 prompt #1 of 1**\n",
      "Creating Chaining class instance\n",
      "***OpenAI model: gpt-3.5-turbo-16k-0613\n",
      "Chaining class instance created\n",
      "\tDone creating prompt\n",
      "\tSending request to gpt-3.5-turbo-16k-0613\n",
      "\t\tRequesting 2 choices using gpt-3.5-turbo-16k-0613\n",
      "An error occurred on line 145 in C:\\Users\\silvh\\OneDrive\\lighthouse\\Ginkgo coding\\content-summarization\\src\\summary_chain.py : This model's maximum context length is 16385 tokens. However, your messages resulted in 55181 tokens. Please reduce the length of the messages.\n",
      "\t**API request failed for `.summarize()`**\n",
      "\t...Completed\n",
      "**Text #1 prompt #1 of 1**\n",
      "Creating Chaining class instance\n",
      "***OpenAI model: gpt-3.5-turbo-16k-0613\n",
      "Chaining class instance created\n",
      "\tDone creating prompt\n",
      "\tSending request to gpt-3.5-turbo-16k-0613\n",
      "\t\tRequesting 2 choices using gpt-3.5-turbo-16k-0613\n",
      "An error occurred on line 145 in C:\\Users\\silvh\\OneDrive\\lighthouse\\Ginkgo coding\\content-summarization\\src\\summary_chain.py : This model's maximum context length is 16385 tokens. However, your messages resulted in 53495 tokens. Please reduce the length of the messages.\n",
      "\t**API request failed for `.summarize()`**\n",
      "\t...Completed\n",
      "Processing text0_prompt00...\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "'summary'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[23], line 21\u001b[0m\n\u001b[0;32m     14\u001b[0m \u001b[39m# Create initial summaries\u001b[39;00m\n\u001b[0;32m     15\u001b[0m chaining_dict \u001b[39m=\u001b[39m batch_summarize_chain(\n\u001b[0;32m     16\u001b[0m     text_dict, folder_path, prep_step, summarize_task, edit_task, chatbot_dict,\n\u001b[0;32m     17\u001b[0m     system_role\u001b[39m=\u001b[39msystem_role, model\u001b[39m=\u001b[39mmodel, max_tokens\u001b[39m=\u001b[39m\u001b[39m1000\u001b[39m,\n\u001b[0;32m     18\u001b[0m     n_choices\u001b[39m=\u001b[39mn_choices, pause_per_request\u001b[39m=\u001b[39mpause_per_request,\n\u001b[0;32m     19\u001b[0m     iteration_id\u001b[39m=\u001b[39miteration_id, save_outputs\u001b[39m=\u001b[39msave_outputs\n\u001b[0;32m     20\u001b[0m     )\n\u001b[1;32m---> 21\u001b[0m qna_dict \u001b[39m=\u001b[39m spreadsheet_columns(\n\u001b[0;32m     22\u001b[0m     qna_dict, chatbot_dict, iteration_id, chatbot_id\u001b[39m=\u001b[39;49mchatbot_id, save\u001b[39m=\u001b[39;49msave\n\u001b[0;32m     23\u001b[0m     )\n\u001b[0;32m     25\u001b[0m \u001b[39m# # Create simple summaries\u001b[39;00m\n\u001b[0;32m     26\u001b[0m \u001b[39m# audience = simplify_audience\u001b[39;00m\n\u001b[0;32m     27\u001b[0m \u001b[39m# simple_summaries = prompt_chaining_dict(user_simplify_task, simplify_audience, simple_summaries_dict, \u001b[39;00m\n\u001b[1;32m   (...)\u001b[0m\n\u001b[0;32m     62\u001b[0m \u001b[39m# )\u001b[39;00m\n\u001b[0;32m     63\u001b[0m \u001b[39m# print(f'\\nCompleted merge_all_chaining_results!:)')\u001b[39;00m\n\u001b[0;32m     65\u001b[0m qna_dict[iteration_id]\n",
      "File \u001b[1;32m~\\OneDrive\\lighthouse\\Ginkgo coding\\content-summarization\\src\\response_processing.py:165\u001b[0m, in \u001b[0;36mspreadsheet_columns\u001b[1;34m(qna_dict, chatbot_dict, iteration_id, chatbot_id, save, filename, path)\u001b[0m\n\u001b[0;32m    159\u001b[0m \u001b[39mdef\u001b[39;00m \u001b[39mspreadsheet_columns\u001b[39m(qna_dict, chatbot_dict, iteration_id, chatbot_id\u001b[39m=\u001b[39m\u001b[39mNone\u001b[39;00m,\n\u001b[0;32m    160\u001b[0m     save\u001b[39m=\u001b[39m\u001b[39mFalse\u001b[39;00m, filename\u001b[39m=\u001b[39m\u001b[39mNone\u001b[39;00m, path\u001b[39m=\u001b[39m\u001b[39m'\u001b[39m\u001b[39m'\u001b[39m\n\u001b[0;32m    161\u001b[0m     ):\n\u001b[0;32m    162\u001b[0m \u001b[39m    \u001b[39m\u001b[39m\"\"\"\u001b[39;00m\n\u001b[0;32m    163\u001b[0m \u001b[39m    Update column names to include corresponding column in a spreadsheet (e.g. A, B, C)\u001b[39;00m\n\u001b[0;32m    164\u001b[0m \u001b[39m    \"\"\"\u001b[39;00m\n\u001b[1;32m--> 165\u001b[0m     qna_dict \u001b[39m=\u001b[39m create_qna_df(\n\u001b[0;32m    166\u001b[0m         qna_dict, chatbot_dict, iteration_id, chatbot_id\u001b[39m=\u001b[39;49mchatbot_id, \n\u001b[0;32m    167\u001b[0m         )\n\u001b[0;32m    168\u001b[0m     qna_dict[iteration_id][\u001b[39m'\u001b[39m\u001b[39mdate\u001b[39m\u001b[39m'\u001b[39m] \u001b[39m=\u001b[39m qna_dict[iteration_id][\u001b[39m'\u001b[39m\u001b[39mdate\u001b[39m\u001b[39m'\u001b[39m]\u001b[39m.\u001b[39mstr\u001b[39m.\u001b[39mreplace(\u001b[39mr\u001b[39m\u001b[39m'\u001b[39m\u001b[39m_\u001b[39m\u001b[39m\\\u001b[39m\u001b[39md*\u001b[39m\u001b[39m'\u001b[39m, \u001b[39mr\u001b[39m\u001b[39m'\u001b[39m\u001b[39m'\u001b[39m, regex\u001b[39m=\u001b[39m\u001b[39mTrue\u001b[39;00m)\n\u001b[0;32m    169\u001b[0m     spreadsheet_columns \u001b[39m=\u001b[39m [letter \u001b[39mfor\u001b[39;00m letter \u001b[39min\u001b[39;00m string\u001b[39m.\u001b[39mascii_uppercase]\u001b[39m+\u001b[39m[\u001b[39m'\u001b[39m\u001b[39mA\u001b[39m\u001b[39m'\u001b[39m\u001b[39m+\u001b[39mletter \u001b[39mfor\u001b[39;00m letter \u001b[39min\u001b[39;00m string\u001b[39m.\u001b[39mascii_uppercase]\n",
      "File \u001b[1;32m~\\OneDrive\\lighthouse\\Ginkgo coding\\content-summarization\\src\\response_processing.py:143\u001b[0m, in \u001b[0;36mcreate_qna_df\u001b[1;34m(qna_dict, chatbot_dict, iteration_id, chatbot_id)\u001b[0m\n\u001b[0;32m    139\u001b[0m \u001b[39mfor\u001b[39;00m chatbot_key \u001b[39min\u001b[39;00m chatbot_dict[chatbot_id]\u001b[39m.\u001b[39mkeys():\n\u001b[0;32m    140\u001b[0m     \u001b[39mprint\u001b[39m(\u001b[39mf\u001b[39m\u001b[39m'\u001b[39m\u001b[39mProcessing \u001b[39m\u001b[39m{\u001b[39;00mchatbot_key\u001b[39m}\u001b[39;00m\u001b[39m...\u001b[39m\u001b[39m'\u001b[39m)\n\u001b[0;32m    141\u001b[0m     dfs_list\u001b[39m.\u001b[39mappend(pd\u001b[39m.\u001b[39mDataFrame(\n\u001b[0;32m    142\u001b[0m         chatbot_dict[chatbot_id][chatbot_key]\u001b[39m.\u001b[39mqna, \n\u001b[1;32m--> 143\u001b[0m         index\u001b[39m=\u001b[39m[choice \u001b[39mfor\u001b[39;00m choice \u001b[39min\u001b[39;00m \u001b[39mrange\u001b[39m(\u001b[39m1\u001b[39m, \u001b[39mlen\u001b[39m(chatbot_dict[chatbot_id][chatbot_key]\u001b[39m.\u001b[39;49mqna[\u001b[39m'\u001b[39;49m\u001b[39msummary\u001b[39;49m\u001b[39m'\u001b[39;49m])\u001b[39m+\u001b[39m\u001b[39m1\u001b[39m)])\n\u001b[0;32m    144\u001b[0m         )\n\u001b[0;32m    146\u001b[0m qna_df \u001b[39m=\u001b[39m pd\u001b[39m.\u001b[39mconcat(dfs_list)\u001b[39m.\u001b[39mreset_index(names\u001b[39m=\u001b[39m[\u001b[39m'\u001b[39m\u001b[39mchoice\u001b[39m\u001b[39m'\u001b[39m])\n\u001b[0;32m    147\u001b[0m columns \u001b[39m=\u001b[39m qna_df\u001b[39m.\u001b[39mcolumns\u001b[39m.\u001b[39mtolist()\n",
      "\u001b[1;31mKeyError\u001b[0m: 'summary'"
     ]
    }
   ],
   "source": [
    "# Set parameters\n",
    "iteration_id = 1\n",
    "n_choices = 2\n",
    "pause_per_request=0\n",
    "chatbot_id = iteration_id\n",
    "# chatbot_id = 0\n",
    "save_outputs = False\n",
    "save = True\n",
    "# save = False\n",
    "empty_columns = True\n",
    "model = 'gpt-3.5-turbo-16k-0613'\n",
    "text_dict = main_text[text_id]\n",
    "\n",
    "# Create initial summaries\n",
    "chaining_dict = batch_summarize_chain(\n",
    "    text_dict, folder_path, prep_step, summarize_task, edit_task, chatbot_dict,\n",
    "    system_role=system_role, model=model, max_tokens=1000,\n",
    "    n_choices=n_choices, pause_per_request=pause_per_request,\n",
    "    iteration_id=iteration_id, save_outputs=save_outputs\n",
    "    )\n",
    "qna_dict = spreadsheet_columns(\n",
    "    qna_dict, chatbot_dict, iteration_id, chatbot_id=chatbot_id, save=save\n",
    "    )\n",
    "\n",
    "# # Create simple summaries\n",
    "# audience = simplify_audience\n",
    "# simple_summaries = prompt_chaining_dict(user_simplify_task, simplify_audience, simple_summaries_dict, \n",
    "#     chatbot_dict[chatbot_id], iteration_id,\n",
    "#     n_choices=1, pause_per_request=pause_per_request, chatbot_id=chatbot_id\n",
    "#     )\n",
    "\n",
    "# # Add relevance\n",
    "# relevance = prompt_chaining_dict(user_relevance_task, relevance_audience, relevance_dict, \n",
    "#     chatbot_dict[chatbot_id], iteration_id, prompt_column='relevance', \n",
    "#     n_choices=1, pause_per_request=pause_per_request, chatbot_id=chatbot_id\n",
    "#     )\n",
    "\n",
    "# # Merge the results\n",
    "# try:\n",
    "#     qna_dict = merge_all_chaining_results(\n",
    "#         chatbot_dict, qna_dict, iteration_id=iteration_id, relevance_audiences=2, pivot=True,\n",
    "#         empty_columns=empty_columns, chatbot_id=chatbot_id,\n",
    "#         save_df=save, save_chatbot=save, \n",
    "#             csv_path=folder_path,\n",
    "#     )\n",
    "#     print(f'\\nCompleted merge_all_chaining_results!:)')\n",
    "# except Exception as error:\n",
    "#     exc_type, exc_obj, tb = sys.exc_info()\n",
    "#     f = tb.tb_frame\n",
    "#     lineno = tb.tb_lineno\n",
    "#     file = f.f_code.co_filename\n",
    "#     print(f'An error occurred on line {lineno} in {file}: {error}')\n",
    "#     print('Unable to merge results')\n",
    "#     if save:\n",
    "#         save_instance_to_dict(chatbot_dict[chatbot_id], ext=None, json_path=folder_path)\n",
    "#         print(f'\\nCould not merge; saved Chaining instances as JSON.')\n",
    "\n",
    "# qna_dict = merge_all_chaining_results2(\n",
    "#     chatbot_dict, qna_dict, iteration_id=iteration_id, relevance_audiences=2, pivot=True,\n",
    "#     empty_columns=empty_columns, chatbot_id=chatbot_id,\n",
    "#         csv_path=folder_path,\n",
    "# )\n",
    "# print(f'\\nCompleted merge_all_chaining_results!:)')\n",
    "\n",
    "qna_dict[iteration_id]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# `trim_text` function : Need to reduce tokens in messages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Endovascular thrombectomy with or without thrombolysis bridging in patients with acute ischaemic stroke: protocol for a systematic review, meta-analysis of randomised trials and cost-effectiveness analysis\\n\\n<div class=\"panel-panel panel-col\">\\n    <div><div class=\"panel-pane pane-highwire-markup author-affiliates col-narrow-12 author-affiliates-corresp article\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div xmlns:xhtml=\"http://www.w3.org/1999/xhtml\" class=\"contributors\"><ol class=\"contributor-list\" id=\"contrib-group-1\"><li class=\"contributor\" id=\"contrib-1\"><a href=\"http://orcid.org/0000-0003-2131-3711\" class=\"bmjj-markup-orcid-logo\" target=\"_blank\">http://orcid.org/0000-0003-2131-3711</a><span class=\"name\">Rami Z Morsi</span><a id=\"xref-aff-1-1\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-2\"><span class=\"name\">Yuan Zhang</span><a id=\"xref-aff-2-1\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"contributor\" id=\"contrib-3\"><span class=\"name\">Julián Carrión-Penagos</span><a id=\"xref-aff-1-2\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-4\"><span class=\"name\">Harsh Desai</span><a id=\"xref-aff-1-3\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-5\"><a href=\"http://orcid.org/0000-0002-1975-190X\" class=\"bmjj-markup-orcid-logo\" target=\"_blank\">http://orcid.org/0000-0002-1975-190X</a><span class=\"name\">Elie Tannous</span><a id=\"xref-aff-3-1\" class=\"xref-aff\" href=\"#aff-3\">3</a>, </li><li class=\"contributor\" id=\"contrib-6\"><span class=\"name\">Sachin Kothari</span><a id=\"xref-aff-1-4\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-7\"><a href=\"http://orcid.org/0000-0002-5567-7065\" class=\"bmjj-markup-orcid-logo\" target=\"_blank\">http://orcid.org/0000-0002-5567-7065</a><span class=\"name\">Assem M Khamis</span><a id=\"xref-aff-4-1\" class=\"xref-aff\" href=\"#aff-4\">4</a>, </li><li class=\"contributor\" id=\"contrib-8\"><a href=\"http://orcid.org/0000-0002-2498-1697\" class=\"bmjj-markup-orcid-logo\" target=\"_blank\">http://orcid.org/0000-0002-2498-1697</a><span class=\"name\">Andrea J Darzi</span><a id=\"xref-aff-2-2\" class=\"xref-aff\" href=\"#aff-2\">2</a>, </li><li class=\"contributor\" id=\"contrib-9\"><span class=\"name\">Ammar Tarabichi</span><a id=\"xref-aff-1-5\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-10\"><span class=\"name\">Reena Bastin</span><a id=\"xref-aff-1-6\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-11\"><span class=\"name\">Layal Hneiny</span><a id=\"xref-aff-5-1\" class=\"xref-aff\" href=\"#aff-5\">5</a>, </li><li class=\"contributor\" id=\"contrib-12\"><span class=\"name\">Sonam Thind</span><a id=\"xref-aff-6-1\" class=\"xref-aff\" href=\"#aff-6\">6</a>, </li><li class=\"contributor\" id=\"contrib-13\"><span class=\"name\">Elisheva Coleman</span><a id=\"xref-aff-1-7\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-14\"><span class=\"name\">James R Brorson</span><a id=\"xref-aff-1-8\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-15\"><span class=\"name\">Scott Mendelson</span><a id=\"xref-aff-1-9\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-16\"><span class=\"name\">Ali Mansour</span><a id=\"xref-aff-1-10\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"contributor\" id=\"contrib-17\"><span class=\"name\">Shyam Prabhakaran</span><a id=\"xref-aff-1-11\" class=\"xref-aff\" href=\"#aff-1\">1</a>, </li><li class=\"last\" id=\"contrib-18\"><span class=\"name\">Tareq Kass-Hout</span><a id=\"xref-aff-1-12\" class=\"xref-aff\" href=\"#aff-1\">1</a><span class=\"xref-sep\">,</span><a id=\"xref-aff-6-2\" class=\"xref-aff\" href=\"#aff-6\">6</a></li></ol><ol class=\"affiliation-list\"><li class=\"aff\"><a id=\"aff-1\" name=\"aff-1\"></a><address><sup>1</sup><span class=\"institution\">Department of Neurology</span>, <span class=\"institution\">University of Chicago</span>, <span class=\"addr-line\">Chicago</span>, <span class=\"addr-line\">Illinois</span>, USA</address></li><li class=\"aff\"><a id=\"aff-2\" name=\"aff-2\"></a><address><sup>2</sup><span class=\"institution\">Department of Health Research Methods, Evidence, and Impact</span>, <span class=\"institution\">McMaster University</span>, <span class=\"addr-line\">Hamilton</span>, <span class=\"addr-line\">Ontario</span>, Canada</address></li><li class=\"aff\"><a id=\"aff-3\" name=\"aff-3\"></a><address><sup>3</sup><span class=\"institution\">Department of Pathology</span>, <span class=\"institution\">Albany Medical Center</span>, <span class=\"addr-line\">Albany</span>, <span class=\"addr-line\">New York</span>, USA</address></li><li class=\"aff\"><a id=\"aff-4\" name=\"aff-4\"></a><address><sup>4</sup><span class=\"institution\">Wolfson Palliative Care Research Centre</span>, <span class=\"institution\">Hull York Medical School</span>, <span class=\"addr-line\">Hull</span>, UK</address></li><li class=\"aff\"><a id=\"aff-5\" name=\"aff-5\"></a><address><sup>5</sup><span class=\"institution\">Wegner Health Sciences Information Center</span>, <span class=\"institution\">University of South Dakota</span>, <span class=\"addr-line\">Sioux Falls</span>, <span class=\"addr-line\">South Dakota</span>, USA</address></li><li class=\"aff\"><a id=\"aff-6\" name=\"aff-6\"></a><address><sup>6</sup><span class=\"institution\">Section of Neurosurgery, Department of Surgery</span>, <span class=\"institution\">University of Chicago</span>, <span class=\"addr-line\">Chicago</span>, <span class=\"addr-line\">Illinois</span>, USA</address></li></ol><ol class=\"corresp-list\"><li class=\"corresp\" id=\"corresp-1\"><span class=\"corresp-label\">Correspondence to</span> Dr Tareq Kass-Hout; <span class=\"em-link\"><span class=\"em-addr\">kasshouttareq{at}gmail.com</span></span></li></ol></div></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup abstract-with-bc\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"content-block\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div class=\"article abstract-view \"><span class=\"highwire-journal-article-marker-start\"></span><div class=\"section abstract\" id=\"abstract-1\"><h2>Abstract</h2><div id=\"sec-1\" class=\"subsection\"><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p></div><div id=\"sec-2\" class=\"subsection\"><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p></div><div id=\"sec-3\" class=\"subsection\"><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p></div><div id=\"sec-4\" class=\"subsection\"><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p></div></div><ul class=\"kwd-group\"><li class=\"kwd\">Stroke</li><li class=\"kwd\">EPIDEMIOLOGY</li><li class=\"kwd\">HEALTH ECONOMICS</li><li class=\"kwd\">STROKE MEDICINE</li></ul><div class=\"license\" id=\"license-1\"><span class=\"ali-license-ref\"><a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a></span><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:\\xa0<a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p></div><span class=\"highwire-journal-article-marker-end\"></span></div><span class=\"related-urls\"></span></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-dfp-pane oas-ads oas-ads-mid pull-right\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div id=\"dfp-ad-mpu-wrapper\" class=\"dfp-tag-wrapper\">\\n\\n<div id=\"dfp-ad-mpu\" class=\"dfp-tag-wrapper\">\\n  <script type=\"text/javascript\">\\n    googletag.cmd.push(function() {\\n      googletag.display(\"dfp-ad-mpu\");\\n    });\\n  </script>\\n</div>\\n</div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-custom pane-3\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p>\\n  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-altmetrics\">\\n  \\n        <h2 class=\"pane-title\">Statistics from Altmetric.com</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div data-badge-details=\"right\" data-badge-type=\"medium-donut\" data-doi=\"10.1136/bmjopen-2022-064322\" data-hide-no-mentions=\"true\" class=\"altmetric-embed\"></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-bmjj-jumplinks\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-list-wrapper\"><div class=\"highwire-list\"><ul></ul></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-custom pane-4 permissions-box\">\\n  \\n        <h2 class=\"pane-title\">Request Permissions</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p>\\n  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-panels-ajax-pane-content permissions-box pane-highwire-permission-link\" id=\"request-permissions\">\\n  \\n        <h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"panels-ajax-pane panels-ajax-pane-new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div class=\"article fulltext-view \"><span class=\"highwire-journal-article-marker-start\"></span><ul class=\"kwd-group\"><li class=\"kwd\"><a href=\"/keyword/stroke\" class=\"hw-term hw-article-keyword hw-article-keyword-stroke\" rel=\"nofollow\">Stroke</a></li><li class=\"kwd\"><a href=\"/keyword/epidemiology\" class=\"hw-term hw-article-keyword hw-article-keyword-epidemiology\" rel=\"nofollow\">EPIDEMIOLOGY</a></li><li class=\"kwd\"><a href=\"/keyword/health-economics\" class=\"hw-term hw-article-keyword hw-article-keyword-health-economics\" rel=\"nofollow\">HEALTH ECONOMICS</a></li><li class=\"kwd\"><a href=\"/keyword/stroke-medicine\" class=\"hw-term hw-article-keyword hw-article-keyword-stroke-medicine\" rel=\"nofollow\">STROKE MEDICINE</a></li></ul><div class=\"boxed-text\" id=\"boxed-text-1\"><h3>Strengths and limitations of this study</h3><ul class=\"list-unord \" id=\"list-1\"><li id=\"list-item-1\"><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p></li><li id=\"list-item-2\"><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p></li><li id=\"list-item-3\"><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p></li><li id=\"list-item-4\"><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p></li></ul></div><div class=\"section intro\" id=\"sec-5\"><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5\\u2009hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6\\u2009hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p></div><div class=\"section methods\" id=\"sec-6\"><h2 class=\"\">Methods and analysis</h2><div id=\"sec-7\" class=\"subsection\"><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p></div><div id=\"sec-8\" class=\"subsection\"><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><div id=\"T1\" class=\"table pos-float\"><div class=\"table-inline table-callout-links\"><div class=\"callout\"><span>View this table:</span><ul class=\"callout-links\"><li class=\"view-inline first\"><a href=\"##\" class=\"table-expand-inline\" data-table-url=\"/highwire/markup/289365/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1\" data-icon-position=\"\" data-hide-link-title=\"0\">View inline</a></li>\\n<li class=\"view-popup last\"><a href=\"/highwire/markup/289365/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\" class=\"colorbox colorbox-load table-expand-popup\" rel=\"gallery-fragment-tables\" data-icon-position=\"\" data-hide-link-title=\"0\">View popup</a></li>\\n</ul></div></div><div class=\"table-caption\"><span class=\"table-label\">Table 1</span> <p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><div class=\"sb-div caption-clear\"></div></div></div></div><div id=\"sec-9\" class=\"subsection\"><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><div id=\"DC1\" class=\"supplementary-material\"><h3 class=\"\">Supplemental material</h3><div><span class=\"inline-linked-media-wrapper\"><span id=\"DC1\" class=\"inline-linked-media\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/DC1/embed/inline-supplementary-material-1.pdf?download=true\" class=\"\" data-icon-position=\"\" data-hide-link-title=\"0\"><span class=\"icon-download-alt\"></span>[bmjopen-2022-064322supp001.pdf]</a></span></span></div></div><div id=\"F1\" class=\"fig pos-float  odd\"><div class=\"highwire-figure\"><div class=\"fig-inline-img-wrapper\"><div class=\"fig-inline-img\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/F1.large.jpg?width=800&amp;height=600&amp;carousel=1\" title=\"Sample search algorithm for MEDLINE(through Ovid).\" class=\"highwire-fragment fragment-images colorbox-load\" rel=\"gallery-fragment-images-538737960\" data-figure-caption=\\'&lt;div class=\"highwire-markup\"&gt;Sample search algorithm for MEDLINE(through Ovid).&lt;/div&gt;\\' data-icon-position=\"\" data-hide-link-title=\"0\"><span class=\"hw-responsive-img\"><img class=\"highwire-fragment fragment-image lazyload\" alt=\"Figure 1\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/F1.medium.gif\" width=\"350\" height=\"440\"><noscript><img class=\"highwire-fragment fragment-image\" alt=\"Figure 1\" src=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/F1.medium.gif\" width=\"350\" height=\"440\"></noscript></span></a></div></div><ul class=\"highwire-figure-links inline\"><li class=\"download-fig first\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/F1.large.jpg?download=true\" class=\"highwire-figure-link highwire-figure-link-download\" title=\"Download Figure 1\" data-icon-position=\"\" data-hide-link-title=\"0\">Download figure</a></li>\\n<li class=\"new-tab\"><a href=\"https://bmjopen.bmj.com/content/bmjopen/13/6/e064322/F1.large.jpg\" class=\"highwire-figure-link highwire-figure-link-newtab\" target=\"_blank\" data-icon-position=\"\" data-hide-link-title=\"0\">Open in new tab</a></li>\\n<li class=\"download-ppt last\"><a href=\"/highwire/powerpoint/289346\" class=\"highwire-figure-link highwire-figure-link-ppt\" data-icon-position=\"\" data-hide-link-title=\"0\">Download powerpoint</a></li>\\n</ul></div><div class=\"fig-caption\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><span class=\"fig-label\">Figure 1</span> <p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><div class=\"sb-div caption-clear\"></div></div></div></div><div id=\"sec-10\" class=\"subsection\"><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p></div><div id=\"sec-11\" class=\"subsection\"><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p></div><div id=\"sec-12\" class=\"subsection\"><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p></div><div id=\"sec-13\" class=\"subsection\"><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95%\\u2009CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p></div><div id=\"sec-14\" class=\"subsection\"><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p></div><div id=\"sec-15\" class=\"subsection\"><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p></div><div id=\"sec-16\" class=\"subsection\"><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p></div><div id=\"sec-17\" class=\"subsection\"><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p></div><div id=\"sec-18\" class=\"subsection\"><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p></div></div><div class=\"section discussion\" id=\"sec-19\"><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p></div><div class=\"section ethics-statement\" id=\"sec-20\"><h2 class=\"\">Ethics statements</h2><div class=\"section\" id=\"sec-21\"><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p></div></div><div class=\"section ref-list\" id=\"ref-list-1\"><h2 class=\"\">References</h2><ol class=\"cit-list\"><li><a class=\"rev-xref-ref\" href=\"#xref-ref-1-1\" title=\"View reference 1 in text\" id=\"ref-1\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.1\" data-doi=\"10.1056/NEJMoa0804656\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Hacke</span>  <span class=\"cit-name-given-names\">W</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kaste</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bluhmki</span>  <span class=\"cit-name-given-names\">E</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2008</span>;<span class=\"cit-vol\">359</span>:<span class=\"cit-fpage\">1317</span>–<span class=\"cit-lpage\">29</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa0804656\">doi:10.1056/NEJMoa0804656</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DHacke%26rft.auinit1%253DW.%26rft.volume%253D359%26rft.issue%253D13%26rft.spage%253D1317%26rft.epage%253D1329%26rft.atitle%253DThrombolysis%2Bwith%2BAlteplase%2B3%2Bto%2B4.5%2BHours%2Bafter%2BAcute%2BIschemic%2BStroke%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0804656%26rft_id%253Dinfo%253Apmid%252F18815396%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa0804656&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=18815396&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000259440900003&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-1-1\" title=\"View reference 2 in text\" id=\"ref-2\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.2\" data-doi=\"10.1056/NEJM199512143332401\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth cit-collab\">National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group</span></li></ol><cite>. <span class=\"cit-article-title\">Tissue plasminogen activator for acute ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">1995</span>;<span class=\"cit-vol\">333</span>:<span class=\"cit-fpage\">1581</span>–<span class=\"cit-lpage\">7</span>. <a href=\"http://dx.doi.org/10.1056/NEJM199512143332401\">doi:10.1056/NEJM199512143332401</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DThe%2BNational%2BInstitute%2Bof%2BNeurological%2BDisorders%2Ba%26rft.auinit1%253D%2B%26rft.volume%253D333%26rft.issue%253D24%26rft.spage%253D1581%26rft.epage%253D1588%26rft.atitle%253DTissue%2BPlasminogen%2BActivator%2Bfor%2BAcute%2BIschemic%2BStroke%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199512143332401%26rft_id%253Dinfo%253Apmid%252F7477192%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJM199512143332401&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=7477192&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=A1995TK06500001&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-3-1\" title=\"View reference 3 in text\" id=\"ref-3\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.3\" data-doi=\"10.1016/S0140-6736(14)60584-5\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Emberson</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lees</span>  <span class=\"cit-name-given-names\">KR</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lyden</span>  <span class=\"cit-name-given-names\">P</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Effect of treatment delay, age, and stroke severity on the effects of intravenous Thrombolysis with Alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials</span>. <abbr class=\"cit-jnl-abbrev\">Lancet</abbr> <span class=\"cit-pub-date\">2014</span>;<span class=\"cit-vol\">384</span>:<span class=\"cit-fpage\">1929</span>–<span class=\"cit-lpage\">35</span>. <a href=\"http://dx.doi.org/10.1016/S0140-6736(14)60584-5\">doi:10.1016/S0140-6736(14)60584-5</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DLancet%26rft.volume%253D384%26rft.spage%253D1929%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252814%252960584-5%26rft_id%253Dinfo%253Apmid%252F25106063%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/S0140-6736(14)60584-5&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25106063&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000345450100028&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-4-1\" title=\"View reference 4 in text\" id=\"ref-4\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.4\" data-doi=\"10.1056/NEJMoa1214300\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Broderick</span>  <span class=\"cit-name-given-names\">JP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Palesch</span>  <span class=\"cit-name-given-names\">YY</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Demchuk</span>  <span class=\"cit-name-given-names\">AM</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular therapy after intravenous t-PA versus t-PA alone for stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2013</span>;<span class=\"cit-vol\">368</span>:<span class=\"cit-fpage\">893</span>–<span class=\"cit-lpage\">903</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1214300\">doi:10.1056/NEJMoa1214300</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D368%26rft.spage%253D893%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1214300%26rft_id%253Dinfo%253Apmid%252F23390923%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1214300&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=23390923&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000315669100005&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-5-1\" title=\"View reference 5 in text\" id=\"ref-5\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.5\" data-doi=\"10.1056/NEJMoa1213701\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ciccone</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Valvassori</span>  <span class=\"cit-name-given-names\">L</span></span>, <span class=\"cit-auth cit-collab\">SYNTHESIS Expansion Investigators</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular treatment for acute ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2013</span>;<span class=\"cit-vol\">368</span>:<span class=\"cit-fpage\">904</span>–<span class=\"cit-lpage\">13</span>. <a href=\"http://dx.doi.org/10.1056/NEJMc1304759\">doi:10.1056/NEJMc1304759</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D368%26rft.spage%253D904%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1213701%26rft_id%253Dinfo%253Apmid%252F23387822%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1213701&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=23387822&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000315669100006&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-6-1\" title=\"View reference 6 in text\" id=\"ref-6\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.6\" data-doi=\"10.1056/NEJMoa1212793\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kidwell</span>  <span class=\"cit-name-given-names\">CS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jahan</span>  <span class=\"cit-name-given-names\">R</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Gornbein</span>  <span class=\"cit-name-given-names\">J</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">A trial of imaging selection and Endovascular treatment for ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2013</span>;<span class=\"cit-vol\">368</span>:<span class=\"cit-fpage\">914</span>–<span class=\"cit-lpage\">23</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1212793\">doi:10.1056/NEJMoa1212793</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D368%26rft.spage%253D914%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1212793%26rft_id%253Dinfo%253Apmid%252F23394476%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1212793&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=23394476&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000315669100007&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 7 in text\" id=\"ref-7\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.7\" data-doi=\"10.1056/NEJMoa1713973\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Albers</span>  <span class=\"cit-name-given-names\">GW</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Marks</span>  <span class=\"cit-name-given-names\">MP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kemp</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">378</span>:<span class=\"cit-fpage\">708</span>–<span class=\"cit-lpage\">18</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1713973\">doi:10.1056/NEJMoa1713973</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D378%26rft.spage%253D708%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1713973%26rft_id%253Dinfo%253Apmid%252F29364767%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1713973&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=29364767&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 8 in text\" id=\"ref-8\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.8\" data-doi=\"10.1056/NEJMoa1411587\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Berkhemer</span>  <span class=\"cit-name-given-names\">OA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Fransen</span>  <span class=\"cit-name-given-names\">PSS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Beumer</span>  <span class=\"cit-name-given-names\">D</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">A randomized trial of Intraarterial treatment for acute ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">372</span>:<span class=\"cit-fpage\">11</span>–<span class=\"cit-lpage\">20</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1411587\">doi:10.1056/NEJMoa1411587</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D11%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1411587%26rft_id%253Dinfo%253Apmid%252F25517348%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1411587&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25517348&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000347100800005&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 9 in text\" id=\"ref-9\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.9\" data-doi=\"10.1016/S1474-4422(16)30177-6\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bracard</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ducrocq</span>  <span class=\"cit-name-given-names\">X</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mas</span>  <span class=\"cit-name-given-names\">JL</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy after intravenous Alteplase versus Alteplase alone after stroke (THRACE): a randomised controlled trial</span>. <abbr class=\"cit-jnl-abbrev\">Lancet Neurol</abbr> <span class=\"cit-pub-date\">2016</span>;<span class=\"cit-vol\">15</span>:<span class=\"cit-fpage\">1138</span>–<span class=\"cit-lpage\">47</span>. <a href=\"http://dx.doi.org/10.1016/S1474-4422(16)30177-6\">doi:10.1016/S1474-4422(16)30177-6</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DLancet%2BNeurol%26rft.volume%253D15%26rft.spage%253D1138%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1474-4422%252816%252930177-6%26rft_id%253Dinfo%253Apmid%252F27567239%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/S1474-4422(16)30177-6&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=27567239&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 10 in text\" id=\"ref-10\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.10\" data-doi=\"10.1056/NEJMoa1414792\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Campbell</span>  <span class=\"cit-name-given-names\">BCV</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mitchell</span>  <span class=\"cit-name-given-names\">PJ</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kleinig</span>  <span class=\"cit-name-given-names\">TJ</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular therapy for ischemic stroke with perfusion-imaging selection</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">372</span>:<span class=\"cit-fpage\">1009</span>–<span class=\"cit-lpage\">18</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1414792\">doi:10.1056/NEJMoa1414792</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D1009%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1414792%26rft_id%253Dinfo%253Apmid%252F25671797%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1414792&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25671797&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 11 in text\" id=\"ref-11\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.11\" data-doi=\"10.1056/NEJMoa1414905\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Goyal</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Demchuk</span>  <span class=\"cit-name-given-names\">AM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Menon</span>  <span class=\"cit-name-given-names\">BK</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Randomized assessment of rapid Endovascular treatment of ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">372</span>:<span class=\"cit-fpage\">1019</span>–<span class=\"cit-lpage\">30</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1414905\">doi:10.1056/NEJMoa1414905</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D1019%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1414905%26rft_id%253Dinfo%253Apmid%252F25671798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1414905&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25671798&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 12 in text\" id=\"ref-12\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.12\" data-doi=\"10.1056/NEJMoa1503780\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jovin</span>  <span class=\"cit-name-given-names\">TG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chamorro</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Cobo</span>  <span class=\"cit-name-given-names\">E</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Thrombectomy within 8 hours after symptom onset in ischemic stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">372</span>:<span class=\"cit-fpage\">2296</span>–<span class=\"cit-lpage\">306</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1503780\">doi:10.1056/NEJMoa1503780</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D2296%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1503780%26rft_id%253Dinfo%253Apmid%252F25882510%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1503780&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25882510&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 13 in text\" id=\"ref-13\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.13\" data-doi=\"10.1161/STROKEAHA.116.013372\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mocco</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zaidat</span>  <span class=\"cit-name-given-names\">OO</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">von Kummer</span>  <span class=\"cit-name-given-names\">R</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Aspiration Thrombectomy after intravenous Alteplase versus intravenous Alteplase alone</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2016</span>;<span class=\"cit-vol\">47</span>:<span class=\"cit-fpage\">2331</span>–<span class=\"cit-lpage\">8</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.116.013372\">doi:10.1161/STROKEAHA.116.013372</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTROKEAHA.116.013372%26rft_id%253Dinfo%253Apmid%252F27486173%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ3LzkvMjMzMSI7czo0OiJhdG9tIjtzOjI2OiIvYm1qb3Blbi8xMy82L2UwNjQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 14 in text\" id=\"ref-14\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.14\" data-doi=\"10.1136/jnnp-2016-314117\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Muir</span>  <span class=\"cit-name-given-names\">KW</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ford</span>  <span class=\"cit-name-given-names\">GA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Messow</span>  <span class=\"cit-name-given-names\">C-M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular therapy for acute ischaemic stroke: the pragmatic ischaemic stroke Thrombectomy evaluation (PISTE) randomised, controlled trial</span>. <abbr class=\"cit-jnl-abbrev\">J Neurol Neurosurg Psychiatry</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">88</span>:<span class=\"cit-fpage\">38</span>–<span class=\"cit-lpage\">44</span>. <a href=\"http://dx.doi.org/10.1136/jnnp-2016-314117\">doi:10.1136/jnnp-2016-314117</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BNeurol%2BNeurosurg%2BPsychiatry%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fjnnp-2016-314117%26rft_id%253Dinfo%253Apmid%252F27756804%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiam5ucCI7czo1OiJyZXNpZCI7czo3OiI4OC8xLzM4IjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA2NDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 15 in text\" id=\"ref-15\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.15\" data-doi=\"10.1056/NEJMoa1706442\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Nogueira</span>  <span class=\"cit-name-given-names\">RG</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jadhav</span>  <span class=\"cit-name-given-names\">AP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Haussen</span>  <span class=\"cit-name-given-names\">DC</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">378</span>:<span class=\"cit-fpage\">11</span>–<span class=\"cit-lpage\">21</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1706442\">doi:10.1056/NEJMoa1706442</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D378%26rft.spage%253D11%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1706442%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1706442&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-7-1\" title=\"View reference 16 in text\" id=\"ref-16\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.16\" data-doi=\"10.1056/NEJMoa1415061\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Saver</span>  <span class=\"cit-name-given-names\">JL</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Goyal</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bonafe</span>  <span class=\"cit-name-given-names\">A</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Stent-retriever Thrombectomy after intravenous t-PA vs. t-PA alone in stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">372</span>:<span class=\"cit-fpage\">2285</span>–<span class=\"cit-lpage\">95</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa1415061\">doi:10.1056/NEJMoa1415061</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D2285%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1415061%26rft_id%253Dinfo%253Apmid%252F25882376%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa1415061&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25882376&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 17 in text\" id=\"ref-17\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.17\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Coutinho</span>  <span class=\"cit-name-given-names\">JM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Liebeskind</span>  <span class=\"cit-name-given-names\">DS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Slater</span>  <span class=\"cit-name-given-names\">L-A</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Combined intravenous Thrombolysis and Thrombectomy vs Thrombectomy alone for acute ischemic stroke: A pooled analysis of the SWIFT and STAR studies</span>. <abbr class=\"cit-jnl-abbrev\">JAMA Neurol</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">74</span>:<span class=\"cit-fpage\">268</span>–<span class=\"cit-lpage\">74</span>. <a href=\"http://dx.doi.org/10.1001/jamaneurol.2016.5374\">doi:10.1001/jamaneurol.2016.5374</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJAMA%2BNeurol%26rft.volume%253D74%26rft.spage%253D268%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 18 in text\" id=\"ref-18\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.18\" data-doi=\"10.1161/STROKEAHA.118.021500\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Gariel</span>  <span class=\"cit-name-given-names\">F</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lapergue</span>  <span class=\"cit-name-given-names\">B</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bourcier</span>  <span class=\"cit-name-given-names\">R</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy outcomes with or without intravenous Thrombolysis</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">49</span>:<span class=\"cit-fpage\">2383</span>–<span class=\"cit-lpage\">90</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.118.021500\">doi:10.1161/STROKEAHA.118.021500</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft.volume%253D49%26rft.spage%253D2383%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTROKEAHA.118.021500%26rft_id%253Dinfo%253Apmid%252F30355117%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1161/STROKEAHA.118.021500&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=30355117&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 19 in text\" id=\"ref-19\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.19\" data-doi=\"10.1056/NEJMoa2107727\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">LeCouffe</span>  <span class=\"cit-name-given-names\">NE</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kappelhof</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Treurniet</span>  <span class=\"cit-name-given-names\">KM</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">A randomized trial of intravenous Alteplase before Endovascular treatment for stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">385</span>:<span class=\"cit-fpage\">1833</span>–<span class=\"cit-lpage\">44</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa2107727\">doi:10.1056/NEJMoa2107727</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D385%26rft.spage%253D1833%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2107727%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa2107727&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 20 in text\" id=\"ref-20\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.20\" data-doi=\"10.1001/jama.2020.23522\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Suzuki</span>  <span class=\"cit-name-given-names\">K</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Matsumaru</span>  <span class=\"cit-name-given-names\">Y</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Takeuchi</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Effect of mechanical Thrombectomy without vs with intravenous Thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial</span>. <abbr class=\"cit-jnl-abbrev\">JAMA</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">325</span>:<span class=\"cit-fpage\">244</span>–<span class=\"cit-lpage\">53</span>. <a href=\"http://dx.doi.org/10.1001/jama.2020.23522\">doi:10.1001/jama.2020.23522</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.volume%253D325%26rft.spage%253D244%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2020.23522%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1001/jama.2020.23522&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 21 in text\" id=\"ref-21\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.21\" data-doi=\"10.1056/NEJMoa2001123\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Yang</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zhang</span>  <span class=\"cit-name-given-names\">Y</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zhang</span>  <span class=\"cit-name-given-names\">L</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular Thrombectomy with or without intravenous Alteplase in acute stroke</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2020</span>;<span class=\"cit-vol\">382</span>:<span class=\"cit-fpage\">1981</span>–<span class=\"cit-lpage\">93</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa2001123\">doi:10.1056/NEJMoa2001123</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D382%26rft.spage%253D1981%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2001123%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa2001123&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-17-1\" title=\"View reference 22 in text\" id=\"ref-22\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.22\" data-doi=\"10.1001/jama.2020.23523\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zi</span>  <span class=\"cit-name-given-names\">W</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Qiu</span>  <span class=\"cit-name-given-names\">Z</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Li</span>  <span class=\"cit-name-given-names\">F</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Effect of Endovascular treatment alone vs intravenous Alteplase plus Endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial</span>. <abbr class=\"cit-jnl-abbrev\">JAMA</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">325</span>:<span class=\"cit-fpage\">234</span>–<span class=\"cit-lpage\">43</span>. <a href=\"http://dx.doi.org/10.1001/jama.2020.23523\">doi:10.1001/jama.2020.23523</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJAMA%26rft.volume%253D325%26rft.spage%253D234%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2020.23523%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1001/jama.2020.23523&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-23-1\" title=\"View reference 23 in text\" id=\"ref-23\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.23\" data-doi=\"10.1177/2396987319832140\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Turc</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Bhogal</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Fischer</span>  <span class=\"cit-name-given-names\">U</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">European stroke Organisation (ESO) - European society for minimally invasive neurological therapy (ESMINT) guidelines on mechanical Thrombectomy in acute ischaemic Strokeendorsed by stroke Alliance for Europe (SAFE)</span>. <abbr class=\"cit-jnl-abbrev\">Eur Stroke J</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">4</span>:<span class=\"cit-fpage\">6</span>–<span class=\"cit-lpage\">12</span>. <a href=\"http://dx.doi.org/10.1177/2396987319832140\">doi:10.1177/2396987319832140</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DEur%2BStroke%2BJ%26rft.volume%253D4%26rft.spage%253D6%26rft_id%253Dinfo%253Adoi%252F10.1177%252F2396987319832140%26rft_id%253Dinfo%253Apmid%252F31165090%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1177/2396987319832140&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=31165090&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-24-1\" title=\"View reference 24 in text\" id=\"ref-24\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.24\" data-doi=\"10.1177/23969873221076968\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Turc</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsivgoulis</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Audebert</span>  <span class=\"cit-name-given-names\">HJ</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">European stroke Organisation - European society for minimally invasive neurological therapy expedited recommendation on indication for intravenous Thrombolysis before mechanical Thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion</span>. <abbr class=\"cit-jnl-abbrev\">Eur Stroke J</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">7</span>:<span class=\"cit-fpage\">I</span>–<span class=\"cit-lpage\">XXVI</span>. <a href=\"http://dx.doi.org/10.1177/23969873221076968\">doi:10.1177/23969873221076968</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DEur%2BStroke%2BJ%26rft.volume%253D7%26rft.spage%253DI%26rft_id%253Dinfo%253Adoi%252F10.1177%252F23969873221076968%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1177/23969873221076968&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-25-1\" title=\"View reference 25 in text\" id=\"ref-25\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.25\" data-doi=\"10.1161/STR.0000000000000211\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Powers</span>  <span class=\"cit-name-given-names\">WJ</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Rabinstein</span>  <span class=\"cit-name-given-names\">AA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ackerson</span>  <span class=\"cit-name-given-names\">T</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for Healthcare professionals from the American heart Association/American stroke Association</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">50</span>:<span class=\"cit-fpage\">e344</span>–<span class=\"cit-lpage\">418</span>. <a href=\"http://dx.doi.org/10.1161/STR.0000000000000211\">doi:10.1161/STR.0000000000000211</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft.volume%253D50%26rft.spage%253De344%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTR.0000000000000211%26rft_id%253Dinfo%253Apmid%252F31662037%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1161/STR.0000000000000211&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=31662037&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 26 in text\" id=\"ref-26\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.26\" data-doi=\"10.1161/STROKEAHA.117.019261\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsivgoulis</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Katsanos</span>  <span class=\"cit-name-given-names\">AH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Schellinger</span>  <span class=\"cit-name-given-names\">PD</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Successful reperfusion with intravenous Thrombolysis preceding mechanical Thrombectomy in large-vessel Occlusions</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">49</span>:<span class=\"cit-fpage\">232</span>–<span class=\"cit-lpage\">5</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.117.019261\">doi:10.1161/STROKEAHA.117.019261</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTROKEAHA.117.019261%26rft_id%253Dinfo%253Apmid%252F29212743%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjQ5LzEvMjMyIjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA2NDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 27 in text\" id=\"ref-27\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.27\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Vidale</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Romoli</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Consoli</span>  <span class=\"cit-name-given-names\">D</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Bridging versus direct mechanical Thrombectomy in acute ischemic stroke: A subgroup pooled meta-analysis for time of intervention, eligibility, and study design</span>. <abbr class=\"cit-jnl-abbrev\">Cerebrovasc Dis</abbr> <span class=\"cit-pub-date\">2020</span>;<span class=\"cit-vol\">49</span>:<span class=\"cit-fpage\">223</span>–<span class=\"cit-lpage\">32</span>. <a href=\"http://dx.doi.org/10.1159/000507844\">doi:10.1159/000507844</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DCerebrovasc%2BDis%26rft.volume%253D49%26rft.spage%253D223%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 28 in text\" id=\"ref-28\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.28\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Vidale</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Romoli</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Clemente Agostoni</span>  <span class=\"cit-name-given-names\">E</span></span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy with or without Thrombolysis: A meta-analysis of Rcts</span>. <abbr class=\"cit-jnl-abbrev\">Acta Neurol Scand</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">143</span>:<span class=\"cit-fpage\">554</span>–<span class=\"cit-lpage\">7</span>. <a href=\"http://dx.doi.org/10.1111/ane.13390\">doi:10.1111/ane.13390</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DActa%2BNeurol%2BScand%26rft.volume%253D143%26rft.spage%253D554%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 29 in text\" id=\"ref-29\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.29\" data-doi=\"10.1161/STROKEAHA.116.013097\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsivgoulis</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Katsanos</span>  <span class=\"cit-name-given-names\">AH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mavridis</span>  <span class=\"cit-name-given-names\">D</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy improves functional outcomes independent of pretreatment with intravenous Thrombolysis</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2016</span>;<span class=\"cit-vol\">47</span>:<span class=\"cit-fpage\">1661</span>–<span class=\"cit-lpage\">4</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.116.013097\">doi:10.1161/STROKEAHA.116.013097</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTROKEAHA.116.013097%26rft_id%253Dinfo%253Apmid%252F27094996%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ3LzYvMTY2MSI7czo0OiJhdG9tIjtzOjI2OiIvYm1qb3Blbi8xMy82L2UwNjQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 30 in text\" id=\"ref-30\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.30\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsivgoulis</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Katsanos</span>  <span class=\"cit-name-given-names\">AH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mavridis</span>  <span class=\"cit-name-given-names\">D</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular Thrombectomy with or without systemic Thrombolysis</span>. <abbr class=\"cit-jnl-abbrev\">Ther Adv Neurol Disord</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">10</span>:<span class=\"cit-fpage\">151</span>–<span class=\"cit-lpage\">60</span>. <a href=\"http://dx.doi.org/10.1177/1756285616680549\">doi:10.1177/1756285616680549</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DTher%2BAdv%2BNeurol%2BDisord%26rft.volume%253D10%26rft.spage%253D151%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 31 in text\" id=\"ref-31\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.31\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Podlasek</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Dhillon</span>  <span class=\"cit-name-given-names\">PS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Butt</span>  <span class=\"cit-name-given-names\">W</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Direct mechanical Thrombectomy without intravenous Thrombolysis versus bridging therapy for acute ischemic stroke: A meta-analysis of randomized controlled trials</span>. <abbr class=\"cit-jnl-abbrev\">Int J Stroke</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">16</span>:<span class=\"cit-fpage\">621</span>–<span class=\"cit-lpage\">31</span>. <a href=\"http://dx.doi.org/10.1177/17474930211021353\">doi:10.1177/17474930211021353</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DInt%2BJ%2BStroke%26rft.volume%253D16%26rft.spage%253D621%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 32 in text\" id=\"ref-32\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.32\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Phan</span>  <span class=\"cit-name-given-names\">K</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Dmytriw</span>  <span class=\"cit-name-given-names\">AA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Maingard</span>  <span class=\"cit-name-given-names\">J</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular Thrombectomy alone versus combined with intravenous Thrombolysis</span>. <abbr class=\"cit-jnl-abbrev\">World Neurosurg</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">108</span>:<span class=\"cit-fpage\">850</span>–<span class=\"cit-lpage\">8 e2</span>. <a href=\"http://dx.doi.org/10.1016/j.wneu.2017.08.040\">doi:10.1016/j.wneu.2017.08.040</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DWorld%2BNeurosurg%26rft.volume%253D108%26rft.spage%253D850%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 33 in text\" id=\"ref-33\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.33\" data-doi=\"10.1136/neurintsurg-2018-014260\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Phan</span>  <span class=\"cit-name-given-names\">K</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Dmytriw</span>  <span class=\"cit-name-given-names\">AA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lloyd</span>  <span class=\"cit-name-given-names\">D</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Direct Endovascular Thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">J NeuroIntervent Surg</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">11</span>:<span class=\"cit-fpage\">443</span>–<span class=\"cit-lpage\">9</span>. <a href=\"http://dx.doi.org/10.1136/neurintsurg-2018-014260\">doi:10.1136/neurintsurg-2018-014260</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BNeuroIntervent%2BSurg%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fneurintsurg-2018-014260%26rft_id%253Dinfo%253Apmid%252F30291209%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjg6IjExLzUvNDQzIjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA2NDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 34 in text\" id=\"ref-34\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.34\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Pan</span>  <span class=\"cit-name-given-names\">X</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Liu</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Wu</span>  <span class=\"cit-name-given-names\">B</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Comparative efficacy and safety of bridging strategies with direct mechanical Thrombectomy in large vessel occlusion: A systematic review and meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">Medicine (Baltimore)</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">98</span>. <a href=\"http://dx.doi.org/10.1097/MD.0000000000014956\">doi:10.1097/MD.0000000000014956</a></cite></div><div class=\"cit-extra\"></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 35 in text\" id=\"ref-35\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.35\" data-doi=\"10.1161/STROKEAHA.117.017320\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mistry</span>  <span class=\"cit-name-given-names\">EA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mistry</span>  <span class=\"cit-name-given-names\">AM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Fusco</span>  <span class=\"cit-name-given-names\">MR</span></span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy outcomes with and without intravenous Thrombolysis in stroke patients: A meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2017</span>;<span class=\"cit-vol\">48</span>:<span class=\"cit-fpage\">2450</span>–<span class=\"cit-lpage\">6</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.117.019116\">doi:10.1161/STROKEAHA.117.019116</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft_id%253Dinfo%253Adoi%252F10.1161%252FSTROKEAHA.117.017320%26rft_id%253Dinfo%253Apmid%252F28747462%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ4LzkvMjQ1MCI7czo0OiJhdG9tIjtzOjI2OiIvYm1qb3Blbi8xMy82L2UwNjQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 36 in text\" id=\"ref-36\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.36\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Katsanos</span>  <span class=\"cit-name-given-names\">AH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Malhotra</span>  <span class=\"cit-name-given-names\">K</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Goyal</span>  <span class=\"cit-name-given-names\">N</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Intravenous Thrombolysis prior to mechanical Thrombectomy in large vessel Occlusions</span>. <abbr class=\"cit-jnl-abbrev\">Ann Neurol</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">86</span>:<span class=\"cit-fpage\">395</span>–<span class=\"cit-lpage\">406</span>. <a href=\"http://dx.doi.org/10.1002/ana.25544\">doi:10.1002/ana.25544</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DAnn%2BNeurol%26rft.volume%253D86%26rft.spage%253D395%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 37 in text\" id=\"ref-37\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.37\" data-doi=\"10.1136/neurintsurg-2018-013834\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kaesmacher</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mordasini</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Arnold</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Direct mechanical Thrombectomy in tPA-ineligible and -Eligible patients versus the bridging approach: a meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">J Neurointerv Surg</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">11</span>:<span class=\"cit-fpage\">20</span>–<span class=\"cit-lpage\">7</span>. <a href=\"http://dx.doi.org/10.1136/neurintsurg-2018-013834\">doi:10.1136/neurintsurg-2018-013834</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BNeurointerv%2BSurg%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fneurintsurg-2018-013834%26rft_id%253Dinfo%253Apmid%252F29705773%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjc6IjExLzEvMjAiO3M6NDoiYXRvbSI7czoyNjoiL2Jtam9wZW4vMTMvNi9lMDY0MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 38 in text\" id=\"ref-38\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.38\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kim</span>  <span class=\"cit-name-given-names\">CH</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jeon</span>  <span class=\"cit-name-given-names\">JP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Kim</span>  <span class=\"cit-name-given-names\">S-E</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular treatment with intravenous Thrombolysis versus Endovascular treatment alone for acute anterior circulation stroke: A meta-analysis of observational studies</span>. <abbr class=\"cit-jnl-abbrev\">J Korean Neurosurg Soc</abbr> <span class=\"cit-pub-date\">2018</span>;<span class=\"cit-vol\">61</span>:<span class=\"cit-fpage\">467</span>–<span class=\"cit-lpage\">73</span>. <a href=\"http://dx.doi.org/10.3340/jkns.2017.0505.006\">doi:10.3340/jkns.2017.0505.006</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BKorean%2BNeurosurg%2BSoc%26rft.volume%253D61%26rft.spage%253D467%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 39 in text\" id=\"ref-39\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.39\" data-doi=\"10.1136/neurintsurg-2021-017928\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zhang</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chen</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Shi</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Direct Endovascular treatment versus bridging therapy in patients with acute ischemic stroke eligible for intravenous Thrombolysis: systematic review and meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">J NeuroIntervent Surg</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">14</span>:<span class=\"cit-fpage\">321</span>–<span class=\"cit-lpage\">5</span>. <a href=\"http://dx.doi.org/10.1136/neurintsurg-2021-017928\">doi:10.1136/neurintsurg-2021-017928</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BNeuroIntervent%2BSurg%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fneurintsurg-2021-017928%26rft_id%253Dinfo%253Apmid%252F34349014%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjg6IjE0LzQvMzIxIjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA2NDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 40 in text\" id=\"ref-40\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.40\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zheng</span>  <span class=\"cit-name-given-names\">W</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lei</span>  <span class=\"cit-name-given-names\">H</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lin</span>  <span class=\"cit-name-given-names\">X</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Intravenous Thrombolysis prior to Endovascular treatment for acute ischemic stroke: a meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">Neurol Sci</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">43</span>:<span class=\"cit-fpage\">5993</span>–<span class=\"cit-lpage\">6002</span>. <a href=\"http://dx.doi.org/10.1007/s10072-022-06233-2\">doi:10.1007/s10072-022-06233-2</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNeurol%2BSci%26rft.volume%253D43%26rft.spage%253D5993%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 41 in text\" id=\"ref-41\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.41\" data-doi=\"10.1136/neurintsurg-2021-018589\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Turc</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Tsivgoulis</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Audebert</span>  <span class=\"cit-name-given-names\">HJ</span></span></li></ol><cite>. <span class=\"cit-article-title\">European stroke Organisation (ESO)-European society for minimally invasive neurological therapy (ESMINT) expedited recommendation on indication for intravenous Thrombolysis before mechanical Thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion</span>. <abbr class=\"cit-jnl-abbrev\">J NeuroIntervent Surg</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">14</span>:<span class=\"cit-fpage\">209</span>. <a href=\"http://dx.doi.org/10.1136/neurintsurg-2021-018589\">doi:10.1136/neurintsurg-2021-018589</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJ%2BNeuroIntervent%2BSurg%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fneurintsurg-2021-018589%26rft_id%253Dinfo%253Apmid%252F35115395%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjg6IjE0LzMvMjA5IjtzOjQ6ImF0b20iO3M6MjY6Ii9ibWpvcGVuLzEzLzYvZTA2NDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-26-1\" title=\"View reference 42 in text\" id=\"ref-42\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.42\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Du</span>  <span class=\"cit-name-given-names\">H</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Lei</span>  <span class=\"cit-name-given-names\">H</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ambler</span>  <span class=\"cit-name-given-names\">G</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Intravenous Thrombolysis before mechanical Thrombectomy for acute ischemic stroke: A meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">J Am Heart Assoc</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">10</span>. <a href=\"http://dx.doi.org/10.1161/JAHA.121.022303\">doi:10.1161/JAHA.121.022303</a></cite></div><div class=\"cit-extra\"></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-43-1\" title=\"View reference 43 in text\" id=\"ref-43\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.43\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Trifan</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Biller</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Testai</span>  <span class=\"cit-name-given-names\">FD</span></span></li></ol><cite>. <span class=\"cit-article-title\">Mechanical Thrombectomy vs bridging therapy for anterior circulation large vessel occlusion stroke: systematic review and meta-analysis</span>. <abbr class=\"cit-jnl-abbrev\">Neurology</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">98</span>:<span class=\"cit-fpage\">e1361</span>–<span class=\"cit-lpage\">73</span>. <a href=\"http://dx.doi.org/10.1212/WNL.0000000000200029\">doi:10.1212/WNL.0000000000200029</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNeurology%26rft.volume%253D98%26rft.spage%253De1361%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-44-1\" title=\"View reference 44 in text\" id=\"ref-44\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.44\" data-doi=\"10.1186/2046-4053-4-1\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Moher</span>  <span class=\"cit-name-given-names\">D</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Shamseer</span>  <span class=\"cit-name-given-names\">L</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Clarke</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement</span>. <abbr class=\"cit-jnl-abbrev\">Syst Rev</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">4</span>:<span class=\"cit-fpage\">1</span>. <a href=\"http://dx.doi.org/10.1186/2046-4053-4-1\">doi:10.1186/2046-4053-4-1</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DSyst%2BRev%26rft.volume%253D4%26rft.spage%253D1%26rft_id%253Dinfo%253Adoi%252F10.1186%252F2046-4053-4-1%26rft_id%253Dinfo%253Apmid%252F25554246%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1186/2046-4053-4-1&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25554246&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-45-1\" title=\"View reference 45 in text\" id=\"ref-45\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.45\" data-doi=\"10.1186/s12874-019-0782-0\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Waffenschmidt</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Knelangen</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sieben</span>  <span class=\"cit-name-given-names\">W</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Single screening versus conventional double screening for study selection in systematic reviews: a methodological systematic review</span>. <abbr class=\"cit-jnl-abbrev\">BMC Med Res Methodol</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">19</span>:<span class=\"cit-fpage\">132</span>. <a href=\"http://dx.doi.org/10.1186/s12874-019-0782-0\">doi:10.1186/s12874-019-0782-0</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBMC%2BMed%2BRes%2BMethodol%26rft.volume%253D19%26rft.spage%253D132%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs12874-019-0782-0%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1186/s12874-019-0782-0&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-46-1\" title=\"View reference 46 in text\" id=\"ref-46\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.46\" data-doi=\"10.1016/j.jclinepi.2020.06.015\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Minozzi</span>  <span class=\"cit-name-given-names\">S</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Cinquini</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Gianola</span>  <span class=\"cit-name-given-names\">S</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">The revised Cochrane risk of bias tool for randomized trials (Rob 2) showed low Interrater Reliability and challenges in its application</span>. <abbr class=\"cit-jnl-abbrev\">Journal of Clinical Epidemiology</abbr> <span class=\"cit-pub-date\">2020</span>;<span class=\"cit-vol\">126</span>:<span class=\"cit-fpage\">37</span>–<span class=\"cit-lpage\">44</span>. <a href=\"http://dx.doi.org/10.1016/j.jclinepi.2020.06.015\">doi:10.1016/j.jclinepi.2020.06.015</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BEpidemiology%26rft.volume%253D126%26rft.spage%253D37%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jclinepi.2020.06.015%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/j.jclinepi.2020.06.015&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-47-1\" title=\"View reference 47 in text\" id=\"ref-47\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.47\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sterne</span>  <span class=\"cit-name-given-names\">JAC</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Savović</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Page</span>  <span class=\"cit-name-given-names\">MJ</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Rob 2: a revised tool for assessing risk of bias in randomised trials</span>. <abbr class=\"cit-jnl-abbrev\">BMJ</abbr> <span class=\"cit-pub-date\">2019</span>;<span class=\"cit-vol\">366</span>:<span class=\"cit-elocation-id\">l4898</span>. <a href=\"http://dx.doi.org/10.1136/bmj.l4898\">doi:10.1136/bmj.l4898</a></cite></div><div class=\"cit-extra\"></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-48-1\" title=\"View reference 48 in text\" id=\"ref-48\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.48\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">McGuinness</span>  <span class=\"cit-name-given-names\">LA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Higgins</span>  <span class=\"cit-name-given-names\">JPT</span></span></li></ol><cite>. <span class=\"cit-article-title\">Risk-of-bias visualization (Robvis): an R package and shiny web App for Visualizing risk-of-bias assessments</span>. <abbr class=\"cit-jnl-abbrev\">Res Synth Methods</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">12</span>:<span class=\"cit-fpage\">55</span>–<span class=\"cit-lpage\">61</span>. <a href=\"http://dx.doi.org/10.1002/jrsm.1411\">doi:10.1002/jrsm.1411</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DRes%2BSynth%2BMethods%26rft.volume%253D12%26rft.spage%253D55%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-49-1\" title=\"View reference 49 in text\" id=\"ref-49\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.49\" data-doi=\"10.1002/sim.2380\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Harbord</span>  <span class=\"cit-name-given-names\">RM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Egger</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Sterne</span>  <span class=\"cit-name-given-names\">JAC</span></span></li></ol><cite>. <span class=\"cit-article-title\">A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints</span>. <abbr class=\"cit-jnl-abbrev\">Stat Med</abbr> <span class=\"cit-pub-date\">2006</span>;<span class=\"cit-vol\">25</span>:<span class=\"cit-fpage\">3443</span>–<span class=\"cit-lpage\">57</span>. <a href=\"http://dx.doi.org/10.1002/sim.2380\">doi:10.1002/sim.2380</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DHarbord%26rft.auinit1%253DR.%2BM.%26rft.volume%253D25%26rft.issue%253D20%26rft.spage%253D3443%26rft.epage%253D3457%26rft.atitle%253DA%2Bmodified%2Btest%2Bfor%2Bsmall-study%2Beffects%2Bin%2Bmeta-analyses%2Bof%2Bcontrolled%2Btrials%2Bwith%2Bbinary%2Bendpoints.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.2380%26rft_id%253Dinfo%253Apmid%252F16345038%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1002/sim.2380&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=16345038&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a><a href=\"/lookup/external-ref?access_num=000241196500004&amp;link_type=ISI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\"><span>Web of Science</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-50-1\" title=\"View reference 50 in text\" id=\"ref-50\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.50\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ahmed</span>  <span class=\"cit-name-given-names\">N</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mazya</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Nunes</span>  <span class=\"cit-name-given-names\">AP</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Safety and outcomes of Thrombectomy in ischemic stroke with vs without IV Thrombolysis</span>. <abbr class=\"cit-jnl-abbrev\">Neurology</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">97</span>:<span class=\"cit-fpage\">e765</span>–<span class=\"cit-lpage\">76</span>. <a href=\"http://dx.doi.org/10.1212/WNL.0000000000012327\">doi:10.1212/WNL.0000000000012327</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNeurology%26rft.volume%253D97%26rft.spage%253De765%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-51-1\" title=\"View reference 51 in text\" id=\"ref-51\">↵</a><div class=\"cit ref-cit ref-book\" id=\"cit-13.6.e064322.51\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Higgins</span>  <span class=\"cit-name-given-names\">JPT</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Thomas</span>  <span class=\"cit-name-given-names\">J</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Chandler</span>  <span class=\"cit-name-given-names\">J</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-source\">Cochrane Handbook for systematic reviews of interventions</span>. <span class=\"cit-publ-name\">John Wiley &amp; Sons</span>, <span class=\"cit-pub-date\">2019</span>. <a href=\"http://dx.doi.org/10.1002/9781119536604\">doi:10.1002/9781119536604</a></cite></div><div class=\"cit-extra\"></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-51-1\" title=\"View reference 52 in text\" id=\"ref-52\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.52\" data-doi=\"10.1186/1471-2288-14-135\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Wan</span>  <span class=\"cit-name-given-names\">X</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Wang</span>  <span class=\"cit-name-given-names\">W</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Liu</span>  <span class=\"cit-name-given-names\">J</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Estimating the sample mean and standard deviation from the sample size, median, range and/or Interquartile range</span>. <abbr class=\"cit-jnl-abbrev\">BMC Med Res Methodol</abbr> <span class=\"cit-pub-date\">2014</span>;<span class=\"cit-vol\">14</span>:<span class=\"cit-fpage\">135</span>. <a href=\"http://dx.doi.org/10.1186/1471-2288-14-135\">doi:10.1186/1471-2288-14-135</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBMC%2BMed%2BRes%2BMethodol%26rft.volume%253D14%26rft.spage%253D135%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1471-2288-14-135%26rft_id%253Dinfo%253Apmid%252F25524443%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1186/1471-2288-14-135&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=25524443&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-53-1\" title=\"View reference 53 in text\" id=\"ref-53\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.53\" data-doi=\"10.1136/bmj.315.7109.629\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Egger</span>  <span class=\"cit-name-given-names\">M</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Davey Smith</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Schneider</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Bias in meta-analysis detected by a simple, graphical test</span>. <abbr class=\"cit-jnl-abbrev\">BMJ</abbr> <span class=\"cit-pub-date\">1997</span>;<span class=\"cit-vol\">315</span>:<span class=\"cit-fpage\">629</span>–<span class=\"cit-lpage\">34</span>. <a href=\"http://dx.doi.org/10.1136/bmj.315.7109.629\">doi:10.1136/bmj.315.7109.629</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.aulast%253DEgger%26rft.auinit1%253DM.%26rft.volume%253D315%26rft.issue%253D7109%26rft.spage%253D629%26rft.epage%253D634%26rft.atitle%253DBias%2Bin%2Bmeta-analysis%2Bdetected%2Bby%2Ba%2Bsimple%252C%2Bgraphical%2Btest%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.315.7109.629%26rft_id%253Dinfo%253Apmid%252F9310563%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjEyOiIzMTUvNzEwOS82MjkiO3M6NDoiYXRvbSI7czoyNjoiL2Jtam9wZW4vMTMvNi9lMDY0MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-54-1\" title=\"View reference 54 in text\" id=\"ref-54\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.54\" data-doi=\"10.1056/NEJMoa2030297\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Langezaal</span>  <span class=\"cit-name-given-names\">LCM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">van der Hoeven</span>  <span class=\"cit-name-given-names\">EJRJ</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Mont’Alverne</span>  <span class=\"cit-name-given-names\">FJA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular therapy for stroke due to basilar-artery occlusion</span>. <abbr class=\"cit-jnl-abbrev\">N Engl J Med</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">384</span>:<span class=\"cit-fpage\">1910</span>–<span class=\"cit-lpage\">20</span>. <a href=\"http://dx.doi.org/10.1056/NEJMoa2030297\">doi:10.1056/NEJMoa2030297</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D384%26rft.spage%253D1910%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2030297%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1056/NEJMoa2030297&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=http://www.n&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-55-1\" title=\"View reference 55 in text\" id=\"ref-55\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.55\" data-doi=\"10.1016/j.jclinepi.2010.04.026\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Guyatt</span>  <span class=\"cit-name-given-names\">G</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Oxman</span>  <span class=\"cit-name-given-names\">AD</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Akl</span>  <span class=\"cit-name-given-names\">EA</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">GRADE guidelines: 1. introduction-GRADE evidence profiles and summary of findings tables</span>. <abbr class=\"cit-jnl-abbrev\">J Clin Epidemiol</abbr> <span class=\"cit-pub-date\">2011</span>;<span class=\"cit-vol\">64</span>:<span class=\"cit-fpage\">383</span>–<span class=\"cit-lpage\">94</span>. <a href=\"http://dx.doi.org/10.1016/j.jclinepi.2010.04.026\">doi:10.1016/j.jclinepi.2010.04.026</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DJournal%2Bof%2Bclinical%2Bepidemiology%26rft.stitle%253DJ%2BClin%2BEpidemiol%26rft.aulast%253DGuyatt%26rft.auinit1%253DG.%26rft.volume%253D64%26rft.issue%253D4%26rft.spage%253D383%26rft.epage%253D394%26rft.atitle%253DGRADE%2Bguidelines%253A%2B1.%2BIntroduction-GRADE%2Bevidence%2Bprofiles%2Band%2Bsummary%2Bof%2Bfindings%2Btables.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jclinepi.2010.04.026%26rft_id%253Dinfo%253Apmid%252F21195583%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1016/j.jclinepi.2010.04.026&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=21195583&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-55-1\" title=\"View reference 56 in text\" id=\"ref-56\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.56\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Iorio</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Spencer</span>  <span class=\"cit-name-given-names\">FA</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Falavigna</span>  <span class=\"cit-name-given-names\">M</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients</span>. <abbr class=\"cit-jnl-abbrev\">BMJ</abbr> <span class=\"cit-pub-date\">2015</span>;<span class=\"cit-vol\">350</span>. <a href=\"http://dx.doi.org/10.1136/bmj.h870\">doi:10.1136/bmj.h870</a></cite></div><div class=\"cit-extra\"></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-57-1\" title=\"View reference 57 in text\" id=\"ref-57\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.57\" data-doi=\"10.1136/svn-2022-001547\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Wang</span>  <span class=\"cit-name-given-names\">X</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Ye</span>  <span class=\"cit-name-given-names\">Z</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Busse</span>  <span class=\"cit-name-given-names\">JW</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Endovascular Thrombectomy with or without intravenous Alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials</span>. <abbr class=\"cit-jnl-abbrev\">Stroke Vasc Neurol</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">7</span>:<span class=\"cit-fpage\">510</span>–<span class=\"cit-lpage\">7</span>. <a href=\"http://dx.doi.org/10.1136/svn-2022-001547\">doi:10.1136/svn-2022-001547</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%2BVasc%2BNeurol%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fsvn-2022-001547%26rft_id%253Dinfo%253Apmid%252F35725244%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Njoic3ZuYm1qIjtzOjU6InJlc2lkIjtzOjc6IjcvNi81MTAiO3M6NDoiYXRvbSI7czoyNjoiL2Jtam9wZW4vMTMvNi9lMDY0MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-abstract\">Abstract</span><span class=\"cit-sep cit-reflinks-variant-name-sep\">/</span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-58-1\" title=\"View reference 58 in text\" id=\"ref-58\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.58\" data-doi=\"10.1212/WNL.0000000000012801\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jadhav</span>  <span class=\"cit-name-given-names\">AP</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Desai</span>  <span class=\"cit-name-given-names\">SM</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Jovin</span>  <span class=\"cit-name-given-names\">TG</span></span></li></ol><cite>. <span class=\"cit-article-title\">Indications for mechanical Thrombectomy for acute ischemic stroke: Current guidelines and beyond</span>. <abbr class=\"cit-jnl-abbrev\">Neurology</abbr> <span class=\"cit-pub-date\">2021</span>;<span class=\"cit-vol\">97</span>(<span class=\"cit-issue\">20 Suppl 2</span>):<span class=\"cit-fpage\">S126</span>–<span class=\"cit-lpage\">36</span>. <a href=\"http://dx.doi.org/10.1212/WNL.0000000000012801\">doi:10.1212/WNL.0000000000012801</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DNeurology%26rft.volume%253D97%26rft.spage%253DS126%26rft_id%253Dinfo%253Adoi%252F10.1212%252FWNL.0000000000012801%26rft_id%253Dinfo%253Apmid%252F34785611%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/external-ref?access_num=10.1212/WNL.0000000000012801&amp;link_type=DOI\" class=\"cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\"><span>CrossRef</span></a><a href=\"/lookup/external-ref?access_num=34785611&amp;link_type=MED&amp;atom=%2Fbmjopen%2F13%2F6%2Fe064322.atom\" class=\"cit-ref-sprinkles cit-ref-sprinkles-medline\"><span>PubMed</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-59-1\" title=\"View reference 59 in text\" id=\"ref-59\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.59\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Zhou</span>  <span class=\"cit-name-given-names\">Y</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Xing</span>  <span class=\"cit-name-given-names\">P</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Li</span>  <span class=\"cit-name-given-names\">Z</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">Effect of occlusion site on the safety and efficacy of intravenous Alteplase before Endovascular Thrombectomy: A Prespecified subgroup analysis of DIRECT-MT</span>. <abbr class=\"cit-jnl-abbrev\">Stroke</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">53</span>:<span class=\"cit-fpage\">7</span>–<span class=\"cit-lpage\">16</span>. <a href=\"http://dx.doi.org/10.1161/STROKEAHA.121.035267\">doi:10.1161/STROKEAHA.121.035267</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%26rft.volume%253D53%26rft.spage%253D7%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a></div></div></li><li><a class=\"rev-xref-ref\" href=\"#xref-ref-60-1\" title=\"View reference 60 in text\" id=\"ref-60\">↵</a><div class=\"cit ref-cit ref-journal\" id=\"cit-13.6.e064322.60\" data-doi=\"10.1136/svn-2021-001465\"><div class=\"cit-metadata\"><ol class=\"cit-auth-list\"><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Podlasek</span>  <span class=\"cit-name-given-names\">A</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Dhillon</span>  <span class=\"cit-name-given-names\">PS</span></span>, </li><li><span class=\"cit-auth\"><span class=\"cit-name-surname\">Butt</span>  <span class=\"cit-name-given-names\">W</span></span>, <span class=\"cit-etal\">et al</span></li></ol><cite>. <span class=\"cit-article-title\">To bridge or not to bridge: summary of the new evidence in Endovascular stroke treatment</span>. <abbr class=\"cit-jnl-abbrev\">Stroke Vasc Neurol</abbr> <span class=\"cit-pub-date\">2022</span>;<span class=\"cit-vol\">7</span>:<span class=\"cit-fpage\">179</span>–<span class=\"cit-lpage\">81</span>. <a href=\"http://dx.doi.org/10.1136/svn-2021-001465\">doi:10.1136/svn-2021-001465</a></cite></div><div class=\"cit-extra\"><a href=\"%7Bopenurl%7D?query=rft.jtitle%253DStroke%2BVasc%2BNeurol%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fsvn-2021-001465%26rft_id%253Dinfo%253Apmid%252F35105731%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\" class=\"cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\"><span>OpenUrl</span></a><a href=\"/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6Njoic3ZuYm1qIjtzOjU6InJlc2lkIjtzOjc6IjcvMy8xNzkiO3M6NDoiYXRvbSI7czoyNjoiL2Jtam9wZW4vMTMvNi9lMDY0MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\" class=\"cit-ref-sprinkles cit-ref-sprinkles-ijlink\"><span><span class=\"cit-reflinks-full-text\"><span class=\"free-full-text\">FREE </span>Full Text</span></span></a></div></div></li></ol></div><span class=\"highwire-journal-article-marker-end\"></span></div><span class=\"related-urls\"></span></div></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-article-data-supp\" id=\"supplementary-materials\">\\n  \\n        <h2 class=\"pane-title\">Supplementary materials</h2>\\n    \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"item-list\"><ul><li class=\"first last\"><div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"content-block\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div><span class=\"highwire-journal-article-marker-start\"></span><div class=\"auto-clean\"><span style=\"font-family: Verdana,Arial,Helvetica,sans-serif;  font-size: 83.33%\">\\n         \\n            <h2>Supplementary Data</h2>\\n            <p>This web only file has been produced by the BMJ Publishing Group from an electronic\\n               file supplied by the author(s) and has not been edited for content.\\n            </p>\\n            <ul><li><a href=\"/highwire/filestream/289400/field_highwire_adjunct_files/0/bmjopen-2022-064322supp001_data_supplement.pdf\" class=\"rewritten\" data-icon-position=\"\" data-hide-link-title=\"0\">Data supplement 1</a> \\n                  \\n               </li></ul>\\n         </span>\\n      \\n   </div><span class=\"highwire-journal-article-marker-end\"></span></div><span id=\"related-urls\"></span></div></div></li>\\n</ul></div>  </div>\\n\\n  \\n  </div>\\n<div class=\"panel-separator\"></div><div class=\"panel-pane pane-highwire-markup footnotes\">\\n  \\n      \\n  \\n  <div class=\"pane-content\">\\n    <div class=\"highwire-markup\"><div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"content-block-markup\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><div xmlns:xhtml=\"http://www.w3.org/1999/xhtml\" class=\"section fn-group\" id=\"fn-group-1\"><h2>Footnotes</h2><ul><li class=\"fn-other\" id=\"fn-1\"><p id=\"p-41\"><span class=\"fn-label\">Twitter</span> @LHneiny</p></li><li class=\"fn-other\" id=\"fn-2\"><p id=\"p-42\"><span class=\"fn-label\">Contributors</span> RZM and TK: conception and design of the work, analysis, drafting of the manuscript and final approval. YZ, AMK and AJD: analysis, design of the work and drafting of the manuscript and final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting of the work and final approval. All authors reviewed and contributed to the final version of this article.</p></li><li class=\"fn-other\" id=\"fn-3\"><p id=\"p-43\"><span class=\"fn-label\">Funding</span> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p></li><li class=\"fn-conflict\" id=\"fn-4\"><p id=\"p-44\"><span class=\"fn-label\">Competing interests</span> None declared.</p></li><li class=\"fn-other\" id=\"fn-5\"><p id=\"p-45\"><span class=\"fn-label\">Patient and public involvement</span> Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.</p></li><li class=\"fn-other\" id=\"fn-6\"><p id=\"p-46\"><span class=\"fn-label\">Provenance and peer review</span> Not commissioned; externally peer reviewed.</p></li><li class=\"fn-other\" id=\"fn-7\"><p id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></li></ul></div></div></div>  </div>\\n\\n  \\n  </div>\\n</div>\\n  </div>'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_dict = main_text[text_id]\n",
    "test_text = text_dict[0]\n",
    "test_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ Journals\"><img src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ Journals\" alt=\"BMJ Journals\"></a></p><h2 class=\"pane-title\"><span class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h2 class=\"element-invisible\">You are here</h2><p><span class=\"icon-article-text\"></span>Article Text</p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" target=\"new\"><img alt=\"Download PDF\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img alt=\"Download PDF + Supplemental Data\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\n",
       "Supplementary<br>\n",
       "Material</strong></a></p><h2>Abstract</h2><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 class=\"pane-title\">Statistics from Altmetric.com</h2><h2 class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References</h2><h2 class=\"pane-title\">Supplementary materials</h2><h2>Supplementary Data</h2><p>This web only file has been produced by the BMJ Publishing Group from an electronic\n",
       "               file supplied by the author(s) and has not been edited for content.\n",
       "            </p><h2>Footnotes</h2><p id=\"p-41\"><span class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span class=\"fn-label\">Contributors</span> RZM and TK: conception and design of the work, analysis, drafting of the manuscript and final approval. YZ, AMK and AJD: analysis, design of the work and drafting of the manuscript and final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting of the work and final approval. All authors reviewed and contributed to the final version of this article.</p><p id=\"p-43\"><span class=\"fn-label\">Funding</span> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing interests</span> None declared.</p><p id=\"p-45\"><span class=\"fn-label\">Patient and public involvement</span> Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance and peer review</span> Not commissioned; externally peer reviewed.</p><p id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or download the PDF:</h2><p><small><span class=\"online-issn issn\">Online ISSN: 2044-6055</span><span class=\"print-issn issn\">Print ISSN: 2044-6055</span></small><br>\n",
       "        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights reserved.</small></p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "from IPython import display\n",
    "def trim_text(text, regex=r'(.*)'):\n",
    "    processed = re.findall(regex, text, re.DOTALL)\n",
    "    try:\n",
    "        return display.HTML(processed[0])\n",
    "    except:\n",
    "        print('No HTML to display')\n",
    "        return processed\n",
    "\n",
    "regex = r'(.*)'\n",
    "trim_text(test_text, regex)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Update crawler script"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Iteration 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ '\n",
      " 'Journals\"><img '\n",
      " 'src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ '\n",
      " 'Journals\" alt=\"BMJ Journals\"></a></p><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h2 '\n",
      " 'class=\"element-invisible\">You are here</h2><p><span '\n",
      " 'class=\"icon-article-text\"></span>Article Text</p><p><a '\n",
      " 'class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" '\n",
      " 'target=\"new\"><img alt=\"Download PDF\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a '\n",
      " 'class=\"article-pdf-download\" '\n",
      " 'href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img '\n",
      " 'alt=\"Download PDF + Supplemental Data\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\\n'\n",
      " 'Supplementary<br>\\n'\n",
      " 'Material</strong></a></p><h2>Abstract</h2><p '\n",
      " 'id=\"p-2\"><strong>Introduction</strong> Current published guidelines and '\n",
      " 'meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT '\n",
      " 'with bridging intravenous thrombolysis (IVT) suggest that EVT alone is '\n",
      " 'non-inferior to EVT with bridging thrombolysis in achieving favourable '\n",
      " 'functional outcome. Because of this controversy, we aimed to systematically '\n",
      " 'update the evidence and meta-analyse data from randomised trials comparing '\n",
      " 'EVT alone versus EVT with bridging thrombolysis, and performed an economic '\n",
      " 'evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and '\n",
      " 'analysis</strong> We will conduct a systematic review of randomised '\n",
      " 'controlled trials comparing EVT with or without bridging thrombolysis in '\n",
      " 'patients presenting with large vessel occlusions. We will identify eligible '\n",
      " 'studies by systematically searching the following databases from inception '\n",
      " 'without any language restrictions: MEDLINE (through Ovid), Embase and the '\n",
      " 'Cochrane Library. The following criteria will be used to assess eligibility '\n",
      " 'for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to '\n",
      " 'EVT alone or to EVT with IVT; and (3) measured outcomes, including '\n",
      " 'functional outcomes, at least 90 days after randomisation. Pairs of '\n",
      " 'reviewers will independently screen the identified articles, extract '\n",
      " 'information and assess the risk of bias of eligible studies. We will use the '\n",
      " 'Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the '\n",
      " 'Grading of Recommendations, Assessment, Development and Evaluation approach '\n",
      " 'to assess the certainty in evidence for each outcome. We will then perform '\n",
      " 'an economic evaluation based on the extracted data.</p><p '\n",
      " 'id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review '\n",
      " 'will not require a research ethics approval because no confidential patient '\n",
      " 'data will be used. We will disseminate our findings by publishing the '\n",
      " 'results in a peer-reviewed journal and via presentation at '\n",
      " 'conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> '\n",
      " 'CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in '\n",
      " 'accordance with the Creative Commons Attribution Non Commercial (CC BY-NC '\n",
      " '4.0) license, which permits others to distribute, remix, adapt, build upon '\n",
      " 'this work non-commercially, and license their derivative works on different '\n",
      " 'terms, provided the original work is properly cited, appropriate credit is '\n",
      " 'given, any changes made indicated, and the use is non-commercial. See:\\xa0<a '\n",
      " 'href=\"http://creativecommons.org/licenses/by-nc/4.0/\" '\n",
      " 'rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a '\n",
      " 'href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" '\n",
      " 'target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 '\n",
      " 'class=\"pane-title\">Statistics from Altmetric.com</h2><h2 '\n",
      " 'class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or '\n",
      " 'all of this article please use the link below which will take you to the '\n",
      " 'Copyright Clearance Center’s RightsLink service. You will be able to get a '\n",
      " 'quick price and instant permission to reuse the content in many different '\n",
      " 'ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" '\n",
      " 'data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><p '\n",
      " 'id=\"p-6\">The broad study eligibility criteria will increase the '\n",
      " 'generalisability of our results.</p><p id=\"p-7\">We will use the Grading of '\n",
      " 'Recommendations, Assessment, Development and Evaluation approach to assess '\n",
      " 'the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform '\n",
      " 'an economic evaluation based on the meta-analysed data to assess which '\n",
      " 'treatment strategy is more cost-effective, and we will rank the treatment '\n",
      " 'strategies based on efficacy, safety and cost-effectiveness.</p><p '\n",
      " 'id=\"p-9\">Our results will be limited by the primary data, for which careful '\n",
      " 'appraisal of the study quality will be carried out.</p><h2 '\n",
      " 'class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has '\n",
      " 'been a long-standing, evidence-based treatment approach for acute ischaemic '\n",
      " 'stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, '\n",
      " 'IVT must be delivered within 4.5\\u2009hours, has many contraindications, may '\n",
      " 'not provide adequate reperfusion, especially in patients with large vessel '\n",
      " 'occlusions, and may even increase the risk of intracranial haemorrhage.<a '\n",
      " 'id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were '\n",
      " 'conducted to evaluate the use of endovascular therapy in patients with acute '\n",
      " 'ischaemic stroke. The Interventional Management of Stroke (IMS) III was a '\n",
      " 'randomised controlled trial (RCT) comparing endovascular therapy after IVT '\n",
      " 'with IVT alone. Endovascular therapy included a variety of techniques, such '\n",
      " 'as mechanical and aspiration thrombectomy, stent-retriever technology or '\n",
      " 'intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute '\n",
      " 'Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including '\n",
      " 'intra-arterial thrombolysis, clot disruption or retrieval or a combination '\n",
      " 'of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke '\n",
      " 'Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent '\n",
      " 'endovascular therapy alone versus those who received standard care.<a '\n",
      " 'id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all '\n",
      " 'failed to show any benefit for endovascular therapy in acute ischaemic '\n",
      " 'stroke. There were several limitations in these trials, ranging from '\n",
      " 'inconsistencies with imaging selection, timing variables and device '\n",
      " 'use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence '\n",
      " 'supporting the use of endovascular therapy in patients who present with an '\n",
      " 'acute ischaemic stroke secondary to a large vessel occlusion.<a '\n",
      " 'id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does '\n",
      " 'not adequately recanalise large or proximal intracranial occlusions, the '\n",
      " 'significant treatment effect of endovascular thrombectomy (EVT) in both '\n",
      " 'IVT-eligible and IVT-ineligible patients with large vessel occlusions, the '\n",
      " 'potential delaying effect of IVT to initiation of EVT and its possible '\n",
      " 'association with increased bleeding events, many RCTs and post hoc analyses '\n",
      " 'of RCTs have evaluated the safety and efficacy of EVT alone versus bridging '\n",
      " 'IVT prior to EVT in patients presenting with acute ischaemic stroke '\n",
      " 'secondary to a large vessel occlusion, and have shown conflicting evidence '\n",
      " 'whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a '\n",
      " 'id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 '\n",
      " 'European Stroke Organisation (ESO)–European Society for Minimally Invasive '\n",
      " 'Neurological Therapy (ESMINT) guidelines found high quality of evidence '\n",
      " 'recommending the use of EVT and best medical management within 6\\u2009hours '\n",
      " 'after symptom onset, and moderate quality of evidence for use of EVT and '\n",
      " 'best medical management in patients presenting within the window of 6–24 '\n",
      " 'hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The '\n",
      " 'ESO-ESMINT guidelines published an expedited recommendation strongly '\n",
      " 'recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart '\n",
      " 'Association guidelines provided a class I recommendation for the use of IVT '\n",
      " 'prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several '\n",
      " 'published systematic reviews exploring the efficacy of bridging IVT prior to '\n",
      " 'EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of '\n",
      " 'bias or the certainty of evidence in each outcome, and vary in their study '\n",
      " 'inclusion criteria and methodology. A recently published systematic review '\n",
      " 'and meta-analysis has focused on comparing the two treatment strategies in '\n",
      " 'patients presenting with large vessel occlusions involving only the anterior '\n",
      " 'circulation and has assessed the certainty of evidence using the Grading of '\n",
      " 'Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a '\n",
      " 'id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, '\n",
      " 'however, excludes patients with large vessel occlusions in the posterior '\n",
      " 'circulation. None of these systematic reviews consistently assessed the '\n",
      " 'overall certainty of evidence and conducted a cost-effectiveness analysis '\n",
      " 'comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to '\n",
      " 'conduct a systematic review and meta-analysis of randomised trials to assess '\n",
      " 'the comparative efficacy and safety of EVT alone versus IVT plus EVT for '\n",
      " 'patients with acute ischaemic stroke secondary to large vessel occlusion and '\n",
      " 'perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 '\n",
      " 'class=\"\">Methods and analysis</h2><p id=\"p-13\">We ensured our protocol was '\n",
      " 'prepared in accordance with the Preferred Reporting Items for Systematic '\n",
      " 'Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered '\n",
      " 'with International Prospective Register of Systematic Reviews (PROSPERO) '\n",
      " '(registration number CRD42022315608).</p><p id=\"p-14\">We will include '\n",
      " 'randomised trials meeting the following criteria: (1) enrolled adult '\n",
      " 'patients ≥18 years old presenting with an acute ischaemic stroke secondary '\n",
      " 'to a large vessel occlusion, regardless of vessel involved, and (2) '\n",
      " 'randomised patients to undergo EVT alone or to receive IVT in addition to '\n",
      " 'EVT. We will include trials that permitted cointerventions (eg, '\n",
      " 'intra-arterial thrombolysis, rescue stenting) only if the same '\n",
      " 'cointerventions were used in patients from all study arms. <a '\n",
      " 'id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides '\n",
      " 'a more detailed representation of the inclusion and exclusion '\n",
      " 'criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion '\n",
      " 'criteria for study eligibility</p><p id=\"p-25\">An information specialist '\n",
      " '(LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" '\n",
      " 'class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a '\n",
      " 'id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" '\n",
      " 'href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our '\n",
      " 'searches systematically looking for eligible studies in MEDLINE (through '\n",
      " 'Ovid), Embase and the Cochrane Library from inception without language '\n",
      " 'restrictions. We will also review the reference lists of included studies '\n",
      " 'and relevant reviews to identify any additional studies meeting the '\n",
      " 'eligibility criteria.</p><p id=\"p-27\" class=\"first-child\">Sample search '\n",
      " 'algorithm for MEDLINE(through Ovid).</p><p id=\"p-28\">Prior to the screening '\n",
      " 'process, teams of two reviewers will participate in calibration exercises. '\n",
      " 'Following the calibration exercises, teams of two reviewers will '\n",
      " 'subsequently double screen the titles and abstracts of all identified '\n",
      " 'citations. These pairs of two reviewers will then retrieve and double screen '\n",
      " 'the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually '\n",
      " 'without the use of software applications. A third reviewer will resolve '\n",
      " 'disagreements if necessary. We will also contact study authors if reviewers '\n",
      " 'find any uncertainties limiting ability to discern study eligibility.</p><p '\n",
      " 'id=\"p-29\">We designed a standardised extraction form and a comprehensive '\n",
      " 'instruction manual to assist with data extraction. We will conduct '\n",
      " 'calibration exercises prior to the data extraction phase to ensure accuracy '\n",
      " 'and consistency. Pairs of two reviewers will subsequently extract data '\n",
      " 'independently and review in duplicate.</p><p id=\"p-30\">Reviewers will '\n",
      " 'extract the following data for all included studies: study characteristics '\n",
      " '(eg, author information, country of origin and study design), patient '\n",
      " 'characteristics (eg, sample size, age and sex of patients, medical history, '\n",
      " 'National Institute of Health Stroke Scale score, the proportion for each '\n",
      " 'vessel involved as well as determined stroke aetiology), characteristics of '\n",
      " 'interventions and comparators (eg, intravenous thrombolytic agent used and '\n",
      " 'respective dose and thrombectomy device used) and treatment outcomes, '\n",
      " 'including mortality, functional independence, successful reperfusion, '\n",
      " 'intracranial haemorrhage (including symptomatic intracranial haemorrhage), '\n",
      " 'and procedural complications and other adverse events. Data will be '\n",
      " 'abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. '\n",
      " 'If there are any missing details, we will contact the authors of included '\n",
      " 'studies when applicable.</p><p id=\"p-31\">We conducted a preliminary '\n",
      " 'literature search of the databases, and conclusion of the search suggests '\n",
      " 'that there will be an estimate of six studies eligible for this '\n",
      " 'review.</p><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of '\n",
      " 'included studies independently and in duplicate using the revised Cochrane '\n",
      " 'Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater '\n",
      " 'reliability and other expected challenges, such as difficult terminology, by '\n",
      " 'training the reviewers to improve the reliability of RoB 2.<a '\n",
      " 'id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the '\n",
      " 'following criteria to assess risk of bias: randomisation process, deviations '\n",
      " 'from intended interventions, missing outcome data, measurement of the '\n",
      " 'outcome and selection of the reported result.<a id=\"xref-ref-47-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements '\n",
      " 'between reviewers through consensus and/or with the assistance of an '\n",
      " 'adjudicator. Risk of bias for included studies will be illustrated in '\n",
      " 'figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-48\">48</a></p><p id=\"p-33\">We will group all '\n",
      " 'outcomes reported by at least two studies for direct comparison. We will '\n",
      " 'standardise the definitions and measurements of each outcome via consensus. '\n",
      " 'We will conduct a meta-analysis of the outcomes of interest when possible '\n",
      " 'using the generic inverse variance method and random effects analysis model '\n",
      " 'via Review Manager V.5.4. We will use Harbord’s test to assess small study '\n",
      " 'effects for binary outcomes and Egger’s test for continuous outcomes when '\n",
      " 'there are at least 10 studies eligible for quantitative assessment.<a '\n",
      " 'id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no '\n",
      " 'meta-analysis could be performed due to heterogeneity of the data, we will '\n",
      " 'narratively synthesise the findings. For dichotomous outcomes reported by at '\n",
      " 'least one RCT, we will calculate the relative risk (RR) using the crude '\n",
      " 'event rate and the associated 95% CIs to inform relative effectiveness. We '\n",
      " 'will calculate risk difference based on the RRs from our study and the '\n",
      " 'baseline risks from a well-designed, high-quality multicentre observational '\n",
      " 'study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by '\n",
      " 'at least one RCT, we will calculate the weighted mean difference and '\n",
      " 'associated 95%\\u2009CI. When only median and range values are reported or '\n",
      " 'when SD are not reported, we will use methods outlined in <em>Cochrane '\n",
      " 'Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et '\n",
      " 'al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel '\n",
      " 'plots to assess for asymmetry per outcome of interest and will also estimate '\n",
      " 'Egger’ test of the intercept to assess for publication bias.<a '\n",
      " 'id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><p '\n",
      " 'id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency '\n",
      " 'measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a '\n",
      " 'priori hypotheses to explain heterogeneity between studies: (1) location of '\n",
      " 'vessel involved (eg, anterior circulation or posterior circulation) will '\n",
      " 'show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger '\n",
      " 'treatment effects; and (3) type of thrombectomy devices used (eg, stent '\n",
      " 'retriever, aspiration, etc). We will perform subgroup analyses irrespective '\n",
      " 'of the heterogeneity estimates as long as there are at least two studies '\n",
      " 'representing each subgroup.</p><p id=\"p-35\">For each outcome, we will assess '\n",
      " 'the certainty of the evidence (as high, moderate, low or very low) using the '\n",
      " 'GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived '\n",
      " 'thresholds for the minimally important difference for favourable functional '\n",
      " 'outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted '\n",
      " 'from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-57\">57</a></p><p id=\"p-36\">We will conduct a model-based '\n",
      " 'cost–utility analysis to determine the cost-effectiveness of EVT alone '\n",
      " 'compared with IVT and EVT for patients with an acute ischaemic stroke '\n",
      " 'secondary to a large vessel occlusion. A Markov decision analytical model '\n",
      " 'with a lifetime horizon will be developed to predict the long-term costs and '\n",
      " 'health outcomes. We will conduct the analysis from a healthcare perspective. '\n",
      " 'We will base the clinical outcome inputs from this systematic review. We '\n",
      " 'will search literature for the long-term clinical outcome inputs. From the '\n",
      " 'healthcare perspective, we will consider both medical costs (ie, costs '\n",
      " 'related to patient care) and non-medical costs (ie, overhead costs such as '\n",
      " 'finance, human resources and administration) that are incurred during '\n",
      " 'treatment. The treatment costs come from the administrative data of the '\n",
      " 'University of Chicago Medical Center. Other cost estimates (ie, health '\n",
      " 'state-related costs) and utility inputs will be based on literature.</p><p '\n",
      " 'id=\"p-37\">Neither patients nor the public was involved in the study.</p><p '\n",
      " 'id=\"p-38\">This systematic review will not require a research ethics approval '\n",
      " 'because no confidential patient data will be used. We will disseminate our '\n",
      " 'findings by publishing the results in a peer-reviewed journal and via '\n",
      " 'presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT '\n",
      " 'has emerged to become a superior treatment modality compared with medical '\n",
      " 'management alone for the treatment of strokes secondary to large vessel '\n",
      " 'occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety '\n",
      " 'and efficacy of bridging IVT prior to thrombectomy remain to be the subject '\n",
      " 'of debate. A recent subgroup analysis showed that the effect of intravenous '\n",
      " 'alteplase prior to thrombectomy is not significantly associated with the '\n",
      " 'occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; '\n",
      " 'however, the trial for which this analysis was based included only '\n",
      " 'occlusions in the internal carotid and M1 or M2 branches of the middle '\n",
      " 'cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly '\n",
      " 'reviewed the combined the trial data from six RCTs and showed that EVT alone '\n",
      " 'is non-inferior to bridging therapy in achieving good functional outcomes at '\n",
      " '3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently '\n",
      " 'recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-23\">23–25</a> there is a need for a high-quality review to '\n",
      " 'provide a clinical summary of the efficacy and safety of mechanical '\n",
      " 'thrombectomy alone versus IVT prior to mechanical thrombectomy and to '\n",
      " 'balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many '\n",
      " 'strengths compared with existing reviews in the literature. First, we will '\n",
      " 'compare the efficacy and safety of mechanical thrombectomy alone versus '\n",
      " 'mechanical thrombectomy and bridging thrombolysis in studies that only '\n",
      " 'directly compare the two interventions strategies. Second, we will '\n",
      " 'investigate the effects of treatment across certain conditions. Third, we '\n",
      " 'will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias '\n",
      " 'and certainty of evidence, respectively, for each outcome. Lastly, this '\n",
      " 'study will be the first to use meta-analysed data to robustly perform an '\n",
      " 'economic evaluation comparing the two treatment strategies, integrate '\n",
      " 'clinical outcome inputs from study-level data and treatment cost inputs from '\n",
      " 'administrative data. Some potential limitations will include the following: '\n",
      " 'heterogeneity of outcome definitions and measurement, such as in the case of '\n",
      " 'symptomatic intracranial haemorrhage; cost estimation cannot assess for '\n",
      " 'lifetime cost as there are limited longitudinal data with respect to the '\n",
      " 'treatment strategies. The findings of our study will help inform providers '\n",
      " 'about the role of IVT in mechanical thrombectomy and identify key areas for '\n",
      " 'future research.</p><h2 class=\"\">Ethics statements</h2><p id=\"p-48\" '\n",
      " 'class=\"ethics-consent-to-publish\">Not applicable.</p><h2 '\n",
      " 'class=\"\">References</h2><h2 class=\"pane-title\">Supplementary '\n",
      " 'materials</h2><h2>Supplementary Data</h2><p>This web only file has been '\n",
      " 'produced by the BMJ Publishing Group from an electronic\\n'\n",
      " '               file supplied by the author(s) and has not been edited for '\n",
      " 'content.\\n'\n",
      " '            </p><h2>Footnotes</h2><p id=\"p-41\"><span '\n",
      " 'class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span '\n",
      " 'class=\"fn-label\">Contributors</span> RZM and TK: conception and design of '\n",
      " 'the work, analysis, drafting of the manuscript and final approval. YZ, AMK '\n",
      " 'and AJD: analysis, design of the work and drafting of the manuscript and '\n",
      " 'final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of '\n",
      " 'the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting '\n",
      " 'of the work and final approval. All authors reviewed and contributed to the '\n",
      " 'final version of this article.</p><p id=\"p-43\"><span '\n",
      " 'class=\"fn-label\">Funding</span> The authors have not declared a specific '\n",
      " 'grant for this research from any funding agency in the public, commercial or '\n",
      " 'not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing '\n",
      " 'interests</span> None declared.</p><p id=\"p-45\"><span '\n",
      " 'class=\"fn-label\">Patient and public involvement</span> Patients and/or the '\n",
      " 'public were not involved in the design, conduct, reporting or dissemination '\n",
      " 'plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance '\n",
      " 'and peer review</span> Not commissioned; externally peer reviewed.</p><p '\n",
      " 'id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content '\n",
      " 'has been supplied by the author(s). It has not been vetted by BMJ Publishing '\n",
      " 'Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or '\n",
      " 'recommendations discussed are solely those of the author(s) and are not '\n",
      " 'endorsed by BMJ. BMJ disclaims all liability and responsibility arising from '\n",
      " 'any reliance placed on the content. Where the content includes any '\n",
      " 'translated material, BMJ does not warrant the accuracy and reliability of '\n",
      " 'the translations (including but not limited to local regulations, clinical '\n",
      " 'guidelines, terminology, drug names and drug dosages), and is not '\n",
      " 'responsible for any error and/or omissions arising from translation and '\n",
      " 'adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or '\n",
      " 'download the PDF:</h2><p><small><span class=\"online-issn issn\">Online ISSN: '\n",
      " '2044-6055</span><span class=\"print-issn issn\">Print ISSN: '\n",
      " '2044-6055</span></small><br>\\n'\n",
      " '        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights '\n",
      " 'reserved.</small></p>')\n"
     ]
    }
   ],
   "source": [
    "import scrapy\n",
    "from scrapy.crawler import CrawlerRunner\n",
    "from crochet import setup, wait_for\n",
    "setup()\n",
    "\n",
    "from pprint import pprint\n",
    "\n",
    "class myspider(scrapy.Spider):\n",
    "    name = \"myspider\"\n",
    "    \n",
    "    def start_requests(self):\n",
    "        urls = ['https://emails.bmj.com/q/1fnLH65XUsNn7Iiph6kELOM/wv']\n",
    "        for url in urls:\n",
    "            yield scrapy.Request(url=url, callback=self.parse_front)\n",
    "    \n",
    "    def parse_front(self, response):\n",
    "        self.article_title = response.css('a.art-title > font::text').extract()\n",
    "        article_url = response.xpath('//a[@class=\"art-title\"]/@href').extract()\n",
    "        # self.article_title = [response.css('a.art-title > font::text').extract_first()]\n",
    "        # article_url = [response.xpath('//a[@class=\"art-title\"]/@href').extract_first()]\n",
    "        for index, url in enumerate(article_url):\n",
    "            article_dict[index] = dict()\n",
    "            article_dict[index]['title'] = self.article_title[index]\n",
    "            article_dict[index]['url'] = url\n",
    "            yield response.follow(url=url, callback=self.parse_pages, cb_kwargs={'index': index})\n",
    "    \n",
    "    def parse_pages(self, response, index):\n",
    "        text = response.xpath('//h2|//p').extract()\n",
    "        article_dict[index]['text'] = ''.join([line for line in text])\n",
    "        \n",
    "@wait_for(10)\n",
    "def run_spider():\n",
    "    crawler = CrawlerRunner()\n",
    "    d = crawler.crawl(myspider)\n",
    "    return d\n",
    "\n",
    "\n",
    "iteration_id = 2\n",
    "main_dict = dict()\n",
    "article_dict = dict()\n",
    "\n",
    "run_spider()\n",
    "main_dict[iteration_id] = article_dict\n",
    "\n",
    "pprint(next(iter(article_dict.values()))['text'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ Journals\"><img src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ Journals\" alt=\"BMJ Journals\"></a></p><h2 class=\"pane-title\"><span class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h2 class=\"element-invisible\">You are here</h2><p><span class=\"icon-article-text\"></span>Article Text</p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" target=\"new\"><img alt=\"Download PDF\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img alt=\"Download PDF + Supplemental Data\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\\nSupplementary<br>\\nMaterial</strong></a></p><h2>Abstract</h2><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:\\xa0<a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 class=\"pane-title\">Statistics from Altmetric.com</h2><h2 class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5\\u2009hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6\\u2009hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95%\\u2009CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References</h2><h2 class=\"pane-title\">Supplementary materials</h2><h2>Supplementary Data</h2><p>This web only file has been produced by the BMJ Publishing Group from an electronic\\n               file supplied by the author(s) and has not been edited for content.\\n            </p><h2>Footnotes</h2><p id=\"p-41\"><span class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span class=\"fn-label\">Contributors</span> RZM and TK: conception and design of the work, analysis, drafting of the manuscript and final approval. YZ, AMK and AJD: analysis, design of the work and drafting of the manuscript and final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting of the work and final approval. All authors reviewed and contributed to the final version of this article.</p><p id=\"p-43\"><span class=\"fn-label\">Funding</span> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing interests</span> None declared.</p><p id=\"p-45\"><span class=\"fn-label\">Patient and public involvement</span> Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance and peer review</span> Not commissioned; externally peer reviewed.</p><p id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or download the PDF:</h2><p><small><span class=\"online-issn issn\">Online ISSN: 2044-6055</span><span class=\"print-issn issn\">Print ISSN: 2044-6055</span></small><br>\\n        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights reserved.</small></p>',\n",
       " '']"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_text = next(iter(article_dict.values()))['text']\n",
    "trim_text(test_text, regex)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ Journals\"><img src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ Journals\" alt=\"BMJ Journals\"></a></p><h2 class=\"pane-title\"><span class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h2 class=\"element-invisible\">You are here</h2><p><span class=\"icon-article-text\"></span>Article Text</p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" target=\"new\"><img alt=\"Download PDF\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img alt=\"Download PDF + Supplemental Data\" src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\n",
       "Supplementary<br>\n",
       "Material</strong></a></p><h2>Abstract</h2><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 class=\"pane-title\">Statistics from Altmetric.com</h2><h2 class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References</h2><h2 class=\"pane-title\">Supplementary materials</h2><h2>Supplementary Data</h2><p>This web only file has been produced by the BMJ Publishing Group from an electronic\n",
       "               file supplied by the author(s) and has not been edited for content.\n",
       "            </p><h2>Footnotes</h2><p id=\"p-41\"><span class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span class=\"fn-label\">Contributors</span> RZM and TK: conception and design of the work, analysis, drafting of the manuscript and final approval. YZ, AMK and AJD: analysis, design of the work and drafting of the manuscript and final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting of the work and final approval. All authors reviewed and contributed to the final version of this article.</p><p id=\"p-43\"><span class=\"fn-label\">Funding</span> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing interests</span> None declared.</p><p id=\"p-45\"><span class=\"fn-label\">Patient and public involvement</span> Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance and peer review</span> Not commissioned; externally peer reviewed.</p><p id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or download the PDF:</h2><p><small><span class=\"online-issn issn\">Online ISSN: 2044-6055</span><span class=\"print-issn issn\">Print ISSN: 2044-6055</span></small><br>\n",
       "        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights reserved.</small></p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "display.HTML(test_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://emails.bmj.com/c/1aDifdDrdRVuIA6ezO2vHCh8xqY4'"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "main_dict[iteration_id][0]['url']"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2.1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ '\n",
      " 'Journals\"><img '\n",
      " 'src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ '\n",
      " 'Journals\" alt=\"BMJ Journals\"></a></p><h3>Log in using your username and '\n",
      " 'password</h3><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h3>Log '\n",
      " 'in using your username and password</h3><h2 class=\"element-invisible\">You '\n",
      " 'are here</h2><p><span class=\"icon-article-text\"></span>Article Text</p><p><a '\n",
      " 'class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" '\n",
      " 'target=\"new\"><img alt=\"Download PDF\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a '\n",
      " 'class=\"article-pdf-download\" '\n",
      " 'href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img '\n",
      " 'alt=\"Download PDF + Supplemental Data\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\\n'\n",
      " 'Supplementary<br>\\n'\n",
      " 'Material</strong></a></p><h2>Abstract</h2><p '\n",
      " 'id=\"p-2\"><strong>Introduction</strong> Current published guidelines and '\n",
      " 'meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT '\n",
      " 'with bridging intravenous thrombolysis (IVT) suggest that EVT alone is '\n",
      " 'non-inferior to EVT with bridging thrombolysis in achieving favourable '\n",
      " 'functional outcome. Because of this controversy, we aimed to systematically '\n",
      " 'update the evidence and meta-analyse data from randomised trials comparing '\n",
      " 'EVT alone versus EVT with bridging thrombolysis, and performed an economic '\n",
      " 'evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and '\n",
      " 'analysis</strong> We will conduct a systematic review of randomised '\n",
      " 'controlled trials comparing EVT with or without bridging thrombolysis in '\n",
      " 'patients presenting with large vessel occlusions. We will identify eligible '\n",
      " 'studies by systematically searching the following databases from inception '\n",
      " 'without any language restrictions: MEDLINE (through Ovid), Embase and the '\n",
      " 'Cochrane Library. The following criteria will be used to assess eligibility '\n",
      " 'for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to '\n",
      " 'EVT alone or to EVT with IVT; and (3) measured outcomes, including '\n",
      " 'functional outcomes, at least 90 days after randomisation. Pairs of '\n",
      " 'reviewers will independently screen the identified articles, extract '\n",
      " 'information and assess the risk of bias of eligible studies. We will use the '\n",
      " 'Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the '\n",
      " 'Grading of Recommendations, Assessment, Development and Evaluation approach '\n",
      " 'to assess the certainty in evidence for each outcome. We will then perform '\n",
      " 'an economic evaluation based on the extracted data.</p><p '\n",
      " 'id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review '\n",
      " 'will not require a research ethics approval because no confidential patient '\n",
      " 'data will be used. We will disseminate our findings by publishing the '\n",
      " 'results in a peer-reviewed journal and via presentation at '\n",
      " 'conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> '\n",
      " 'CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in '\n",
      " 'accordance with the Creative Commons Attribution Non Commercial (CC BY-NC '\n",
      " '4.0) license, which permits others to distribute, remix, adapt, build upon '\n",
      " 'this work non-commercially, and license their derivative works on different '\n",
      " 'terms, provided the original work is properly cited, appropriate credit is '\n",
      " 'given, any changes made indicated, and the use is non-commercial. See:\\xa0<a '\n",
      " 'href=\"http://creativecommons.org/licenses/by-nc/4.0/\" '\n",
      " 'rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a '\n",
      " 'href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" '\n",
      " 'target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 '\n",
      " 'class=\"pane-title\">Statistics from Altmetric.com</h2><h2 '\n",
      " 'class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or '\n",
      " 'all of this article please use the link below which will take you to the '\n",
      " 'Copyright Clearance Center’s RightsLink service. You will be able to get a '\n",
      " 'quick price and instant permission to reuse the content in many different '\n",
      " 'ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" '\n",
      " 'data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><h3>Strengths '\n",
      " 'and limitations of this study</h3><p id=\"p-6\">The broad study eligibility '\n",
      " 'criteria will increase the generalisability of our results.</p><p '\n",
      " 'id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development '\n",
      " 'and Evaluation approach to assess the certainty in evidence for each '\n",
      " 'outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the '\n",
      " 'meta-analysed data to assess which treatment strategy is more '\n",
      " 'cost-effective, and we will rank the treatment strategies based on efficacy, '\n",
      " 'safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by '\n",
      " 'the primary data, for which careful appraisal of the study quality will be '\n",
      " 'carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous '\n",
      " 'thrombolysis (IVT) has been a long-standing, evidence-based treatment '\n",
      " 'approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5\\u2009hours, '\n",
      " 'has many contraindications, may not provide adequate reperfusion, especially '\n",
      " 'in patients with large vessel occlusions, and may even increase the risk of '\n",
      " 'intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of '\n",
      " 'endovascular therapy in patients with acute ischaemic stroke. The '\n",
      " 'Interventional Management of Stroke (IMS) III was a randomised controlled '\n",
      " 'trial (RCT) comparing endovascular therapy after IVT with IVT alone. '\n",
      " 'Endovascular therapy included a variety of techniques, such as mechanical '\n",
      " 'and aspiration thrombectomy, stent-retriever technology or intra-arterial '\n",
      " 'thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The '\n",
      " 'Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) '\n",
      " 'trial compared endovascular therapy, including intra-arterial thrombolysis, '\n",
      " 'clot disruption or retrieval or a combination of these approaches, with IVT '\n",
      " 'alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The '\n",
      " 'Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy '\n",
      " '(MR RESCUE) trial compared patients who underwent endovascular therapy alone '\n",
      " 'versus those who received standard care.<a id=\"xref-ref-6-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show '\n",
      " 'any benefit for endovascular therapy in acute ischaemic stroke. There were '\n",
      " 'several limitations in these trials, ranging from inconsistencies with '\n",
      " 'imaging selection, timing variables and device use.</p><p id=\"p-11\">Since '\n",
      " '2015, several RCTs have shown robust evidence supporting the use of '\n",
      " 'endovascular therapy in patients who present with an acute ischaemic stroke '\n",
      " 'secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or '\n",
      " 'proximal intracranial occlusions, the significant treatment effect of '\n",
      " 'endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible '\n",
      " 'patients with large vessel occlusions, the potential delaying effect of IVT '\n",
      " 'to initiation of EVT and its possible association with increased bleeding '\n",
      " 'events, many RCTs and post hoc analyses of RCTs have evaluated the safety '\n",
      " 'and efficacy of EVT alone versus bridging IVT prior to EVT in patients '\n",
      " 'presenting with acute ischaemic stroke secondary to a large vessel '\n",
      " 'occlusion, and have shown conflicting evidence whether EVT alone would be '\n",
      " 'non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke '\n",
      " 'Organisation (ESO)–European Society for Minimally Invasive Neurological '\n",
      " 'Therapy (ESMINT) guidelines found high quality of evidence recommending the '\n",
      " 'use of EVT and best medical management within 6\\u2009hours after symptom '\n",
      " 'onset, and moderate quality of evidence for use of EVT and best medical '\n",
      " 'management in patients presenting within the window of 6–24 hours.<a '\n",
      " 'id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT '\n",
      " 'guidelines published an expedited recommendation strongly recommending IVT '\n",
      " 'plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association '\n",
      " 'guidelines provided a class I recommendation for the use of IVT prior to EVT '\n",
      " 'in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic '\n",
      " 'reviews exploring the efficacy of bridging IVT prior to EVT compared with '\n",
      " 'EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; '\n",
      " 'however, they do not adequately assess risk of bias or the certainty of '\n",
      " 'evidence in each outcome, and vary in their study inclusion criteria and '\n",
      " 'methodology. A recently published systematic review and meta-analysis has '\n",
      " 'focused on comparing the two treatment strategies in patients presenting '\n",
      " 'with large vessel occlusions involving only the anterior circulation and has '\n",
      " 'assessed the certainty of evidence using the Grading of Recommendations, '\n",
      " 'Assessment, Development and Evaluation (GRADE) approach.<a '\n",
      " 'id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, '\n",
      " 'however, excludes patients with large vessel occlusions in the posterior '\n",
      " 'circulation. None of these systematic reviews consistently assessed the '\n",
      " 'overall certainty of evidence and conducted a cost-effectiveness analysis '\n",
      " 'comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to '\n",
      " 'conduct a systematic review and meta-analysis of randomised trials to assess '\n",
      " 'the comparative efficacy and safety of EVT alone versus IVT plus EVT for '\n",
      " 'patients with acute ischaemic stroke secondary to large vessel occlusion and '\n",
      " 'perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 '\n",
      " 'class=\"\">Methods and analysis</h2><h3>Standardised reporting and '\n",
      " 'registration</h3><p id=\"p-13\">We ensured our protocol was prepared in '\n",
      " 'accordance with the Preferred Reporting Items for Systematic Review and '\n",
      " 'Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-44\">44</a> This systematic review is registered with '\n",
      " 'International Prospective Register of Systematic Reviews (PROSPERO) '\n",
      " '(registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p '\n",
      " 'id=\"p-14\">We will include randomised trials meeting the following criteria: '\n",
      " '(1) enrolled adult patients ≥18 years old presenting with an acute ischaemic '\n",
      " 'stroke secondary to a large vessel occlusion, regardless of vessel involved, '\n",
      " 'and (2) randomised patients to undergo EVT alone or to receive IVT in '\n",
      " 'addition to EVT. We will include trials that permitted cointerventions (eg, '\n",
      " 'intra-arterial thrombolysis, rescue stenting) only if the same '\n",
      " 'cointerventions were used in patients from all study arms. <a '\n",
      " 'id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides '\n",
      " 'a more detailed representation of the inclusion and exclusion '\n",
      " 'criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion '\n",
      " 'criteria for study eligibility</p><h3>Data sources and search '\n",
      " 'strategy</h3><p id=\"p-25\">An information specialist (LH) developed the '\n",
      " 'search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" '\n",
      " 'href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" '\n",
      " 'class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix '\n",
      " '1</a>). We will conduct our searches systematically looking for eligible '\n",
      " 'studies in MEDLINE (through Ovid), Embase and the Cochrane Library from '\n",
      " 'inception without language restrictions. We will also review the reference '\n",
      " 'lists of included studies and relevant reviews to identify any additional '\n",
      " 'studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental '\n",
      " 'material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for '\n",
      " 'MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the '\n",
      " 'screening process, teams of two reviewers will participate in calibration '\n",
      " 'exercises. Following the calibration exercises, teams of two reviewers will '\n",
      " 'subsequently double screen the titles and abstracts of all identified '\n",
      " 'citations. These pairs of two reviewers will then retrieve and double screen '\n",
      " 'the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually '\n",
      " 'without the use of software applications. A third reviewer will resolve '\n",
      " 'disagreements if necessary. We will also contact study authors if reviewers '\n",
      " 'find any uncertainties limiting ability to discern study '\n",
      " 'eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a '\n",
      " 'standardised extraction form and a comprehensive instruction manual to '\n",
      " 'assist with data extraction. We will conduct calibration exercises prior to '\n",
      " 'the data extraction phase to ensure accuracy and consistency. Pairs of two '\n",
      " 'reviewers will subsequently extract data independently and review in '\n",
      " 'duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all '\n",
      " 'included studies: study characteristics (eg, author information, country of '\n",
      " 'origin and study design), patient characteristics (eg, sample size, age and '\n",
      " 'sex of patients, medical history, National Institute of Health Stroke Scale '\n",
      " 'score, the proportion for each vessel involved as well as determined stroke '\n",
      " 'aetiology), characteristics of interventions and comparators (eg, '\n",
      " 'intravenous thrombolytic agent used and respective dose and thrombectomy '\n",
      " 'device used) and treatment outcomes, including mortality, functional '\n",
      " 'independence, successful reperfusion, intracranial haemorrhage (including '\n",
      " 'symptomatic intracranial haemorrhage), and procedural complications and '\n",
      " 'other adverse events. Data will be abstracted into an Excel spreadsheeting '\n",
      " 'using Microsoft Office Excel V.2021. If there are any missing details, we '\n",
      " 'will contact the authors of included studies when applicable.</p><p '\n",
      " 'id=\"p-31\">We conducted a preliminary literature search of the databases, and '\n",
      " 'conclusion of the search suggests that there will be an estimate of six '\n",
      " 'studies eligible for this review.</p><h3>Risk of bias assessment</h3><p '\n",
      " 'id=\"p-32\">Pairs of reviewers will assess the risk of bias of included '\n",
      " 'studies independently and in duplicate using the revised Cochrane '\n",
      " 'Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater '\n",
      " 'reliability and other expected challenges, such as difficult terminology, by '\n",
      " 'training the reviewers to improve the reliability of RoB 2.<a '\n",
      " 'id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the '\n",
      " 'following criteria to assess risk of bias: randomisation process, deviations '\n",
      " 'from intended interventions, missing outcome data, measurement of the '\n",
      " 'outcome and selection of the reported result.<a id=\"xref-ref-47-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements '\n",
      " 'between reviewers through consensus and/or with the assistance of an '\n",
      " 'adjudicator. Risk of bias for included studies will be illustrated in '\n",
      " 'figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p '\n",
      " 'id=\"p-33\">We will group all outcomes reported by at least two studies for '\n",
      " 'direct comparison. We will standardise the definitions and measurements of '\n",
      " 'each outcome via consensus. We will conduct a meta-analysis of the outcomes '\n",
      " 'of interest when possible using the generic inverse variance method and '\n",
      " 'random effects analysis model via Review Manager V.5.4. We will use '\n",
      " 'Harbord’s test to assess small study effects for binary outcomes and Egger’s '\n",
      " 'test for continuous outcomes when there are at least 10 studies eligible for '\n",
      " 'quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-49\">49</a> When no meta-analysis could be performed due to '\n",
      " 'heterogeneity of the data, we will narratively synthesise the findings. For '\n",
      " 'dichotomous outcomes reported by at least one RCT, we will calculate the '\n",
      " 'relative risk (RR) using the crude event rate and the associated 95% CIs to '\n",
      " 'inform relative effectiveness. We will calculate risk difference based on '\n",
      " 'the RRs from our study and the baseline risks from a well-designed, '\n",
      " 'high-quality multicentre observational study of 6350 patients who had '\n",
      " 'ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, '\n",
      " 'we will calculate the weighted mean difference and associated 95%\\u2009CI. '\n",
      " 'When only median and range values are reported or when SD are not reported, '\n",
      " 'we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews '\n",
      " 'of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a '\n",
      " 'id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report '\n",
      " 'our synthesised findings as funnel plots to assess for asymmetry per outcome '\n",
      " 'of interest and will also estimate Egger’ test of the intercept to assess '\n",
      " 'for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will '\n",
      " 'evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q '\n",
      " 'test and I<sup>2</sup>. We will use the following a priori hypotheses to '\n",
      " 'explain heterogeneity between studies: (1) location of vessel involved (eg, '\n",
      " 'anterior circulation or posterior circulation) will show different treatment '\n",
      " 'effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) '\n",
      " 'high risk of bias studies will show larger treatment effects; and (3) type '\n",
      " 'of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will '\n",
      " 'perform subgroup analyses irrespective of the heterogeneity estimates as '\n",
      " 'long as there are at least two studies representing each '\n",
      " 'subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For '\n",
      " 'each outcome, we will assess the certainty of the evidence (as high, '\n",
      " 'moderate, low or very low) using the GRADE approach and developed GRADE '\n",
      " 'evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 '\n",
      " '56</a> We will use previously derived thresholds for the minimally important '\n",
      " 'difference for favourable functional outcome, mortality and symptomatic '\n",
      " 'intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a '\n",
      " 'id=\"xref-ref-57-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will '\n",
      " 'conduct a model-based cost–utility analysis to determine the '\n",
      " 'cost-effectiveness of EVT alone compared with IVT and EVT for patients with '\n",
      " 'an acute ischaemic stroke secondary to a large vessel occlusion. A Markov '\n",
      " 'decision analytical model with a lifetime horizon will be developed to '\n",
      " 'predict the long-term costs and health outcomes. We will conduct the '\n",
      " 'analysis from a healthcare perspective. We will base the clinical outcome '\n",
      " 'inputs from this systematic review. We will search literature for the '\n",
      " 'long-term clinical outcome inputs. From the healthcare perspective, we will '\n",
      " 'consider both medical costs (ie, costs related to patient care) and '\n",
      " 'non-medical costs (ie, overhead costs such as finance, human resources and '\n",
      " 'administration) that are incurred during treatment. The treatment costs come '\n",
      " 'from the administrative data of the University of Chicago Medical Center. '\n",
      " 'Other cost estimates (ie, health state-related costs) and utility inputs '\n",
      " 'will be based on literature.</p><h3>Patient and public involvement</h3><p '\n",
      " 'id=\"p-37\">Neither patients nor the public was involved in the '\n",
      " 'study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic '\n",
      " 'review will not require a research ethics approval because no confidential '\n",
      " 'patient data will be used. We will disseminate our findings by publishing '\n",
      " 'the results in a peer-reviewed journal and via presentation at '\n",
      " 'conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to '\n",
      " 'become a superior treatment modality compared with medical management alone '\n",
      " 'for the treatment of strokes secondary to large vessel occlusions, '\n",
      " 'particularly in the anterior circulation.<a id=\"xref-ref-58-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety '\n",
      " 'and efficacy of bridging IVT prior to thrombectomy remain to be the subject '\n",
      " 'of debate. A recent subgroup analysis showed that the effect of intravenous '\n",
      " 'alteplase prior to thrombectomy is not significantly associated with the '\n",
      " 'occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; '\n",
      " 'however, the trial for which this analysis was based included only '\n",
      " 'occlusions in the internal carotid and M1 or M2 branches of the middle '\n",
      " 'cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly '\n",
      " 'reviewed the combined the trial data from six RCTs and showed that EVT alone '\n",
      " 'is non-inferior to bridging therapy in achieving good functional outcomes at '\n",
      " '3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently '\n",
      " 'recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-23\">23–25</a> there is a need for a high-quality review to '\n",
      " 'provide a clinical summary of the efficacy and safety of mechanical '\n",
      " 'thrombectomy alone versus IVT prior to mechanical thrombectomy and to '\n",
      " 'balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many '\n",
      " 'strengths compared with existing reviews in the literature. First, we will '\n",
      " 'compare the efficacy and safety of mechanical thrombectomy alone versus '\n",
      " 'mechanical thrombectomy and bridging thrombolysis in studies that only '\n",
      " 'directly compare the two interventions strategies. Second, we will '\n",
      " 'investigate the effects of treatment across certain conditions. Third, we '\n",
      " 'will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias '\n",
      " 'and certainty of evidence, respectively, for each outcome. Lastly, this '\n",
      " 'study will be the first to use meta-analysed data to robustly perform an '\n",
      " 'economic evaluation comparing the two treatment strategies, integrate '\n",
      " 'clinical outcome inputs from study-level data and treatment cost inputs from '\n",
      " 'administrative data. Some potential limitations will include the following: '\n",
      " 'heterogeneity of outcome definitions and measurement, such as in the case of '\n",
      " 'symptomatic intracranial haemorrhage; cost estimation cannot assess for '\n",
      " 'lifetime cost as there are limited longitudinal data with respect to the '\n",
      " 'treatment strategies. The findings of our study will help inform providers '\n",
      " 'about the role of IVT in mechanical thrombectomy and identify key areas for '\n",
      " 'future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent '\n",
      " 'for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not '\n",
      " 'applicable.</p><h2 class=\"\">References</h2><h2 '\n",
      " 'class=\"pane-title\">Supplementary materials</h2><h2>Supplementary '\n",
      " 'Data</h2><p>This web only file has been produced by the BMJ Publishing Group '\n",
      " 'from an electronic\\n'\n",
      " '               file supplied by the author(s) and has not been edited for '\n",
      " 'content.\\n'\n",
      " '            </p><h2>Footnotes</h2><p id=\"p-41\"><span '\n",
      " 'class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span '\n",
      " 'class=\"fn-label\">Contributors</span> RZM and TK: conception and design of '\n",
      " 'the work, analysis, drafting of the manuscript and final approval. YZ, AMK '\n",
      " 'and AJD: analysis, design of the work and drafting of the manuscript and '\n",
      " 'final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of '\n",
      " 'the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting '\n",
      " 'of the work and final approval. All authors reviewed and contributed to the '\n",
      " 'final version of this article.</p><p id=\"p-43\"><span '\n",
      " 'class=\"fn-label\">Funding</span> The authors have not declared a specific '\n",
      " 'grant for this research from any funding agency in the public, commercial or '\n",
      " 'not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing '\n",
      " 'interests</span> None declared.</p><p id=\"p-45\"><span '\n",
      " 'class=\"fn-label\">Patient and public involvement</span> Patients and/or the '\n",
      " 'public were not involved in the design, conduct, reporting or dissemination '\n",
      " 'plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance '\n",
      " 'and peer review</span> Not commissioned; externally peer reviewed.</p><p '\n",
      " 'id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content '\n",
      " 'has been supplied by the author(s). It has not been vetted by BMJ Publishing '\n",
      " 'Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or '\n",
      " 'recommendations discussed are solely those of the author(s) and are not '\n",
      " 'endorsed by BMJ. BMJ disclaims all liability and responsibility arising from '\n",
      " 'any reliance placed on the content. Where the content includes any '\n",
      " 'translated material, BMJ does not warrant the accuracy and reliability of '\n",
      " 'the translations (including but not limited to local regulations, clinical '\n",
      " 'guidelines, terminology, drug names and drug dosages), and is not '\n",
      " 'responsible for any error and/or omissions arising from translation and '\n",
      " 'adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or '\n",
      " 'download the PDF:</h2><h3>Log in using your username and '\n",
      " 'password</h3><p><small><span class=\"online-issn issn\">Online ISSN: '\n",
      " '2044-6055</span><span class=\"print-issn issn\">Print ISSN: '\n",
      " '2044-6055</span></small><br>\\n'\n",
      " '        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights '\n",
      " 'reserved.</small></p>')\n"
     ]
    }
   ],
   "source": [
    "import scrapy\n",
    "from scrapy.crawler import CrawlerRunner\n",
    "from crochet import setup, wait_for\n",
    "setup()\n",
    "\n",
    "from pprint import pprint\n",
    "\n",
    "class myspider(scrapy.Spider):\n",
    "    name = \"myspider\"\n",
    "    \n",
    "    def start_requests(self):\n",
    "        urls = ['https://emails.bmj.com/q/1fnLH65XUsNn7Iiph6kELOM/wv']\n",
    "        for url in urls:\n",
    "            yield scrapy.Request(url=url, callback=self.parse_front)\n",
    "    \n",
    "    def parse_front(self, response):\n",
    "        # self.article_title = response.css('a.art-title > font::text').extract()\n",
    "        # article_url = response.xpath('//a[@class=\"art-title\"]/@href').extract()\n",
    "        self.article_title = [response.css('a.art-title > font::text').extract_first()]\n",
    "        article_url = [response.xpath('//a[@class=\"art-title\"]/@href').extract_first()]\n",
    "        for index, url in enumerate(article_url):\n",
    "            article_dict[index] = dict()\n",
    "            article_dict[index]['title'] = self.article_title[index]\n",
    "            article_dict[index]['url'] = url\n",
    "            yield response.follow(url=url, callback=self.parse_pages, cb_kwargs={'index': index})\n",
    "    \n",
    "    def parse_pages(self, response, index):\n",
    "        text = response.xpath('//h2|//p|//h3').extract()\n",
    "        article_dict[index]['text'] = ''.join([line for line in text])\n",
    "        \n",
    "@wait_for(10)\n",
    "def run_spider():\n",
    "    crawler = CrawlerRunner()\n",
    "    d = crawler.crawl(myspider)\n",
    "    return d\n",
    "\n",
    "\n",
    "iteration_id = 2.1\n",
    "# main_dict = dict()\n",
    "article_dict = dict()\n",
    "\n",
    "run_spider()\n",
    "main_dict[iteration_id] = article_dict\n",
    "\n",
    "pprint(next(iter(article_dict.values()))['text'])"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **2.2 This version of crawler"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('<p class=\"logo-bmj-journals\"><a href=\"http://journals.bmj.com/\" title=\"BMJ '\n",
      " 'Journals\"><img '\n",
      " 'src=\"/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg\" title=\"BMJ '\n",
      " 'Journals\" alt=\"BMJ Journals\"></a></p><h3>Log in using your username and '\n",
      " 'password</h3><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-search\"></span></h2><h2 class=\"pane-title\"><span '\n",
      " 'class=\"icon-menu\"></span></h2><h2 class=\"pane-title\">Main menu</h2><h3>Log '\n",
      " 'in using your username and password</h3><h2 class=\"element-invisible\">You '\n",
      " 'are here</h2><p><span class=\"icon-article-text\"></span>Article Text</p><p><a '\n",
      " 'class=\"article-pdf-download\" href=\"/content/bmjopen/13/6/e064322.full.pdf\" '\n",
      " 'target=\"new\"><img alt=\"Download PDF\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF</strong></a></p><p><a '\n",
      " 'class=\"article-pdf-download\" '\n",
      " 'href=\"/content/bmjopen/13/6/e064322.full.pdf?with-ds=yes\" target=\"new\"><img '\n",
      " 'alt=\"Download PDF + Supplemental Data\" '\n",
      " 'src=\"/sites/default/themes/bmjj/img/icon-pdf.png\"><strong>PDF +<br>\\n'\n",
      " 'Supplementary<br>\\n'\n",
      " 'Material</strong></a></p><h2>Abstract</h2><p '\n",
      " 'id=\"p-2\"><strong>Introduction</strong> Current published guidelines and '\n",
      " 'meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT '\n",
      " 'with bridging intravenous thrombolysis (IVT) suggest that EVT alone is '\n",
      " 'non-inferior to EVT with bridging thrombolysis in achieving favourable '\n",
      " 'functional outcome. Because of this controversy, we aimed to systematically '\n",
      " 'update the evidence and meta-analyse data from randomised trials comparing '\n",
      " 'EVT alone versus EVT with bridging thrombolysis, and performed an economic '\n",
      " 'evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and '\n",
      " 'analysis</strong> We will conduct a systematic review of randomised '\n",
      " 'controlled trials comparing EVT with or without bridging thrombolysis in '\n",
      " 'patients presenting with large vessel occlusions. We will identify eligible '\n",
      " 'studies by systematically searching the following databases from inception '\n",
      " 'without any language restrictions: MEDLINE (through Ovid), Embase and the '\n",
      " 'Cochrane Library. The following criteria will be used to assess eligibility '\n",
      " 'for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to '\n",
      " 'EVT alone or to EVT with IVT; and (3) measured outcomes, including '\n",
      " 'functional outcomes, at least 90 days after randomisation. Pairs of '\n",
      " 'reviewers will independently screen the identified articles, extract '\n",
      " 'information and assess the risk of bias of eligible studies. We will use the '\n",
      " 'Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the '\n",
      " 'Grading of Recommendations, Assessment, Development and Evaluation approach '\n",
      " 'to assess the certainty in evidence for each outcome. We will then perform '\n",
      " 'an economic evaluation based on the extracted data.</p><p '\n",
      " 'id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review '\n",
      " 'will not require a research ethics approval because no confidential patient '\n",
      " 'data will be used. We will disseminate our findings by publishing the '\n",
      " 'results in a peer-reviewed journal and via presentation at '\n",
      " 'conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> '\n",
      " 'CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in '\n",
      " 'accordance with the Creative Commons Attribution Non Commercial (CC BY-NC '\n",
      " '4.0) license, which permits others to distribute, remix, adapt, build upon '\n",
      " 'this work non-commercially, and license their derivative works on different '\n",
      " 'terms, provided the original work is properly cited, appropriate credit is '\n",
      " 'given, any changes made indicated, and the use is non-commercial. See:\\xa0<a '\n",
      " 'href=\"http://creativecommons.org/licenses/by-nc/4.0/\" '\n",
      " 'rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a '\n",
      " 'href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" '\n",
      " 'target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 '\n",
      " 'class=\"pane-title\">Statistics from Altmetric.com</h2><h2 '\n",
      " 'class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or '\n",
      " 'all of this article please use the link below which will take you to the '\n",
      " 'Copyright Clearance Center’s RightsLink service. You will be able to get a '\n",
      " 'quick price and instant permission to reuse the content in many different '\n",
      " 'ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" '\n",
      " 'data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><h3>Strengths '\n",
      " 'and limitations of this study</h3><p id=\"p-6\">The broad study eligibility '\n",
      " 'criteria will increase the generalisability of our results.</p><p '\n",
      " 'id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development '\n",
      " 'and Evaluation approach to assess the certainty in evidence for each '\n",
      " 'outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the '\n",
      " 'meta-analysed data to assess which treatment strategy is more '\n",
      " 'cost-effective, and we will rank the treatment strategies based on efficacy, '\n",
      " 'safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by '\n",
      " 'the primary data, for which careful appraisal of the study quality will be '\n",
      " 'carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous '\n",
      " 'thrombolysis (IVT) has been a long-standing, evidence-based treatment '\n",
      " 'approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5\\u2009hours, '\n",
      " 'has many contraindications, may not provide adequate reperfusion, especially '\n",
      " 'in patients with large vessel occlusions, and may even increase the risk of '\n",
      " 'intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of '\n",
      " 'endovascular therapy in patients with acute ischaemic stroke. The '\n",
      " 'Interventional Management of Stroke (IMS) III was a randomised controlled '\n",
      " 'trial (RCT) comparing endovascular therapy after IVT with IVT alone. '\n",
      " 'Endovascular therapy included a variety of techniques, such as mechanical '\n",
      " 'and aspiration thrombectomy, stent-retriever technology or intra-arterial '\n",
      " 'thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The '\n",
      " 'Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) '\n",
      " 'trial compared endovascular therapy, including intra-arterial thrombolysis, '\n",
      " 'clot disruption or retrieval or a combination of these approaches, with IVT '\n",
      " 'alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The '\n",
      " 'Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy '\n",
      " '(MR RESCUE) trial compared patients who underwent endovascular therapy alone '\n",
      " 'versus those who received standard care.<a id=\"xref-ref-6-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show '\n",
      " 'any benefit for endovascular therapy in acute ischaemic stroke. There were '\n",
      " 'several limitations in these trials, ranging from inconsistencies with '\n",
      " 'imaging selection, timing variables and device use.</p><p id=\"p-11\">Since '\n",
      " '2015, several RCTs have shown robust evidence supporting the use of '\n",
      " 'endovascular therapy in patients who present with an acute ischaemic stroke '\n",
      " 'secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or '\n",
      " 'proximal intracranial occlusions, the significant treatment effect of '\n",
      " 'endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible '\n",
      " 'patients with large vessel occlusions, the potential delaying effect of IVT '\n",
      " 'to initiation of EVT and its possible association with increased bleeding '\n",
      " 'events, many RCTs and post hoc analyses of RCTs have evaluated the safety '\n",
      " 'and efficacy of EVT alone versus bridging IVT prior to EVT in patients '\n",
      " 'presenting with acute ischaemic stroke secondary to a large vessel '\n",
      " 'occlusion, and have shown conflicting evidence whether EVT alone would be '\n",
      " 'non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke '\n",
      " 'Organisation (ESO)–European Society for Minimally Invasive Neurological '\n",
      " 'Therapy (ESMINT) guidelines found high quality of evidence recommending the '\n",
      " 'use of EVT and best medical management within 6\\u2009hours after symptom '\n",
      " 'onset, and moderate quality of evidence for use of EVT and best medical '\n",
      " 'management in patients presenting within the window of 6–24 hours.<a '\n",
      " 'id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT '\n",
      " 'guidelines published an expedited recommendation strongly recommending IVT '\n",
      " 'plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association '\n",
      " 'guidelines provided a class I recommendation for the use of IVT prior to EVT '\n",
      " 'in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic '\n",
      " 'reviews exploring the efficacy of bridging IVT prior to EVT compared with '\n",
      " 'EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; '\n",
      " 'however, they do not adequately assess risk of bias or the certainty of '\n",
      " 'evidence in each outcome, and vary in their study inclusion criteria and '\n",
      " 'methodology. A recently published systematic review and meta-analysis has '\n",
      " 'focused on comparing the two treatment strategies in patients presenting '\n",
      " 'with large vessel occlusions involving only the anterior circulation and has '\n",
      " 'assessed the certainty of evidence using the Grading of Recommendations, '\n",
      " 'Assessment, Development and Evaluation (GRADE) approach.<a '\n",
      " 'id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, '\n",
      " 'however, excludes patients with large vessel occlusions in the posterior '\n",
      " 'circulation. None of these systematic reviews consistently assessed the '\n",
      " 'overall certainty of evidence and conducted a cost-effectiveness analysis '\n",
      " 'comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to '\n",
      " 'conduct a systematic review and meta-analysis of randomised trials to assess '\n",
      " 'the comparative efficacy and safety of EVT alone versus IVT plus EVT for '\n",
      " 'patients with acute ischaemic stroke secondary to large vessel occlusion and '\n",
      " 'perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 '\n",
      " 'class=\"\">Methods and analysis</h2><h3>Standardised reporting and '\n",
      " 'registration</h3><p id=\"p-13\">We ensured our protocol was prepared in '\n",
      " 'accordance with the Preferred Reporting Items for Systematic Review and '\n",
      " 'Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-44\">44</a> This systematic review is registered with '\n",
      " 'International Prospective Register of Systematic Reviews (PROSPERO) '\n",
      " '(registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p '\n",
      " 'id=\"p-14\">We will include randomised trials meeting the following criteria: '\n",
      " '(1) enrolled adult patients ≥18 years old presenting with an acute ischaemic '\n",
      " 'stroke secondary to a large vessel occlusion, regardless of vessel involved, '\n",
      " 'and (2) randomised patients to undergo EVT alone or to receive IVT in '\n",
      " 'addition to EVT. We will include trials that permitted cointerventions (eg, '\n",
      " 'intra-arterial thrombolysis, rescue stenting) only if the same '\n",
      " 'cointerventions were used in patients from all study arms. <a '\n",
      " 'id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides '\n",
      " 'a more detailed representation of the inclusion and exclusion '\n",
      " 'criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion '\n",
      " 'criteria for study eligibility</p><h3>Data sources and search '\n",
      " 'strategy</h3><p id=\"p-25\">An information specialist (LH) developed the '\n",
      " 'search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" '\n",
      " 'href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" '\n",
      " 'class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix '\n",
      " '1</a>). We will conduct our searches systematically looking for eligible '\n",
      " 'studies in MEDLINE (through Ovid), Embase and the Cochrane Library from '\n",
      " 'inception without language restrictions. We will also review the reference '\n",
      " 'lists of included studies and relevant reviews to identify any additional '\n",
      " 'studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental '\n",
      " 'material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for '\n",
      " 'MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the '\n",
      " 'screening process, teams of two reviewers will participate in calibration '\n",
      " 'exercises. Following the calibration exercises, teams of two reviewers will '\n",
      " 'subsequently double screen the titles and abstracts of all identified '\n",
      " 'citations. These pairs of two reviewers will then retrieve and double screen '\n",
      " 'the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually '\n",
      " 'without the use of software applications. A third reviewer will resolve '\n",
      " 'disagreements if necessary. We will also contact study authors if reviewers '\n",
      " 'find any uncertainties limiting ability to discern study '\n",
      " 'eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a '\n",
      " 'standardised extraction form and a comprehensive instruction manual to '\n",
      " 'assist with data extraction. We will conduct calibration exercises prior to '\n",
      " 'the data extraction phase to ensure accuracy and consistency. Pairs of two '\n",
      " 'reviewers will subsequently extract data independently and review in '\n",
      " 'duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all '\n",
      " 'included studies: study characteristics (eg, author information, country of '\n",
      " 'origin and study design), patient characteristics (eg, sample size, age and '\n",
      " 'sex of patients, medical history, National Institute of Health Stroke Scale '\n",
      " 'score, the proportion for each vessel involved as well as determined stroke '\n",
      " 'aetiology), characteristics of interventions and comparators (eg, '\n",
      " 'intravenous thrombolytic agent used and respective dose and thrombectomy '\n",
      " 'device used) and treatment outcomes, including mortality, functional '\n",
      " 'independence, successful reperfusion, intracranial haemorrhage (including '\n",
      " 'symptomatic intracranial haemorrhage), and procedural complications and '\n",
      " 'other adverse events. Data will be abstracted into an Excel spreadsheeting '\n",
      " 'using Microsoft Office Excel V.2021. If there are any missing details, we '\n",
      " 'will contact the authors of included studies when applicable.</p><p '\n",
      " 'id=\"p-31\">We conducted a preliminary literature search of the databases, and '\n",
      " 'conclusion of the search suggests that there will be an estimate of six '\n",
      " 'studies eligible for this review.</p><h3>Risk of bias assessment</h3><p '\n",
      " 'id=\"p-32\">Pairs of reviewers will assess the risk of bias of included '\n",
      " 'studies independently and in duplicate using the revised Cochrane '\n",
      " 'Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater '\n",
      " 'reliability and other expected challenges, such as difficult terminology, by '\n",
      " 'training the reviewers to improve the reliability of RoB 2.<a '\n",
      " 'id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the '\n",
      " 'following criteria to assess risk of bias: randomisation process, deviations '\n",
      " 'from intended interventions, missing outcome data, measurement of the '\n",
      " 'outcome and selection of the reported result.<a id=\"xref-ref-47-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements '\n",
      " 'between reviewers through consensus and/or with the assistance of an '\n",
      " 'adjudicator. Risk of bias for included studies will be illustrated in '\n",
      " 'figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p '\n",
      " 'id=\"p-33\">We will group all outcomes reported by at least two studies for '\n",
      " 'direct comparison. We will standardise the definitions and measurements of '\n",
      " 'each outcome via consensus. We will conduct a meta-analysis of the outcomes '\n",
      " 'of interest when possible using the generic inverse variance method and '\n",
      " 'random effects analysis model via Review Manager V.5.4. We will use '\n",
      " 'Harbord’s test to assess small study effects for binary outcomes and Egger’s '\n",
      " 'test for continuous outcomes when there are at least 10 studies eligible for '\n",
      " 'quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-49\">49</a> When no meta-analysis could be performed due to '\n",
      " 'heterogeneity of the data, we will narratively synthesise the findings. For '\n",
      " 'dichotomous outcomes reported by at least one RCT, we will calculate the '\n",
      " 'relative risk (RR) using the crude event rate and the associated 95% CIs to '\n",
      " 'inform relative effectiveness. We will calculate risk difference based on '\n",
      " 'the RRs from our study and the baseline risks from a well-designed, '\n",
      " 'high-quality multicentre observational study of 6350 patients who had '\n",
      " 'ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, '\n",
      " 'we will calculate the weighted mean difference and associated 95%\\u2009CI. '\n",
      " 'When only median and range values are reported or when SD are not reported, '\n",
      " 'we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews '\n",
      " 'of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a '\n",
      " 'id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report '\n",
      " 'our synthesised findings as funnel plots to assess for asymmetry per outcome '\n",
      " 'of interest and will also estimate Egger’ test of the intercept to assess '\n",
      " 'for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will '\n",
      " 'evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q '\n",
      " 'test and I<sup>2</sup>. We will use the following a priori hypotheses to '\n",
      " 'explain heterogeneity between studies: (1) location of vessel involved (eg, '\n",
      " 'anterior circulation or posterior circulation) will show different treatment '\n",
      " 'effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) '\n",
      " 'high risk of bias studies will show larger treatment effects; and (3) type '\n",
      " 'of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will '\n",
      " 'perform subgroup analyses irrespective of the heterogeneity estimates as '\n",
      " 'long as there are at least two studies representing each '\n",
      " 'subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For '\n",
      " 'each outcome, we will assess the certainty of the evidence (as high, '\n",
      " 'moderate, low or very low) using the GRADE approach and developed GRADE '\n",
      " 'evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 '\n",
      " '56</a> We will use previously derived thresholds for the minimally important '\n",
      " 'difference for favourable functional outcome, mortality and symptomatic '\n",
      " 'intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a '\n",
      " 'id=\"xref-ref-57-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will '\n",
      " 'conduct a model-based cost–utility analysis to determine the '\n",
      " 'cost-effectiveness of EVT alone compared with IVT and EVT for patients with '\n",
      " 'an acute ischaemic stroke secondary to a large vessel occlusion. A Markov '\n",
      " 'decision analytical model with a lifetime horizon will be developed to '\n",
      " 'predict the long-term costs and health outcomes. We will conduct the '\n",
      " 'analysis from a healthcare perspective. We will base the clinical outcome '\n",
      " 'inputs from this systematic review. We will search literature for the '\n",
      " 'long-term clinical outcome inputs. From the healthcare perspective, we will '\n",
      " 'consider both medical costs (ie, costs related to patient care) and '\n",
      " 'non-medical costs (ie, overhead costs such as finance, human resources and '\n",
      " 'administration) that are incurred during treatment. The treatment costs come '\n",
      " 'from the administrative data of the University of Chicago Medical Center. '\n",
      " 'Other cost estimates (ie, health state-related costs) and utility inputs '\n",
      " 'will be based on literature.</p><h3>Patient and public involvement</h3><p '\n",
      " 'id=\"p-37\">Neither patients nor the public was involved in the '\n",
      " 'study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic '\n",
      " 'review will not require a research ethics approval because no confidential '\n",
      " 'patient data will be used. We will disseminate our findings by publishing '\n",
      " 'the results in a peer-reviewed journal and via presentation at '\n",
      " 'conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to '\n",
      " 'become a superior treatment modality compared with medical management alone '\n",
      " 'for the treatment of strokes secondary to large vessel occlusions, '\n",
      " 'particularly in the anterior circulation.<a id=\"xref-ref-58-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety '\n",
      " 'and efficacy of bridging IVT prior to thrombectomy remain to be the subject '\n",
      " 'of debate. A recent subgroup analysis showed that the effect of intravenous '\n",
      " 'alteplase prior to thrombectomy is not significantly associated with the '\n",
      " 'occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; '\n",
      " 'however, the trial for which this analysis was based included only '\n",
      " 'occlusions in the internal carotid and M1 or M2 branches of the middle '\n",
      " 'cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly '\n",
      " 'reviewed the combined the trial data from six RCTs and showed that EVT alone '\n",
      " 'is non-inferior to bridging therapy in achieving good functional outcomes at '\n",
      " '3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" '\n",
      " 'class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently '\n",
      " 'recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" '\n",
      " 'href=\"#ref-23\">23–25</a> there is a need for a high-quality review to '\n",
      " 'provide a clinical summary of the efficacy and safety of mechanical '\n",
      " 'thrombectomy alone versus IVT prior to mechanical thrombectomy and to '\n",
      " 'balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many '\n",
      " 'strengths compared with existing reviews in the literature. First, we will '\n",
      " 'compare the efficacy and safety of mechanical thrombectomy alone versus '\n",
      " 'mechanical thrombectomy and bridging thrombolysis in studies that only '\n",
      " 'directly compare the two interventions strategies. Second, we will '\n",
      " 'investigate the effects of treatment across certain conditions. Third, we '\n",
      " 'will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias '\n",
      " 'and certainty of evidence, respectively, for each outcome. Lastly, this '\n",
      " 'study will be the first to use meta-analysed data to robustly perform an '\n",
      " 'economic evaluation comparing the two treatment strategies, integrate '\n",
      " 'clinical outcome inputs from study-level data and treatment cost inputs from '\n",
      " 'administrative data. Some potential limitations will include the following: '\n",
      " 'heterogeneity of outcome definitions and measurement, such as in the case of '\n",
      " 'symptomatic intracranial haemorrhage; cost estimation cannot assess for '\n",
      " 'lifetime cost as there are limited longitudinal data with respect to the '\n",
      " 'treatment strategies. The findings of our study will help inform providers '\n",
      " 'about the role of IVT in mechanical thrombectomy and identify key areas for '\n",
      " 'future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent '\n",
      " 'for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not '\n",
      " 'applicable.</p><h2 class=\"\">References</h2><h2 '\n",
      " 'class=\"pane-title\">Supplementary materials</h2><h2>Supplementary '\n",
      " 'Data</h2><p>This web only file has been produced by the BMJ Publishing Group '\n",
      " 'from an electronic\\n'\n",
      " '               file supplied by the author(s) and has not been edited for '\n",
      " 'content.\\n'\n",
      " '            </p><h2>Footnotes</h2><p id=\"p-41\"><span '\n",
      " 'class=\"fn-label\">Twitter</span> @LHneiny</p><p id=\"p-42\"><span '\n",
      " 'class=\"fn-label\">Contributors</span> RZM and TK: conception and design of '\n",
      " 'the work, analysis, drafting of the manuscript and final approval. YZ, AMK '\n",
      " 'and AJD: analysis, design of the work and drafting of the manuscript and '\n",
      " 'final approval. JC-P, HD, ET, SK, AT and RB: data collection. LH: design of '\n",
      " 'the work and final approval. ST, EC, JRB, SM, AM and SP: analysis, drafting '\n",
      " 'of the work and final approval. All authors reviewed and contributed to the '\n",
      " 'final version of this article.</p><p id=\"p-43\"><span '\n",
      " 'class=\"fn-label\">Funding</span> The authors have not declared a specific '\n",
      " 'grant for this research from any funding agency in the public, commercial or '\n",
      " 'not-for-profit sectors.</p><p id=\"p-44\"><span class=\"fn-label\">Competing '\n",
      " 'interests</span> None declared.</p><p id=\"p-45\"><span '\n",
      " 'class=\"fn-label\">Patient and public involvement</span> Patients and/or the '\n",
      " 'public were not involved in the design, conduct, reporting or dissemination '\n",
      " 'plans of this research.</p><p id=\"p-46\"><span class=\"fn-label\">Provenance '\n",
      " 'and peer review</span> Not commissioned; externally peer reviewed.</p><p '\n",
      " 'id=\"p-47\"><span class=\"fn-label\">Supplemental material</span> This content '\n",
      " 'has been supplied by the author(s). It has not been vetted by BMJ Publishing '\n",
      " 'Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or '\n",
      " 'recommendations discussed are solely those of the author(s) and are not '\n",
      " 'endorsed by BMJ. BMJ disclaims all liability and responsibility arising from '\n",
      " 'any reliance placed on the content. Where the content includes any '\n",
      " 'translated material, BMJ does not warrant the accuracy and reliability of '\n",
      " 'the translations (including but not limited to local regulations, clinical '\n",
      " 'guidelines, terminology, drug names and drug dosages), and is not '\n",
      " 'responsible for any error and/or omissions arising from translation and '\n",
      " 'adaptation or otherwise.</p><h2 class=\"pane-title\">Read the full text or '\n",
      " 'download the PDF:</h2><h3>Log in using your username and '\n",
      " 'password</h3><p><small><span class=\"online-issn issn\">Online ISSN: '\n",
      " '2044-6055</span><span class=\"print-issn issn\">Print ISSN: '\n",
      " '2044-6055</span></small><br>\\n'\n",
      " '        <small>Copyright © 2023 BMJ Publishing Group Ltd. All rights '\n",
      " 'reserved.</small></p>')\n"
     ]
    }
   ],
   "source": [
    "import scrapy\n",
    "from scrapy.crawler import CrawlerRunner\n",
    "from crochet import setup, wait_for\n",
    "setup()\n",
    "\n",
    "from pprint import pprint\n",
    "\n",
    "class myspider(scrapy.Spider):\n",
    "    name = \"myspider\"\n",
    "    \n",
    "    def start_requests(self):\n",
    "        urls = ['https://emails.bmj.com/q/1fnLH65XUsNn7Iiph6kELOM/wv']\n",
    "        for url in urls:\n",
    "            yield scrapy.Request(url=url, callback=self.parse_front)\n",
    "    \n",
    "    def parse_front(self, response):\n",
    "        # self.article_title = response.css('a.art-title > font::text').extract()\n",
    "        # article_url = response.xpath('//a[@class=\"art-title\"]/@href').extract()\n",
    "        self.article_title = [response.css('a.art-title > font::text').extract_first()]\n",
    "        article_url = [response.xpath('//a[@class=\"art-title\"]/@href').extract_first()]\n",
    "        for index, url in enumerate(article_url):\n",
    "            article_dict[index] = dict()\n",
    "            article_dict[index]['title'] = self.article_title[index]\n",
    "            article_dict[index]['url'] = url\n",
    "            yield response.follow(url=url, callback=self.parse_pages, cb_kwargs={'index': index})\n",
    "    \n",
    "    def parse_pages(self, response, index):\n",
    "        text = response.xpath('//h2|//p|//h3|//h4').extract()\n",
    "        article_dict[index]['text'] = ''.join([line for line in text])\n",
    "        \n",
    "@wait_for(10)\n",
    "def run_spider():\n",
    "    crawler = CrawlerRunner()\n",
    "    d = crawler.crawl(myspider)\n",
    "    return d\n",
    "\n",
    "\n",
    "iteration_id = 2.1\n",
    "# main_dict = dict()\n",
    "article_dict = dict()\n",
    "\n",
    "run_spider()\n",
    "main_dict[iteration_id] = article_dict\n",
    "\n",
    "pprint(next(iter(article_dict.values()))['text'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Abstract</h2><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 class=\"pane-title\">Statistics from Altmetric.com</h2><h2 class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><h3>Strengths and limitations of this study</h3><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References<"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "regex = r'.*(<h2>Abstract</h2>.*References<).*'\n",
    "trim_text(next(iter(article_dict.values()))['text'], regex=regex)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Update `text_dict_from_web` function to trim text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys([0])"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "article_dict.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys([0])"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "texts.keys()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Regex 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "text_dict keys: [0]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<h2>Abstract</h2><p id=\"p-2\"><strong>Introduction</strong> Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in achieving favourable functional outcome. Because of this controversy, we aimed to systematically update the evidence and meta-analyse data from randomised trials comparing EVT alone versus EVT with bridging thrombolysis, and performed an economic evaluation comparing both strategies.</p><p id=\"p-3\"><strong>Methods and analysis</strong> We will conduct a systematic review of randomised controlled trials comparing EVT with or without bridging thrombolysis in patients presenting with large vessel occlusions. We will identify eligible studies by systematically searching the following databases from inception without any language restrictions: MEDLINE (through Ovid), Embase and the Cochrane Library. The following criteria will be used to assess eligibility for inclusion: (1) adult patients ≥18 years old; (2) randomised patients to EVT alone or to EVT with IVT; and (3) measured outcomes, including functional outcomes, at least 90 days after randomisation. Pairs of reviewers will independently screen the identified articles, extract information and assess the risk of bias of eligible studies. We will use the Cochrane Risk-of-Bias tool to evaluate risk of bias. We will also use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome. We will then perform an economic evaluation based on the extracted data.</p><p id=\"p-4\"><strong>Ethics and dissemination</strong> This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><p id=\"p-5\"><strong>PROSPERO registration number</strong> CRD42022315608.</p><p id=\"p-1\">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href=\"http://creativecommons.org/licenses/by-nc/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p><p><a href=\"http://dx.doi.org/10.1136/bmjopen-2022-064322\" target=\"_new\">http://dx.doi.org/10.1136/bmjopen-2022-064322</a></p><h2 class=\"pane-title\">Statistics from Altmetric.com</h2><h2 class=\"pane-title\">Request Permissions</h2><p>If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.</p><h2 class=\"pane-title\"><span class=\"panels-ajax-pane-title\" data-pid=\"new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\"></span></h2><h3>Strengths and limitations of this study</h3><p id=\"p-6\">The broad study eligibility criteria will increase the generalisability of our results.</p><p id=\"p-7\">We will use the Grading of Recommendations, Assessment, Development and Evaluation approach to assess the certainty in evidence for each outcome.</p><p id=\"p-8\">We will perform an economic evaluation based on the meta-analysed data to assess which treatment strategy is more cost-effective, and we will rank the treatment strategies based on efficacy, safety and cost-effectiveness.</p><p id=\"p-9\">Our results will be limited by the primary data, for which careful appraisal of the study quality will be carried out.</p><h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References<"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "from IPython import display\n",
    "def trim_text(text, regex=r'(.*)'):\n",
    "    processed = re.findall(regex, text, re.DOTALL)\n",
    "    return processed, display.HTML(processed[0])\n",
    "    \n",
    "def text_dict_from_web(article_dict, regex=r'(.*)', to_display=0):\n",
    "    \"\"\"\n",
    "    Create a text dictionary from a dictionary containing web-scraped articles.\n",
    "\n",
    "    Parameters:\n",
    "        article_dict (dict): Values of each dictionary item are a dictionary representing the data from a \n",
    "            single article: 'url', 'text', and 'title'.\n",
    "\n",
    "    Returns:\n",
    "        text_dict: Dictionary where each item is a string of the text of an article, starting with the title.\n",
    "    \"\"\"\n",
    "    text_dict = dict()\n",
    "    display_dict = dict()\n",
    "    to_display = [to_display] if type(to_display) != list else display\n",
    "    for article_key in article_dict:\n",
    "        # print(f'Article key: {article_key}')\n",
    "        trimmed_text, display = trim_text(article_dict[article_key]['text'], regex)\n",
    "        text_dict[article_key] = f\"{article_dict[article_key]['title']}\\n\\n{trimmed_text}\"\n",
    "        if article_key in to_display:\n",
    "            display_dict[article_key] = display\n",
    "    print(f'text_dict keys: {[key for key in text_dict.keys()]}')\n",
    "    return text_dict, display\n",
    "    \n",
    "regex = r'.*(<h2>Abstract</h2>.*References<).*'\n",
    "text_id = 2\n",
    "texts[text_id], display = text_dict_from_web(article_dict, regex=regex, to_display=0)\n",
    "display"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Regex 2 Trim away the Abstract"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "text_dict keys: [0]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References<"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "from IPython import display\n",
    "def trim_text(text, regex=r'(.*)'):\n",
    "    processed = re.findall(regex, text, re.DOTALL)\n",
    "    return processed, display.HTML(processed[0])\n",
    "    \n",
    "def text_dict_from_web(article_dict, regex=r'(.*)', to_display=0):\n",
    "    \"\"\"\n",
    "    Create a text dictionary from a dictionary containing web-scraped articles.\n",
    "\n",
    "    Parameters:\n",
    "        article_dict (dict): Values of each dictionary item are a dictionary representing the data from a \n",
    "            single article: 'url', 'text', and 'title'.\n",
    "\n",
    "    Returns:\n",
    "        text_dict: Dictionary where each item is a string of the text of an article, starting with the title.\n",
    "    \"\"\"\n",
    "    text_dict = dict()\n",
    "    display_dict = dict()\n",
    "    to_display = [to_display] if type(to_display) != list else display\n",
    "    for article_key in article_dict:\n",
    "        # print(f'Article key: {article_key}')\n",
    "        trimmed_text, display = trim_text(article_dict[article_key]['text'], regex)\n",
    "        text_dict[article_key] = f\"{article_dict[article_key]['title']}\\n\\n{trimmed_text}\"\n",
    "        if article_key in to_display:\n",
    "            display_dict[article_key] = display\n",
    "    print(f'text_dict keys: {[key for key in text_dict.keys()]}')\n",
    "    return text_dict, display\n",
    "    \n",
    "regex = r'.*<h2>Abstract</h2>.*(?:Introduction)?.*<h2.*?>(Introduction</h2>.*References<).*'\n",
    "text_id = 2\n",
    "texts[text_id], display = text_dict_from_web(article_dict, regex=regex, to_display=0)\n",
    "display"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Regex 3 use any header"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "text_dict keys: [0]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5 hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6 hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95% CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "from IPython import display\n",
    "def trim_text(text, regex=r'(.*)'):\n",
    "    processed = re.findall(regex, text, re.DOTALL)\n",
    "    return processed, display.HTML(processed[0])\n",
    "    \n",
    "def text_dict_from_web(article_dict, regex=r'(.*)', to_display=0):\n",
    "    \"\"\"\n",
    "    Create a text dictionary from a dictionary containing web-scraped articles.\n",
    "\n",
    "    Parameters:\n",
    "        article_dict (dict): Values of each dictionary item are a dictionary representing the data from a \n",
    "            single article: 'url', 'text', and 'title'.\n",
    "\n",
    "    Returns:\n",
    "        text_dict: Dictionary where each item is a string of the text of an article, starting with the title.\n",
    "    \"\"\"\n",
    "    text_dict = dict()\n",
    "    display_dict = dict()\n",
    "    to_display = [to_display] if type(to_display) != list else display\n",
    "    for article_key in article_dict:\n",
    "        # print(f'Article key: {article_key}')\n",
    "        trimmed_text, display = trim_text(article_dict[article_key]['text'], regex)\n",
    "        text_dict[article_key] = f\"{article_dict[article_key]['title']}\\n\\n{trimmed_text}\"\n",
    "        if article_key in to_display:\n",
    "            display_dict[article_key] = display\n",
    "    print(f'text_dict keys: {[key for key in text_dict.keys()]}')\n",
    "    return text_dict, display\n",
    "    \n",
    "regex = r'.*<h\\d>Abstract</h\\d>.*(?:Introduction)?.*(<h\\d.*?>Introduction</h\\d>.*References)<.*'\n",
    "text_id = 2\n",
    "texts[text_id], display = text_dict_from_web(article_dict, regex=regex, to_display=0)\n",
    "display"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'str'>\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'Endovascular thrombectomy with or without thrombolysis bridging in patients with acute ischaemic stroke: protocol for a systematic review, meta-analysis of randomised trials and cost-effectiveness analysis\\n\\n[\\'<h2 class=\"\">Introduction</h2><p id=\"p-10\">Intravenous thrombolysis (IVT) has been a long-standing, evidence-based treatment approach for acute ischaemic stroke.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"#ref-1\">1 2</a> However, IVT must be delivered within 4.5\\\\u2009hours, has many contraindications, may not provide adequate reperfusion, especially in patients with large vessel occlusions, and may even increase the risk of intracranial haemorrhage.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"#ref-3\">3</a> As such, trials were conducted to evaluate the use of endovascular therapy in patients with acute ischaemic stroke. The Interventional Management of Stroke (IMS) III was a randomised controlled trial (RCT) comparing endovascular therapy after IVT with IVT alone. Endovascular therapy included a variety of techniques, such as mechanical and aspiration thrombectomy, stent-retriever technology or intra-arterial thrombolysis.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"#ref-4\">4</a> The Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS) trial compared endovascular therapy, including intra-arterial thrombolysis, clot disruption or retrieval or a combination of these approaches, with IVT alone.<a id=\"xref-ref-5-1\" class=\"xref-bibr\" href=\"#ref-5\">5</a> The Mechanical Retrieval and Recanalisation of Stroke Clots Using Embolectomy (MR RESCUE) trial compared patients who underwent endovascular therapy alone versus those who received standard care.<a id=\"xref-ref-6-1\" class=\"xref-bibr\" href=\"#ref-6\">6</a> These three RCTs all failed to show any benefit for endovascular therapy in acute ischaemic stroke. There were several limitations in these trials, ranging from inconsistencies with imaging selection, timing variables and device use.</p><p id=\"p-11\">Since 2015, several RCTs have shown robust evidence supporting the use of endovascular therapy in patients who present with an acute ischaemic stroke secondary to a large vessel occlusion.<a id=\"xref-ref-7-1\" class=\"xref-bibr\" href=\"#ref-7\">7–16</a> Because IVT does not adequately recanalise large or proximal intracranial occlusions, the significant treatment effect of endovascular thrombectomy (EVT) in both IVT-eligible and IVT-ineligible patients with large vessel occlusions, the potential delaying effect of IVT to initiation of EVT and its possible association with increased bleeding events, many RCTs and post hoc analyses of RCTs have evaluated the safety and efficacy of EVT alone versus bridging IVT prior to EVT in patients presenting with acute ischaemic stroke secondary to a large vessel occlusion, and have shown conflicting evidence whether EVT alone would be non-inferior to EVT with pretreatment IVT.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"#ref-17\">17–22</a> The 2019 European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines found high quality of evidence recommending the use of EVT and best medical management within 6\\\\u2009hours after symptom onset, and moderate quality of evidence for use of EVT and best medical management in patients presenting within the window of 6–24 hours.<a id=\"xref-ref-23-1\" class=\"xref-bibr\" href=\"#ref-23\">23</a> The ESO-ESMINT guidelines published an expedited recommendation strongly recommending IVT plus EVT over EVT alone.<a id=\"xref-ref-24-1\" class=\"xref-bibr\" href=\"#ref-24\">24</a> Similarly, the 2019 American Heart Association guidelines provided a class I recommendation for the use of IVT prior to EVT in IVT-eligible patients.<a id=\"xref-ref-25-1\" class=\"xref-bibr\" href=\"#ref-25\">25</a></p><p id=\"p-12\">There are several published systematic reviews exploring the efficacy of bridging IVT prior to EVT compared with EVT alone<a id=\"xref-ref-26-1\" class=\"xref-bibr\" href=\"#ref-26\">26–42</a>; however, they do not adequately assess risk of bias or the certainty of evidence in each outcome, and vary in their study inclusion criteria and methodology. A recently published systematic review and meta-analysis has focused on comparing the two treatment strategies in patients presenting with large vessel occlusions involving only the anterior circulation and has assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<a id=\"xref-ref-43-1\" class=\"xref-bibr\" href=\"#ref-43\">43</a> This review, however, excludes patients with large vessel occlusions in the posterior circulation. None of these systematic reviews consistently assessed the overall certainty of evidence and conducted a cost-effectiveness analysis comparing bridging IVT prior to EVT versus EVT alone. Thus, we propose to conduct a systematic review and meta-analysis of randomised trials to assess the comparative efficacy and safety of EVT alone versus IVT plus EVT for patients with acute ischaemic stroke secondary to large vessel occlusion and perform a cost-effectiveness analysis using the meta-analysed data.</p><h2 class=\"\">Methods and analysis</h2><h3>Standardised reporting and registration</h3><p id=\"p-13\">We ensured our protocol was prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols checklist.<a id=\"xref-ref-44-1\" class=\"xref-bibr\" href=\"#ref-44\">44</a> This systematic review is registered with International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42022315608).</p><h3>Eligibility criteria</h3><p id=\"p-14\">We will include randomised trials meeting the following criteria: (1) enrolled adult patients ≥18 years old presenting with an acute ischaemic stroke secondary to a large vessel occlusion, regardless of vessel involved, and (2) randomised patients to undergo EVT alone or to receive IVT in addition to EVT. We will include trials that permitted cointerventions (eg, intra-arterial thrombolysis, rescue stenting) only if the same cointerventions were used in patients from all study arms. <a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"#T1\">Table 1</a> provides a more detailed representation of the inclusion and exclusion criteria.</p><p id=\"p-15\" class=\"first-child\">Inclusion and exclusion criteria for study eligibility</p><h3>Data sources and search strategy</h3><p id=\"p-25\">An information specialist (LH) developed the search strategy for the databases (<a id=\"xref-fig-1-1\" class=\"xref-fig\" href=\"#F1\">figure 1</a>, <a id=\"xref-supplementary-material-1-1\" class=\"xref-supplementary-material\" href=\"#DC1\">online supplemental appendix 1</a>). We will conduct our searches systematically looking for eligible studies in MEDLINE (through Ovid), Embase and the Cochrane Library from inception without language restrictions. We will also review the reference lists of included studies and relevant reviews to identify any additional studies meeting the eligibility criteria.</p><h3 class=\"\">Supplemental material</h3><p id=\"p-27\" class=\"first-child\">Sample search algorithm for MEDLINE(through Ovid).</p><h3>Study selection</h3><p id=\"p-28\">Prior to the screening process, teams of two reviewers will participate in calibration exercises. Following the calibration exercises, teams of two reviewers will subsequently double screen the titles and abstracts of all identified citations. These pairs of two reviewers will then retrieve and double screen the full texts of all citations for eligibility.<a id=\"xref-ref-45-1\" class=\"xref-bibr\" href=\"#ref-45\">45</a> Screening will be done manually without the use of software applications. A third reviewer will resolve disagreements if necessary. We will also contact study authors if reviewers find any uncertainties limiting ability to discern study eligibility.</p><h3>Data extraction</h3><p id=\"p-29\">We designed a standardised extraction form and a comprehensive instruction manual to assist with data extraction. We will conduct calibration exercises prior to the data extraction phase to ensure accuracy and consistency. Pairs of two reviewers will subsequently extract data independently and review in duplicate.</p><p id=\"p-30\">Reviewers will extract the following data for all included studies: study characteristics (eg, author information, country of origin and study design), patient characteristics (eg, sample size, age and sex of patients, medical history, National Institute of Health Stroke Scale score, the proportion for each vessel involved as well as determined stroke aetiology), characteristics of interventions and comparators (eg, intravenous thrombolytic agent used and respective dose and thrombectomy device used) and treatment outcomes, including mortality, functional independence, successful reperfusion, intracranial haemorrhage (including symptomatic intracranial haemorrhage), and procedural complications and other adverse events. Data will be abstracted into an Excel spreadsheeting using Microsoft Office Excel V.2021. If there are any missing details, we will contact the authors of included studies when applicable.</p><p id=\"p-31\">We conducted a preliminary literature search of the databases, and conclusion of the search suggests that there will be an estimate of six studies eligible for this review.</p><h3>Risk of bias assessment</h3><p id=\"p-32\">Pairs of reviewers will assess the risk of bias of included studies independently and in duplicate using the revised Cochrane Risk-of-Bias V.2 (RoB 2) tool. We will address concerns for low interrater reliability and other expected challenges, such as difficult terminology, by training the reviewers to improve the reliability of RoB 2.<a id=\"xref-ref-46-1\" class=\"xref-bibr\" href=\"#ref-46\">46</a> We will use the following criteria to assess risk of bias: randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result.<a id=\"xref-ref-47-1\" class=\"xref-bibr\" href=\"#ref-47\">47</a> We will resolve any disagreements between reviewers through consensus and/or with the assistance of an adjudicator. Risk of bias for included studies will be illustrated in figures produced by Risk-of-bias Visualization.<a id=\"xref-ref-48-1\" class=\"xref-bibr\" href=\"#ref-48\">48</a></p><h3>Data synthesis</h3><p id=\"p-33\">We will group all outcomes reported by at least two studies for direct comparison. We will standardise the definitions and measurements of each outcome via consensus. We will conduct a meta-analysis of the outcomes of interest when possible using the generic inverse variance method and random effects analysis model via Review Manager V.5.4. We will use Harbord’s test to assess small study effects for binary outcomes and Egger’s test for continuous outcomes when there are at least 10 studies eligible for quantitative assessment.<a id=\"xref-ref-49-1\" class=\"xref-bibr\" href=\"#ref-49\">49</a> When no meta-analysis could be performed due to heterogeneity of the data, we will narratively synthesise the findings. For dichotomous outcomes reported by at least one RCT, we will calculate the relative risk (RR) using the crude event rate and the associated 95% CIs to inform relative effectiveness. We will calculate risk difference based on the RRs from our study and the baseline risks from a well-designed, high-quality multicentre observational study of 6350 patients who had ischaemic stroke.<a id=\"xref-ref-50-1\" class=\"xref-bibr\" href=\"#ref-50\">50</a> For continuous outcomes reported by at least one RCT, we will calculate the weighted mean difference and associated 95%\\\\u2009CI. When only median and range values are reported or when SD are not reported, we will use methods outlined in <em>Cochrane Handbook for Systematic Reviews of Interventions</em> and by Wan <em>et al</em> to estimate means and SD.<a id=\"xref-ref-51-1\" class=\"xref-bibr\" href=\"#ref-51\">51 52</a> We will report our synthesised findings as funnel plots to assess for asymmetry per outcome of interest and will also estimate Egger’ test of the intercept to assess for publication bias.<a id=\"xref-ref-53-1\" class=\"xref-bibr\" href=\"#ref-53\">53</a></p><h3>Subgroup analysis</h3><p id=\"p-34\">We will evaluate statistical heterogeneity using inconsistency measures, Cochran’s Q test and I<sup>2</sup>. We will use the following a priori hypotheses to explain heterogeneity between studies: (1) location of vessel involved (eg, anterior circulation or posterior circulation) will show different treatment effects<a id=\"xref-ref-54-1\" class=\"xref-bibr\" href=\"#ref-54\">54</a>; (2) high risk of bias studies will show larger treatment effects; and (3) type of thrombectomy devices used (eg, stent retriever, aspiration, etc). We will perform subgroup analyses irrespective of the heterogeneity estimates as long as there are at least two studies representing each subgroup.</p><h3>Assessing certainty of the evidence</h3><p id=\"p-35\">For each outcome, we will assess the certainty of the evidence (as high, moderate, low or very low) using the GRADE approach and developed GRADE evidence profiles.<a id=\"xref-ref-55-1\" class=\"xref-bibr\" href=\"#ref-55\">55 56</a> We will use previously derived thresholds for the minimally important difference for favourable functional outcome, mortality and symptomatic intracranial hemorrhage (sICH), adapted from Wang and colleagues.<a id=\"xref-ref-57-1\" class=\"xref-bibr\" href=\"#ref-57\">57</a></p><h3>Cost–utility analysis</h3><p id=\"p-36\">We will conduct a model-based cost–utility analysis to determine the cost-effectiveness of EVT alone compared with IVT and EVT for patients with an acute ischaemic stroke secondary to a large vessel occlusion. A Markov decision analytical model with a lifetime horizon will be developed to predict the long-term costs and health outcomes. We will conduct the analysis from a healthcare perspective. We will base the clinical outcome inputs from this systematic review. We will search literature for the long-term clinical outcome inputs. From the healthcare perspective, we will consider both medical costs (ie, costs related to patient care) and non-medical costs (ie, overhead costs such as finance, human resources and administration) that are incurred during treatment. The treatment costs come from the administrative data of the University of Chicago Medical Center. Other cost estimates (ie, health state-related costs) and utility inputs will be based on literature.</p><h3>Patient and public involvement</h3><p id=\"p-37\">Neither patients nor the public was involved in the study.</p><h3>Ethics and dissemination</h3><p id=\"p-38\">This systematic review will not require a research ethics approval because no confidential patient data will be used. We will disseminate our findings by publishing the results in a peer-reviewed journal and via presentation at conferences.</p><h2 class=\"\">Discussion</h2><p id=\"p-39\">EVT has emerged to become a superior treatment modality compared with medical management alone for the treatment of strokes secondary to large vessel occlusions, particularly in the anterior circulation.<a id=\"xref-ref-58-1\" class=\"xref-bibr\" href=\"#ref-58\">58</a> However, controversies in the safety and efficacy of bridging IVT prior to thrombectomy remain to be the subject of debate. A recent subgroup analysis showed that the effect of intravenous alteplase prior to thrombectomy is not significantly associated with the occlusion site<a id=\"xref-ref-59-1\" class=\"xref-bibr\" href=\"#ref-59\">59</a>; however, the trial for which this analysis was based included only occlusions in the internal carotid and M1 or M2 branches of the middle cerebral artery.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"#ref-21\">21</a> An editorial by Podlasek and colleagues briefly reviewed the combined the trial data from six RCTs and showed that EVT alone is non-inferior to bridging therapy in achieving good functional outcomes at 3 months with a 6% margin of confidence.<a id=\"xref-ref-60-1\" class=\"xref-bibr\" href=\"#ref-60\">60</a> While most guidelines currently recommend IVT prior to thrombectomy,<a id=\"xref-ref-23-2\" class=\"xref-bibr\" href=\"#ref-23\">23–25</a> there is a need for a high-quality review to provide a clinical summary of the efficacy and safety of mechanical thrombectomy alone versus IVT prior to mechanical thrombectomy and to balance those outcomes with cost.</p><p id=\"p-40\">Our study will have many strengths compared with existing reviews in the literature. First, we will compare the efficacy and safety of mechanical thrombectomy alone versus mechanical thrombectomy and bridging thrombolysis in studies that only directly compare the two interventions strategies. Second, we will investigate the effects of treatment across certain conditions. Third, we will apply the RoB 2 tool and GRADE approach to evaluate the risk of bias and certainty of evidence, respectively, for each outcome. Lastly, this study will be the first to use meta-analysed data to robustly perform an economic evaluation comparing the two treatment strategies, integrate clinical outcome inputs from study-level data and treatment cost inputs from administrative data. Some potential limitations will include the following: heterogeneity of outcome definitions and measurement, such as in the case of symptomatic intracranial haemorrhage; cost estimation cannot assess for lifetime cost as there are limited longitudinal data with respect to the treatment strategies. The findings of our study will help inform providers about the role of IVT in mechanical thrombectomy and identify key areas for future research.</p><h2 class=\"\">Ethics statements</h2><h3>Patient consent for publication</h3><p id=\"p-48\" class=\"ethics-consent-to-publish\">Not applicable.</p><h2 class=\"\">References\\']'"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(type(texts[text_id][0]))\n",
    "texts[text_id][0]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# *End of Page*"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.9.13 64-bit",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "11938c6bc6919ae2720b4d5011047913343b08a43b18698fd82dedb0d4417594"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
